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ABSTRACT 
 This thesis presents the design and synthesis of [2]pseudorotaxane and 
[2]rotaxane ligands and their incorporation into Metal Organic Polygons to form Metal 
Organic Rotaxane Polygons.  Chapter 1 introduces the concepts of supramolecular 
chemistry and coordination-driven self-assembly, as well as interpenetrated and 
interlocked molecules and discrete self-assembled architectures with definitions and 
representative examples from the literature.   
Chapter 2 presents the incorporation of the bis(pyridinium)ethane/24-crown-8 
macrocycle recognition motif into molecular squares and molecular necklaces.  It 
describes the synthesis as well as characterization by means of 1D 1H, 13C, and 31P NMR 
of a series of molecular polygons incorporating a [2]pseudorotaxane as well as the 
analogous naked axle ligand.  Where possible the single crystal X-ray data is presented, 
where unavailable structure elucidation was via DOSY NMR. 
Chapter 3 builds upon chapter 2 with the synthesis of an interlocked [2]rotaxane 
and matching axle intended for incorporation into molecular polygons.  Both resulting 
supramolecular assemblies we successfully crystallized and characterized using single 
crystal X-ray structure elucidation, and the results confirmed with DOSY NMR.  The 
highlight of this chapter is the single crystal structure of a novel triangular molecular 
necklace. 
In chapter 4 a more rigid and compact [2]rotaxane is synthesized to prevent the 
formation of triangular molecular necklaces during self-assembly.  The accompanying 
axle was also synthesized for comparison.  Two supramolecular assemblies are presented.  
Abstract 
 
vii 
The [2] rotaxane lived up to its design, forming an interpenetrated, catenated square 
molecular necklace instead of the triangular version as was desired. 
Chapter 5 presents the synthesis of a novel unsymmetrical [2]rotaxane and its free 
axle analogue, designed to result in the synthesis of M2L4 molecular cages when 
combined with naked Pd(II) anions.  The design, synthesis, and characterization of the 
two ligands, as well as efforts toward incorporation into supramolecular assemblies is 
presented. 
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CHAPTER 1 
 
Introduction 
 
1.1 SUPRAMOLECULAR CHEMISTRY 
1.1.1 Origin of Supramolecular Chemistry 
Supramolecular chemistry is the “chemistry beyond the molecule” as defined by 
Jean-Marie Lehn.1  It an interdisciplinary field concerned with the chemical and physical 
properties of chemical species that are organized and held together by intermolecular or 
non-covalent interactions.2  The field started with the pioneering work of Pedersen, 
Cram, and Lehn, who were jointly awarded “for their development and use of molecules 
with structure-specific interactions of high selectivity” the Nobel Prize in Chemistry in 
1987.3  Pederson’s contribution was the discovery of crown ethers and their complexation 
of alkali metal and other cations.4  The first discovered crown ether, dibenzo[l8]crown-6 
(DB18C6, Figure 1.1) was the first neutral synthetic compound capable of binding alkali 
metal cations.5   
 
Figure 1.1 – Pederson’s first crown ether, DB18C6 (left),5 Lehn’s [2.2.2]cryptand 
(middle),7,8 and Cram’s spherand (right).10,11 
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Inspired by the work of Pederson, Lehn6 extended the concept into the third 
dimension with the synthesis of cryptands.7,8  Noting that both the above systems require 
host reorganization upon complexation, Cram9 designed a molecule with permanent 
cavity, which he named a spherand.10,11 
1.1.2 Non-Covalent Interactions 
Whereas molecular chemistry is the chemistry of individual molecules connected 
through covalent bonds ranging in strength from as low as 151 kJ/mol (I-I) to as high as 
570 kJ/mol (H-F) for single bonds,12 supramolecular chemistry is the chemistry of 
molecules connected through any of a number of intermolecular interactions.  It is the 
cooperation of these generally weaker intermolecular or non-covalent interactions that 
gives supramolecular complexes their overall stability.  Some intermolecular interactions 
are directional, useful for controlling the geometry of supramolecular assemblies while 
others that are nondirectional influence the relative distances and orientations in 
supramolecular assemblies.13  Table 1.1 lists the intermolecular forces encountered in the 
assemblies presented in this thesis, their directionality and their bond energies.  
Table 1.1 – Supramolecular Interactions.14 
Interaction Directionality Energy (kJ/mol) 
Ion-ion Nondirectional 100-350 
van der Waals Nondirectional <5 
Ion-dipole Slightly directional 50-200 
Dipole-dipole Slightly directional 5-50 
Coordination bonds Directional 100-300 
Hydrogen Bonds Directional 4-120 
π-π interactions Directional 2-50 
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 Ion-ion and van der Waals forces are both nondirectional, with the first being a 
strong interaction, and the latter weak.  Ion-ion interactions govern the lattice structures 
of simple inorganic salts, while van der Waals forces are at their most influential in the 
solid state (crystal packing).  Ion-dipole and dipole-dipole are two closely related 
intermolecular forces that result from the electrostatic interaction between an ion and 
neutral molecule with a dipole or between two molecules that each have a dipole.  
Dipole-dipole interactions are weak to moderate, while ion-dipole interactions are 
intermediate to strong.  The slight directionality arises from the anisotropic or somewhat 
directional nature of dipoles.  An example of a dipole-dipole interaction is the 
interactions between highly polar molecules where the positive end of one molecule will 
be attracted to the negative end of another.  An ion-dipole interaction occurs when the 
negative end of a polar molecule is attracted to a cation such as the solvation of a metal 
cation, or vice versa.13 
 The last three supramolecular interactions listed in Table 1.1, all directional, play 
the most important roles in the assemblies presented in this thesis.  Hydrogen bonding is 
highly directional and can vary in strength from weak to strong.  Hydrogen bond donors 
are groups where a hydrogen atom is covalently bonded to a more electronegative atom, 
leaving the proton partially unshielded.  Hydrogen bond acceptors are molecules with 
lone pairs of electrons.  H-bonds are generally denoted as AH···B.  When both A and B 
are fairly electronegative the resulting hydrogen bond is “conventional” or strong (ex. 
NH···O).  Conversely, when A and B are only weakly electronegative the hydrogen bond 
is “nonconventional” or weak (ex. CH···O).13 
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 There are three variations of π-π interactions as illustrated in Figure 2.2.  The 
face-to-face parallel and offset parallel are applicable to the assemblies presented in this 
thesis, the edge-to-face variation was not encountered in this work.  
 
Figure 1.2 – The three different types of π-π interaction: face-to-face parallel (left), 
offset parallel (middle), and edge-to-face (right).13 
 
 Coordination bonds are both directional and strong interactions and so have been 
widely applied in supramolecular chemistry.  Labile coordination bonds are especially 
useful as their reversible nature allows a supramolecular structure to form a stable and 
thermodynamically favored product after a series of error corrections.13 
1.1.3 Self-Assembly 
 Self-assembly has been defined as “the spontaneous assembly of molecules into 
structured, stable, noncovalently joined aggregates” by George Whitesides.15  
Self-assembly is driven by non-covalent interactions, in particular by hydrogen bonds and 
coordination bonds, and form aggregates that represent the thermodynamically most 
favored structure which preserves the structural integrity of self-assembled aggregates 
after formation.  It is reversible which allows mismatches and mistakes to be excluded 
from the final structure by means of self-correction.13,16 
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1.2 SUPRAMOLECULAR COORDINATION COMPLEXES 
 Self-assembled coordination complexes are discrete constructs in which organic 
ligand edges or faces are connected by metal ion vertices to form polyhedral 
architectures.  The directional nature of coordination bonds allows for the dependable and 
expedient design of supramolecular polygons and polyhedra, many of which possess 
large and stable internal cavities capable of encapsulating one or more guests.16,17  The 
earliest examples were M2L2 metallacycles (Figure 1.3).   
 
Figure 1.3 – Van Koten’s M2L2 metallacycle (left),18 and Maverick’s M2L2 
metallacycle with DABCO guest (right).19 
 
 Van Koten and coworkers discovered that the combination of a ligand containing 
two bidentate coordinating sites with either Cu(I) or Ag(I) leads to the formation of a 
dimeric metallacycle.18  Maverick et al. discovered the first example of the self-assembly 
of an artificial host-guest coordination system.19  Their system consisted of two bis(β-
diketone) ligands with aromatic cores and two Cu(II) centers that self-assembles into an 
M2L2 metallacycle.  The naphthylene spacered analogue exhibited high binding affinities 
for diamines.  
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1.2.1 Bidentate Pyridine Donor Ligands and Cis-Protected Metal Corners 
  A few years later Fujita et al. reported the synthesis of an M4L4 “molecular 
square” by means of the combination of linear `bidentate ligand, 4,4’bipyridine, as the 
edge unit, and cis-protected [cis-Pd(en)]2+ as the corner unit (Figure 1.4).20  This was the 
first example of a palladium(II)-driven self-assembly, as well as the first polygon 
self-assembly.  The square, hydrophobic, π-electron walled cavity showed affinity for 
neutral organic guests in a water solution.    
 
Figure 1.4 – Fujita’s M4L4 molecular square.20 
 
 Stang and coworkers followed up with the syntheses of molecular squares that are 
soluble in organic solvents using the same 4,4’bipyridine linear ligand and a series of 
phosphine-based cis-protected palladium(II) and platinum(II) corner units (Figure 1.5).21  
This was followed by molecular squares using planar aromatic as well as nitrile-based 
linkers,22 chiral corners,23 crown-ether and calixarene-based corners,24 a bimetallic 
ferrocene-containing corner,25 and porphyrin-based linkers.26,27  
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Figure 1.5 – Stang’s Pd(II) and Pt(II) molecular squares.21 
 
Other researchers have published molecular squares that are fluorescent or light-
harvesting,28,29 contain extended alkyne-based,30 fluorinated,31 or chiral ligands,32,33 or 
corners with lipophilic appendages.34 
The use of longer linear dipyridyl ligands result in the formation of the M4L4 
molecular square in equilibrium with M3L3 molecular triangles (Figure 1.6).35  The M4L4 
square dominates at higher concentration while at lower concentrations the M3L3 triangle 
becomes more abundant.  Increasing the length of the ligand also favors the formation of 
the triangle.   
 
Figure 1.6 – M4L4 molecular square in equilibrium with M3L3 molecular triangle.35 
Introduction 
 
8 
The M4L4 square is strainless and is enthalpically more favorable, whereas the 
M3L3 triangle has strain, but is entropically favored since it assembles from fewer 
components.  In addition to concentration, and ligand length and flexibility, the 
equilibrium between assemblies has also been found to be affected by the temperature, 
polarity of solvent, steric demand of the cis-protecting unit on the corner, steric demand 
of linker appendages, and host-guest interactions. 
M3L3 triangles only occur fairly rarely not in equilibrium with a molecular square 
or other oligomer.  Puddephatt and coworkers utilized an unsymmetrical flexible amide-
based ligand and the more sterically demanding [Pd(tBu2bipy)] cis-protected corner to 
produces the molecular triangle exclusively (Figure 1.7).36  The amide-moieties of 
adjacent triangles hydrogen bond in the solid state forming stacked pairs. 
 
Figure 1.7 – Puddephatts’s M3L3 molecular triangle.36 
 
A detailed study of M3L3 triangle/M4L4 square equilibria of assemblies using 
both the platinum(II) and palladium(II) versions of the [M(dppp)]2+ corner was 
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undertaken by Schalley et al.37  Their results indicate that for both Pd(II) and Pt(II) 
assemblies the interconversion between triangles and squares in dimethylformamide is 
slow on the NMR timescale at room temp, and while the Pd(II) interconversion became 
fast on the NMR timescale above ~325 K, the Pt(II) interconversion stayed slow up to 
353 K.  This indicates that the equilibration is faster for Pd(II) than Pt(II) assemblies, a 
result that is in agreement with the relative kinetic stabilities/labilities of the two metal 
centers.   
 
Figure 1.8 – M4L4 molecular square in equilibrium with M3L3 molecular triangle.37 
 
A thermodynamic analysis of the [Pt(dppp)]2+ corner in combination with the 
second ligand illustrated in Figure 1.8,  indicated that the enthalpy for the interconversion 
of three M4L4 squares into four M3L3 triangles is positive (ΔHeq = 35.1 kJ/mol) as would 
be expected when taking the strain in the triangle structure into account.  The entropy is 
large and positive (ΔSeq = 113 J mol-1K-1) reflecting the entropic favourability of forming 
a larger number of molecules from the same number of components.  Thus, at high 
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temperatures the entropic contribution becomes dominant.  A concentration study using 
both the Pd(II) and Pt(II) corners in combination with the same ligand as utilized in the 
thermodynamic analysis found that at low concentrations (2.5 mM) the M3L3 triangle 
dominates, while at higher concentration (20 mM) the M4L4 square becomes more 
abundant.  This agrees with the results of the Fujita group discussed above. 
An examination of the influence of solvent polarity on the equilibrium reveals that 
the addition of a nonpolar solvent to a polar aprotic solvent solution shifts the equilibrium 
in favor the formation of the M3L3 triangles.  It was also found that for the systems in this 
study crystallization favors the M3L3 triangle.  Based on this study it is concluded that for 
the formation of exclusively M4L4 squares, the choice of bidentate dipyridyl-based ligand 
is limited to those that are not significantly longer than the original 4,4’-bipyridine linker.  
The formation of larger M4L4 squares requires a strategy that takes the rigidity 
requirements to prevent triangle formation into account. 
The use of a very flexible or bent dipyridine ligand with a cis-protected corner 
unit results in the synthesis of an M2L2 metallacycle as first reported by Fujita et al. 
(Figure 1.9).38   
 
Figure 1.9 – Fujita’s M2L2 metallacycles.38 
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The first basic metallacycle was too small for even solvent or nitrate anions to fit 
in the cavity, but the metallacycle formed from the tetrafluorophenylene-based ligand 
showed a high ability for molecular recognition of aromatic electron-rich compounds.    
A related ligand, 1,4-bis[(4-pyridyl)methyl]benzene, also results in the synthesis 
of an M2L2 metallacycle, which was shown to be in equilibrium with the [2]catenane that 
results from the interpenetration of two metallacycles (Figure 1.10).39  At low 
concentrations the equilibrium lies toward the free metallacycle, while the interlocked 
[2]catenane is the dominant species at higher concentrations. 
 
Figure 1.10 – An M2L2 metallacycle in equilibrium with a [2]catenane.39 
 
Numerous flexible or bent linkers have since been shown to self-assemble into 
M2L2 metallacycles in combination with a cis-protected metal fragment,40 including 
iodonium-containing,23,25,41,42 chiral,43,44 imidazole-donor,45 porphyrin-based,27 
cyclophane-containing,46 and anthracene- and ferrocene-containing ligands.47  An 
N-heterocyclic carbene containing corner has also been reported.48  M2L2 metallacycles 
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have shown recognition for a variety of guests, including aromatic anions,43 gas 
adsorption in the solid state,49 and the sensing of inorganic anions.47 
A sufficiently flexible and long ligand results in a mononuclear M1L1 complex 
when combined with a cis-protected metal corner which is in equilibrium with the 
[2]catenane that results from interpenetration under aqueous conditions (Figure 1.11).50   
 
Figure 1.11 – M1L1 metallacycle in equilibrium with a [2]catenane.50 
 
The equilibrium can be biased towards the [2]catenane by increasing the ratio of 
water in the solvent mixture which indicates that the catenation is driven by a 
hydrophobic effect.  The equilibrium was also dependent upon concentration, at lower 
concentration the M1L1 complex was favored, whereas at higher concentration the 
[2]catenane species was dominant.  The same study also included similar M1L1 
complexes formed from a tetrafluoro-substituted version of the ligand, as well as a chiral 
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cis-protected Pd(II) corner.  A similar M1L1 complex has also been shown to act as the 
wheel component of a [2]rotaxane.51 
1.2.2 Higher Denticity Ligands and Cis-Protected Metal Corners 
 Tridentate ligands in combination with 90 metal vertices give rise to either M3L2 
or M6L4 assemblies.  Fujita and coworkers synthesized an M3L2 cage from the [Pd(en)] 
corner unit and 1,3,5-tris(4-pyridy1methyl)benzene as the tridentate ligand, as illustrated 
in Figure 1.12.52  Interestingly, the cage only assembles in high yields in the presence of 
specific guests, otherwise oligomeric mixtures are obtained. 
 
Figure 1.12 – Synthesis of an M3L2 cage.52 
 
 
Figure 1.13 – Synthesis of an M6L4 cage.53 
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The same group also synthesized an M6L4 cage using a more rigid tridentate 
ligand as illustrated in Figure 1.13.53  Each ligands acts as a panel, forming an octahedron 
where half the faces are uncovered, with tetrahedral symmetry.  The cage is highly water 
soluble due to the 12+ total charge contributed by the metal centers, and therefore 
encapsulates neutral organic molecules within its hydrophobic cavity in water solution. 
 
 
Figure 1.14 – Synthesis of an M4L2 capsule with a tetradentate ligand.54 
 
An extended flexible tetradentate ligand such as the porphyrin-based ligand in 
Figure 1.14 gives rise to an M4L2 capsule, with the ligands taking on a bowl-like shape.  
This capsule was shown to encapsulate 4,4’-trimethylenedipyridine.54 
The more compact rigid tetradentate porphyrin ligand shown in Figure 1.15 forms 
an M6L3 prism, with each ligand acting as a panel and the top and bottom of the prism 
open.55 
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Figure 1.15 – Synthesis of an M6L3 molecular prism.55 
 
A similarly sized and shaped 3,5-bis-(3-pyridyl)phenyl-based tetradentate ligand 
formed the M8L4 molecular box instead (Figure 1.16).56  Each ligand again acts as a 
panel with the top and bottom of the box open.  This M8L4 molecular box can be 
converted into the analogous M6L3 prism by the addition of biphenyl as a template.   
 
Figure 1.16 – Synthesis of an M8L4 molecular box.56 
 
A few examples exist for even higher denticity ligands and their self-assembly 
into cage-like structures.  Fujita et al. utilized the exo-hexadentate ligand, 
1,3,5-tris(3,5-pyrimidyl)benzene,  which  in  combination  with  the  [Pd(en)]  corner  unit  
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Figure 1.17 – Synthesis of an M18L6 trigonal bipyramid.57 
 
 
Figure 1.18 – Synthesis of M6L2 sandwich.58 
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assembles into an M18L6 hexahedral capsule, in a trigonal bipyramidal configuration.57  
The ligands again act as panels, covering all six faces in this example (Figure 1.17). 
The extended exo-hexadentate ligand illustrated in Figure 1.18 in combination 
with the [Pd(en)] corner and a guest of D3h symmetry self-assembles into an M6L2 
sandwich like structure.58  When the guest is absent a less distorted, unsymmetrical, 
tetrameric M12L4 complex is formed instead.  
1.2.3 Assemblies With Naked Pd(II) Ions and Bidentate Pyridyl Ligands 
 The use of naked palladium(II) ions in combination with various pyridyl-based 
ligands has exploded in popularity in the last decade and there are now more examples 
than can be adequately covered in the space available in this introductory chapter.  
Therefore only one of the best examples, elegant in its simplicity, and the source of 
“great esthetic pleasure” as eloquently phrased by Pedersen in his Nobel Prize Lecture,4 
will be discussed.  
 The Fujita group have systematically investigated the assembly of a series of 
spherical complexes using simple bent bidentate ligands and square planar Pd(II) ions.16  
Depending on the bend angle of the ligand (Figure 1.19), M6L12, M12L24, and M24L48 
spheres, have been obtained.   
 
Figure 1.19 – Bent Ligands for synthesis of spheres with Pd(II) cations.59-62 
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Figure 1.20 – An M6L12 cube (top left), and M12L24 (top right) and M24L48 (bottom) 
spheres.59-62 
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 A ligand with a 90 angle produced an M6L12 cube as illustrated in the top left of 
Figure 1.20,59 while ligands with angles 120 - 130 produced M12L24 spheres (Figure 
1.20 top right).60  To produce M24L48 spheres, ligands with angles 135-150 are 
employed (Figure 1.20 bottom).61,62   
 The simplicity of the design allows the modification of these spheres for 
numerous applications simply by attaching desired functional group to the future exo- or 
endohedral side of the ligand before self-assembly.  Fujita and coworkers have used this 
strategy in the use of their M12L24 sphere to create pseudo-poly(ethylene oxide) 
nanoparticles,63 fluorous “droplets” that dissolved fluoroalkanes in a polar organic 
solution,64 and poly(methyl methacrylate) nanoparticles,65 form aggregates with 
proteins,66 create monodisperse silica nanoparticles,67 inverse dendrimers,68 a smaller 
M12L24 sphere inside of a larger M12L24 sphere,69 and an M18L24 cuboctahedron,70 
encapsulated a protein within the M12L24 sphere,71 control the size, mass, and density of 
titanium dioxide nanoparticles,72 and more.73,74 
1.3 INTERPENETRATED AND INTERLOCKED MOLECULES 
 The second main category of supramolecular chemistry in conjunction with self-
assembly is that of host-guest chemistry, which includes the concept of molecular 
recognition through non-covalent interactions.  One important class of host-guest 
complexes are the interpenetrated complexes termed pseudorotaxanes and the related 
interlocked rotaxanes and catenanes. 
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1.3.1 Pseudorotaxanes and Rotaxanes 
 Pseudorotaxanes are supramolecular host-guest complexes where a macrocyclic 
“wheel” with a large enough cavity to accommodate a linear “axle”, are interpenetrated, 
held together by means of non-covalent interactions, but free to dissociate (Figure 1.21).  
A wide range of non-covalent interactions have been used in the template-directed 
synthesis of pseudorotaxanes and rotaxanes including hydrogen bonding, the 
hydrophobic effect, aromatic π-π interactions, and metal-ligand coordination. 
 
Figure 1.21 – [2]Pseudorotaxane formation from linear axle and macrocyclic wheel. 
 
  A pseudorotaxane is described as an [n]pseudorotaxane where the total number 
of components is equal to n.  Thus, the simplest system is a [2]pseudorotaxane composed 
of one wheel and one axle.  The addition of “stopper” groups, bulky enough to prevent 
the wheel from dissociation from the axle, onto the ends of the axle of a pseudorotaxane 
produces a rotaxane (Figure 1.22).  [2]Rotaxanes can be constructed in a few different 
ways including snapping, stoppering, clipping, and slipping as illustrated in Figure 1.23.75 
 
Figure 1.22 – Conversion of a [2]pseudorotaxane into a [2]rotaxane. 
 
+ 
+2 
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Figure 1.23 – General synthetic approaches for the production of [2]rotaxanes, from 
top to bottom: snapping, clipping, stoppering, and slippage. 
 
An example of a template employing hydrogen bonding in the construction of a 
[2]rotaxane is the diamide template employed by Leigh et al.76  Multiple cooperative 
hydrogen bonds between the axle and macrocycle precursor promotes rapid cyclization 
by means of the reaction between an amine and acyl chloride held in close proximity, 
resulting in the mechanically interlocked [2]rotaxane as illustrated in Figure 1.24.  This 
synthesis is an example of the clipping method. 
The recognition of a hydrophobic guest in the hydrophobic cavity of a 
macrocyclic host in aqueous solution has been used to template a variety of 
pseudorotaxanes and rotaxanes using both cyclodextrins (CDs) or cucurbiturils (CBs) as 
the wheels.   
+ 
+ 
+2 
+ 
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Figure 1.24 – Synthesis of [2]rotaxane using hydrogen bonding between amides.76 
 
One example uses α-CD as the macrocyclic wheel and a 1,4- diethynylbiphenyl 
containing linear axle as illustrated in Figure 1.25.77  The α-CD macrocycle threads the 
1,4-diethynylbiphenyl axle in aqueous solution due to the hydrophobic effect.  A double 
Sonogashira-type coupling with two equivalents 5-iodo-isophthalic acid as bulky stopper 
units produces the [2]rotaxane using the stoppering method of rotaxane synthesis.  The 
axle in this [2]rotaxane is an acetylene dye, and its encapsulation within the α-CD 
macrocycle was found to stabilize the chromophore against a metal ion quencher in 
comparison with the free naked axle. 
The donor-acceptor π-π interaction template synthetic strategy was pioneered by 
the Stoddart group,78 who have since synthesized a number of different interpenetrated 
and interlocked  molecules using this strategy.79   The  most  regularly  used  electron-rich  
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Figure 1.25 – Synthesis of [2]rotaxane using the hydrophobic effect.77 
 
 
Figure 1.26 – [2]Pseudorotaxanes using donor-acceptor π-π interactions.78,79 
= 
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donor units include 1,5-dioxynapthalene and tetrathiafulvene.  The most frequently used 
electron-poor acceptor units are cyclobis(paraquat-p-phenylene) and viologen.  
Cyclobis(paraquat-p-phenylene) in combination with 1,5-dioxynapthalene, as well as 
cyclobis(paraquat-p-phenylene) in combination with tetrathiafulvene, as illustrated in 
Figure 1.26 are frequently used. 
Metal-ligand coordination as a strategy for the template-directed synthesis of 
rotaxanes was introduced by Sauvage et al.80  This strategy relies upon a transition metal 
templating agent causing the macrocycle to thread onto the axle (Figure 1.27).81   
 
Figure 1.27 – [2]Rotaxane with components held together by means of metal-ligand 
coordination.80,81 
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The axle of the [2]rotaxane contains a 2,2’bipyridine unit and the macrocyclic 
wheel contains both a bidentate 1,10-phenanthroline unit as well as a tridentate 
2,2':6',2"-terpyridine (terpy) unit.  The [2]rotaxane is synthesized in the presence of 
copper(I) ions which coordinates to the two bidentate chelating  units on the axle and the 
macrocycle bringing the components in close proximity.  After the stoppering of the axle 
the copper(I) can be oxidized to copper(II), rotating the macrocycle in order to form a 
5-coordinate complex with the bidentate chelating unit on the axle and the tridentate 
terpy unit on the macrocyclic wheel.  The template can also be removed by the addition 
of potassium cyanide, which competitively removes the copper from the system. 
 Several more templates using 24-membered crown ethers and a variety of non-
covalent interactions are described in the introduction sections of the following chapters. 
1.3.2 Catenanes 
A catenane is a compound with two or more macrocyclic rings that are 
mechanically interlocked so that a covalent bond would have to be broken in order to 
separate the components.  These supramolecular compounds are named, similarly to 
rotaxanes, according to the number of components that make up the compound.   
There are three synthetic routes by which a [2]catenane might be synthesized: the 
clipping of a molecule threaded through a macrocycle, the double clipping of two 
associated molecules, and the “magic ring synthesis” where at least one of two non-
interlocked macrocycles is able to open, associate with the other macrocycle, then close 
again to form the [2]rotaxane (Figure 1.28).82 
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Figure 1.27 – General synthetic approaches for the production of [2]catenanes, from 
top to bottom: clipping, double clipping, and the magic ring synthesis. 
 
Two examples of the magic ring synthesis of [2]catenanes are described in the 
supramolecular coordination complexes section of this introduction.  Catenanes are 
synthesized using many of the same template strategies employed in the synthesis of 
[2]pseudo- and [2]rotaxanes as described above. 
1.4 SCOPE OF THESIS 
 This thesis describes the incorporation of interpenetrated and interlocked 
molecules into supramolecular coordination complexes.  Three different templating 
motifs for the formation of [2]pseudorotaxanes and [2]rotaxanes are utilized in 
combination with three different types of metal-ligand interaction.   
  Chapter 2 explores the use of [2]pseudorotaxanes based on the 
1,2-bis(pyridinium)ethane/24-crown-8 templating motif with pyridine donors as the 
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edges in the synthesis of polygons in combination with cis-protected platinum(II) and 
palladium(II) metal fragments as corners.  The synthesis, characterization, and structure 
elucidation of a number of metal-ligand self-assembled supramolecular compounds are 
described. 
 In Chapter 3 the [2]pseudorotaxane ligand is swapped for an interlocked 
[2]rotaxane based on the N-benzylanilinium/24-crown-6 templating motif incorporating 
pyridine coordinating groups.  The synthesis and characterization of the [2]rotaxane 
ligand as well as the result of its combination with a cis-protected platinum(II) corner 
units is discussed.  A [2]rotaxane using the same N-benzylanilinium/24-crown-6 
templating motif, this time with pyrazole donors is synthesized and characterized in 
Chapter 4.  The combination of this new di-pyrazole [2]rotaxane ligand with a pre-
organized dimeric cis-protected palladium(II) metal fragment is also covered. 
 Chapter 5 details the design, synthesis and characterization of a new 
unsymmetrical [2]rotaxane based on the bis(benzimidazolium)/24-crown-8 template 
incorporating pyridine donors for combination with naked palladium(II) ions. 
 In each chapter the effect of the macrocyclic wheel component on the structure of 
the supramolecular coordination complexes is explored by means of the comparison of 
assemblies formed from the [2]pseudorotaxane or [2]rotaxane ligands and assemblies 
formed from the analogous naked axle ligands where the macrocyclic wheels are absent. 
 
CHAPTER 2 
 
A [2]Pseudorotaxane Ligand for the Self-Assembly of MORPs 
 
2.1 INTRODUCTION 
The 1,2-bis(dipyridinium)ethane, dibenzo-24-crown-8 (Loeb) motif has been 
shown to be a versatile template for the formation of various interpenetrated and 
interlocked molecules.  The electron-poor, cationic axle and electron-rich macrocyclic 
wheel are held together by three sets of non-covalent interactions (Figure 2.1): (i) ion-
dipole interactions between the cationic pyridinium nitrogen atoms and the oxygen atoms 
of the crown ether, (ii) weak hydrogen bonds between the ortho-N+ and alpha-N+ 
hydrogen atoms and the oxygen atoms on the crown ether and (iii) π-π stacking 
interactions between the pyridinium rings of the axle and the catechol rings of the crown 
ether. 
 
Figure 2.1 - Non-covalent interactions between a 1,2-bis(dipyridinium)ethane4+ axle 
and DB24C8 wheel. 
 
This chapter describes the combination of this well-established motif with other 
components well established in the literature to produce metal organic polygons (MOPs) 
incorporating [2]pseudorotaxanes as the organic linker.  The basic idea (Figure 2.2) 
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involves combining an appropriate cis-protected transition metal complex with a linear 
ditopic [2]pseudorotaxane linker, to produce a metal organic rotaxane polygons 
(MORPs) via transition-metal mediated self-assembly. 
 
Figure 2.2 – Formation of Metal Organic Rotaxane Polyhedra (MORPs). 
 
The product is a discrete interlocked structure in which a number of smaller rings 
are threaded on a larger ring, denoted as a molecular necklace (MN), where n - 1 smaller 
rings threaded on a larger ring for a total of n rings is known as an [n]MN, where n ≥ 4, 
as the smaller necklaces where n = 2 or 3 are equivalent to [2] and [3]catenanes. 
The first MNs were a serendipitous discovery by Sauvage and coworkers, who 
observed the unanticipated formation of a mixture of [n]MN (n = 4 - 7), while engaged in 
the synthesis of [3]catenanes.83  Similarly, Stoddart et al. also produced a [4]MN while 
working on the synthesis of oligocatenanes.84  The synthesis of these MNs are carried out 
under kinetic control which generally leads to a mixture of products, laborious 
separations, and low yields.85 
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Kim and coworkers synthesized a series of MNs under thermodynamic control 
using a strategy similar to Figure 2.2, where a cis-protected transition metal complex was 
reacted with some of their well-established cucubit[6]uril (CB[6]) and flexible 
diaminoalkane [2]pseudorotaxanes, to produce [4]MN and mixtures of [4]MN and 
[5]MN in high yields without purification.86-90  Another successful strategy employed by 
the same group used the combination of two L-shaped CB[6] [3]rotaxanes with two cis-
protected transition metal complexes to produce [5]MN exclusively, using a 2+2 
approach.88,90,91  More recently, the combination of CB[8] with a rigid bent linker/axle 
connecting electron-rich and electron-poor guests, lead to the non-covalent synthesis of a 
[6]MN using host-stabilized charge transfer interactions from 10 components.92,93  An 
important detail to note, is that due to the flexible nature of the linkers/axles employed as 
well as the large size of the CB[n] wheel components, these MNs lack cavities. 
 
Figure 2.3 – Combination of metal corner fragment with linker/naked axle to give 
Metal Organic Polygons (MOPs). 
 
Another relevant series of studies was carried out by Quintela et al., where they 
utilized cis-protected transition metal complexes and positively charged 
4,4'-bipyridin-1-ium based rigid bent ligands to synthesize a series of rectangular and 
square metallomacrocycles, sometimes with the aid of one or more organic molecules 
acting as templates.94-102  Combining this strategy with macrocyclic crown ethers resulted 
in the formation of a series of [2]catenanes,95 [3]catenanes,96,100,101,103 and doubly 
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interlocked [2]catenanes.104  The rigid nature of the bent ligands means that these 
materials crystallize relatively easily, but also that only one conformation is possible for 
each ligand. 
 
Figure 2.4 – Addition of wheel component to MOPs to give Metal Organic Rotaxane 
Polygons. 
 
The approach used in the study discussed in this chapter involves the investigation 
of the MORPs as well as the architectures formed when omitting the wheel component of 
the [2]pseudorotaxane, utilizing the axle component as a conventional organic linker as 
illustrated in Figure 2.3.  Omission or addition of the wheel component allows for control 
over molecular architecture by changing the conformational preference of the axle; bent 
vs. linear (Figure 2.4). 
2.2 SYNTHESIS AND CHARACTERIZATION OF COMPONENTS 
2.2.1 Synthesis 
The components synthesized as building blocks for the self-assembly of MORPs 
include several different cis-protected transition metal complexes that have been shown 
A [2]Pseudorotaxane Ligand for the Self-Assembly of MORPs 
 
32 
to be successful building blocks for molecular squares and other supramolecular 
complexes, as well as a linker/axle that has been shown to be a versatile starting point in 
the synthesis of numerous interpenetrated and interlocked compounds. 
 
Scheme 2.1 – Synthesis of 1,2-bis(dipyridinium)ethane4+ axle, [BPE][OTf]2. 
 
The axle was synthesized via the 4 steps showed in Scheme 2.1.  The first step 
consists of refluxing 4,4'-bipyridine with 1,2-dibromoethane for 3 hours to produce 
[DE][Br], which was isolated by filtration and washed with diethyl ether.  Next, 
[DE][Br] was refluxed with 4,4'-bipyridine in 1-butanol for 12 hours to produce 
[BPE][Br]2.  The resulting mixture was filtered hot, and the precipitate washed with 
methanol and nitromethane.  The product was converted to the triflate salt, [BPE][OTf]2, 
by a two layer aqueous sodium triflate/nitromethane extraction (Scheme 2.1). 
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Scheme 2.2 – Synthesis of the [Pt(dppp)(OTf)2], and cis-[Pt(PEt3)2(OTf)2] corners. 
 
The phosphine based cis-protected platinum metal complexes were synthesized 
by a slightly modified literature procedure (Scheme 2.2).22,105  To produce the 
[Pt(dppp)(OTf)2] corner, the [Pt(N≡CEt)2Cl2] starting material was stirred with 
1,3-bis(diphenylphosphino)propane (dppp) in dichloromethane for 24 hours to produce 
[Pt(dppp)Cl2], which was then stirred with silver trifluoromethanesulfonate (silver 
triflate) in dichloromethane for 24 hours in the absence of light, to yield [Pt(dppp)(OTf)2] 
after silver chloride was filtered off.  Similarly, cis-[Pt(PEt3)2(OTf)2] was produced by 
stirring cis-[Pt(PEt3)2Cl2] with silver triflate in dichloromethane for 24 hours in the 
absence of light, then filtering off silver chloride. 
 
Scheme 2.3 – Synthesis of the [Pd(en)(OH2)2][OTf]2 corner. 
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The precursor to the amine based cis-protected palladium metal complex was 
synthesized using a modified literature preparation (Scheme 2.3).106  Refluxing K2PdCl4 
with ethylenediamine (en) hydrochloride in water for 3 hours produces [Pd(en)Cl2].  To 
produce the desired [Pd(en)(OH2)2][OTf]2 corner, [Pd(en)Cl2] was stirred with AgOTf in 
water for 72 hours in the absence of light, followed by filtering off the silver chloride 
precipitate. 
2.2.2 1H NMR Analysis 
 The 1H NMR spectra for the macrocyclic wheel, DB24C8, the naked axle, 
[BPE][OTf]2, and the [2]pseudorotaxane ligand that results from the combination of the 
two components are depicted in Figure 2.5.  To obtain the spectrum of the 
[2]pseudorotaxane an excess of DB24C8 was added to a deuterated nitromethane 
solution of the axle to shift the equilibrium in favor of the [2]pseudorotaxane.  The peaks 
are somewhat broadened due to slow exchange on the NMR timescale as macrocycles 
thread on and off the axle. 
Comparing the spectra of DB24C8 with that of the [2]pseudorotaxane reveals that 
aromatic crown protons, f and g shift ~0.2 ppm upfield due to π-π stacking interactions 
between the pyridinium rings of the axle and the catechol rings of the crown ether.  The 
ethylene glycol chain protons, h, i, and j, shift slightly downfield, but due to the excess 
free DB24C8 the complexed DB24C8 signals are partially obscured. 
When comparing the free axle with the [2]pseudorotaxane it can be seen that 
meta-pyridinium protons, a, furthest removed from the macrocyclic host shift the least, 
~0.1 ppm upfield.  Ortho-pyridinium protons, b and c, shift ~0.3 and 0.4 ppm upfield due 
to π-π stacking with the catechol rings of the macrocycle.          
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Figure 2.5 – Structure of [BPE⊂DB24C8]2+ with labeling scheme, and 1H NMR 
spectra of DB24C8 (top), the [BPE⊂DB24C8][OTf]2 [2]pseudorotaxane (middle), 
and the [BPE][OTf]2 naked axle (botom) in MeNO2. 
 
Meta-pyridinium protons, d, and ethylene protons, e, shift ~0.3 ppm downfield, 
due to hydrogen bonding with the oxygen atoms on the crown ether macrocyclic wheel.  
2.2.3 X-Ray Crystalography of [2]Pseudorotaxane Ligand 
  The single crystal X-ray structure of the [2]pseudorotaxane ligand, 
[BPE⊂DB24C8]2+ (Figure 2.6),107 shows that the interaction between the axle and 
macrocyclic wheel is symmetrical with a colinear arangement.  The length of the 
[2]pseudorotaxane between nitrogen donors measures 17.7 Å, and the distance between 
center macrocycle ethylene glycol chain hydrogen atoms on opposite sides of the axle 
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measures 10.2 Å.  Thus, the ligand shape is that of a rectangular box almost twice as long 
as it is wide.    
 
Figure 2.6 – Single crystal structure of [BPE⊂DB24C8]2+, ball and stick side view 
with hydrogen atoms omitted for clarity.107 
 
 
 
Figure 2.7 – Single crystal structure of [BPE⊂DB24C8]2+, space filling side view 
(top), and top-down view (bottom).107 
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The ortho-pyridinium hydrogen bond C···O distances range between 3.28 and 
3.32 Å, with C-H···O angles between 145.0 and 146.1°.  The hydrogen bonds between 
the alpha-pyridinium hydrogen atoms have C···O distances of between 3.25 and 3.33 Å, 
with C-H···O angles between 129.7 and 156.6°.  The outer and inner pyridine rings are 
very close to parallel with a torsion angle of 1.6°.  The space-filling views (Figure 2.7) 
show how the axle is threaded through the cavity of the macrocyclic ring while 
positioning the electron-rich catechol rings of the crown ether over the electron-poor 
pyridinium rings of the axle with a spacing of ~3.5 Å. 
2.3 SYNTHESIS AND CHARACTERIZATION OF MOPS 
2.3.1 Synthesis of Polyhedra with Labile Metal Fragments 
Synthesis of MOPs with the three metal fragments, [Pt(dppp)(OTf)2], 
cis-[Pt(PEt3)2(OTf)2], or [Pd(en)(OH2)2][OTf]2, and naked axle, [BPE][OTf]2, involved 
combining the cis-protected metal complex with the axle component in nitromethane.  
 
Scheme 2.4 - Synthesis of dimers [Pt2(BPE)2(dppp)2][OTf]8, 
[Pt2(BPE)2(PEt3)4][OTf]8, and [Pd2(BPE)2(en)2][OTf]8, utilizing labile cis-protected 
platinum and palladium metal complexes. 
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Stiring for a few minutes, then crystalizing by slow difusion of isopropyl ether 
into the solution, produces molecular square/dimers, [Pt2(BPE)2(dppp)2][OTf]8, 
[Pt2(BPE)2(PEt3)4][OTf]8, and [Pd2(BPE)2(en)2][OTf]8 (Scheme 2.4). Characterization 
included analysis of the effect of coordination on the ligand through 1H NMR 
spectroscopy, as wel as single crystal X-ray structural determination of 
[Pt2(BPE)2(dppp)2][OTf]8, and [Pd2(BPE)2(en)2][OTf]8. 
2.3.2 1H NMR Analysis 
Figure 2.8 shows the 1H NMR spectra of the ligand, [BPE][OTf]2, as wel as the 
dimeric molecular squares, [Pt2(BPE)2(dppp)2][OTf]8, [Pt2(BPE)2(PEt3)4][OTf]8, and 
[Pd2(BPE)2(en)2][OTf]8, which shows the chemical shift changes of the signals of the 
protons belonging to the ligand upon coordination to the metal center. 
 
Figure 2.8 – 1H NMR spectra of, from top to botom, the axle, [BPE][OTf]2, and 
dimers, [Pt2(BPE)2(dppp)2][OTf]8, [Pt2(BPE)2(PEt3)4][OTf]8,  and 
[Pd2(BPE)2(en)2][OTf]8 in CD3NO2. 
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When comparing naked axle ligand, [BPE][OTf]2, with dimer 
[Pt2(BPE)2(dppp)2][OTf]8, the ortho-, and meta- pyridinium protons, b, c, and d, shift 
upfield by ~0.2-0.4 ppm, while meta- pyridinium proton a, closest to the coordinating 
pyridine, shifts downfield by ~0.1 ppm.  For [Pt2(BPE)2(PEt3)4][OTf]8 and 
[Pd2(BPE)2(en)2][OTf]8, the protons ortho- and meta- to the center pyridinium c, and d, 
shift upfield by ~0.2-0.3 ppm, while the protons meta and ortho to the coordinating 
pyridine a, and b, shift downfield by ~0.2-0.3 ppm.   
The differences observed between [Pt2(BPE)2(dppp)2][OTf]8 and the latter two 
are due to the presence of the aromatic rings on the chelating ligand of the metal 
fragment, which allows for π-π stacking interactions with the pyridinium rings of the 
linker.  This interaction causes an upfield shift for all the aromatic protons in 
[Pt2(BPE)2(dppp)2][OTf]8 compared with [Pt2(BPE)2(PEt3)4][OTf]8 and 
[Pd2(BPE)2(en)2][OTf]8, where this interaction is absent.  The largest effect is on proton 
b which shifts ~0.5 ppm upfield, followed by c (~0.3 ppm upfield), a (~0.1-0.2 ppm 
upfield) and d (~0.1 ppm upfield). Proton e does not shift significantly upon 
coordination, or when comparing the different dimers, as it is not in close proximity to 
the coordination site. 
2.3.3 X-Ray Crystallography  
Crystals suitable for single crystal X-ray structural determination were grown by 
slow diffusion of isopropyl ether into nitromethane solutions of 
[Pt2(BPE)2(dppp)2][OTf]8 and [Pd2(BPE)2(en)2][OTf]8, producing colourless plates and 
yellow cubes, respectively.  Attempts to grow crystals suitable for a single crystal X-ray 
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structural determination of [Pt2(BPE)2(PEt3)4][OTf]8 were not successful, as all attempts 
resulted in the precipitation of white microcrystallline solids. 
The single crystal X-ray structure of [Pt2(BPE)2(dppp)2][OTf]8 (Figure 2.9) 
verifies the dimeric formulation and square-like structure and confirms the π-π stacking 
interaction observed in the 1H NMR spectrum of this compound. 
 
Figure 2.9 – Single crystal structure of [Pt2(BPE)2(dppp)2]8+, ball and stick view 
omitting ions, solvent, and H-atoms for clarity. 
 
The distances between the atoms of the aromatic ring on the corner and the 
coordinating pyridinium ring on the linker range between 3.06 and 4.20 Å, which 
encompasses the range usually observed for π-π stacking interactions (~3.5Å).108  The 
distance between platinum atoms is 15.3 Å, while the other diagonal measures 15.7 Å.  
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Also of note is the dihedral angle between the pyridinium rings of the linker which ranges 
between 28.9 and 41.3°, with an average of 32.3°.  The N···Pt···N angle deviates from 
90° by a small amount as the bite angles in the structure are 87.1 and 85.0°.  The 
complementary P···Pt···P angles are 90.5 and 93.7°.  The lengths of the sides of the 
square measure 10.6 and 11.4 Å, revealing that the structure deviates slightly from a true 
square shape.  The open area inside the square was calculated to be ~121 Å2. 
  The packing diagram (Figure 2.10) reveals that the dimers stack along the a-axis, 
creating channel-like cavities.  Stacking dimer units are 13.4 Å apart and the space 
between is filled with solvent and ions. 
 
Figure 2.10 – Packing diagram of [Pt2(BPE)2(dppp)2]8+, viewing along the a-axis, 
wireframe view omitting ions, solvent, and H-atoms for clarity. 
 
The single crystal X-ray structure of [Pd2(BPE)2(en)2][OTf]8 (Figure 2.11) only 
differs substantially in that the aromatic rings involved in the π-π stacking interaction in 
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the previous structure are not present here.  This allows the pyridinium rings of the linker 
to twist further, resulting in larger dihedral angles of 43.2 - 46.4°, with an average of 
45.3°.   
 
Figure 2.11 – Single crystal structure of [Pd2(BPE)2(en)2]8+, ball and stick view with 
anions, solvent, and H-atoms omitted for clarity. 
 
The square is also slightly smaller in size.  The distance between palladium atoms 
is 15.0 Å, while the other diagonal measures 15.5 Å.  The pyridine N···Pd···N angle 
deviates from 90° by a smaller amount as the bite angles in the structure are both 90.9°, 
while the complementary ethylenediamine N···Pd···N angles are both 83.6°.  The lengths 
of the sides of the square measure 10.5 and 11.1 Å, and the open area inside the square 
was calculated to be ~117 Å2. 
The packing diagram for [Pd2(BPE)2(en)2][OTf]8 (Figure 2.12) shows that the 
dimers stack along the c-axis, again creating channel-like cavities.  The stacking dimer 
units are 15.6 Å apart with the space between filled with solvent and anions. 
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Figure 2.12 – Packing diagram of [Pd2(BPE)2(en)2]8+, viewing along the c-axis, 
wireframe view omitting anions, solvent, and H-atoms for clarity. 
 
2.3.4 Variable Concentration 1H NMR Experiments 
To ascertain that the structure of [Pt2(BPE)2(PEt3)4][OTf]8 is indeed a that of a 
dimer similar to [Pt2(BPE)2(dppp)2][OTf]8 and [Pd2(BPE)2(en)2][OTf]8, in the absence 
of a single crystal X-ray structure, a comparison of solution behavior by 1H NMR 
spectroscopy was undertaken. 
The 1H NMR spectra of [Pt2(BPE)2(dppp)2][OTf]8 at different concentrations 
(Figure 2.13) shows that at low concentrations (≤10 mM) the dimer is the main species, 
while at higher concentrations (≥10 mM), a second and third species starts to appear.  
These are likely an interlocked [2]catenane species and/or larger oligomers. 
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Figure 2.13 – 1H NMR spectra of [Pt2(BPE)2(dppp)2][OTf]8 at 1, 10 and 50 mM 
concentrations. 
 
The 1H NMR spectra of [Pt2(BPE)2(PEt3)4][OTf]8 at diferent concentrations 
(Figure 2.14) shows that at low concentrations (≤10 mM) the dimer is again the main 
species, while at higher concentrations (≥10 mM), interlocked and/or other larger 
oligomeric species again start to dominate. 
 
Figure 2.14 – 1H NMR spectra of [Pt2(BPE)2(PEt3)4][OTf]8 at 1, 10 and 50 mM 
concentrations. 
 
The metal fragments utilized as corners in both [Pt2(BPE)2(dppp)2][OTf]8 and 
[Pt2(BPE)2(PEt3)4][OTf]8 are fairly bulky, and likely capable of stericaly hindering the 
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formation of the interlocked [2]catenane species favoured at high concentration, and this 
results in the oligomeric mixture observed in both circumstances. 
In the case of [Pd2(BPE)2(en)2][OTf]8 however (Figure 2.15), which contains a 
much less bulky corner unit, the spectra show a clean change from exclusively dimer at 
low concentrations (<10 mM) to mostly a second (presumably interlocked [2]catenane) 
species at higher concentrations (≥50 mM). 
 
Figure 2.15 – 1H NMR spectra of [Pd2(BPE)2(en)2][OTf]8 at 1, 10, 50, and 100 mM 
concentrations. 
 
The similarities in solution behaviour between [Pt2(BPE)2(dppp)2][OTf]8, and 
[Pd2(BPE)2(en)2][OTf]8, for which the dimeric structure was confirmed by X-ray 
crystalography, and the observed solution behaviour of [Pt2(BPE)2(PEt3)4][OTf]8, 
indicates that the structure of the later is also that of a dimer. The similarity in size and 
shape was also confirmed using pulsed field gradient difusion NMR techniques, which 
wil be discussed later in this chapter. 
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2.4 SYNTHESIS AND CHARACTERIZATION OF MORPS 
2.4.1 Synthesis of MORPs 
 
Scheme 2.5 - Synthesis of a [4]MN or [5]MN from dimers [Pt2(BPE)2(dppp)2][OTf]8, 
[Pt2(BPE)2(PEt3)4][OTf]8, and [Pd2(BPE)2(en)2][OTf]8. 
 
The combination of MOPs [Pt2(BPE)2(dppp)2][OTf]8, 
[Pt2(BPE)2(PEt3)4][OTf]8, and [Pd2(BPE)2(en)2][OTf]8 with an excess amount of 
DB24C8 should result in the synthesis of a MORP style MN, or some oligomeric 
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mixture of species, depending on sterics and the flexibility of the [2]rotaxane ligand, as 
ilustrated in Scheme 2.5. The possibility of larger cyclic as wel as linear oligomers also 
exists. 
2.4.2 1H NMR Analysis 
The efect of adding DB24C8 to MOP [Pt2(BPE)2(dppp)2][OTf]8 is ilustrated in 
the 1H NMR spectra shown in Figure 2.16. At 20 equivalents of DB24C8 a MORP with 
[2]pseudorotaxane linkers is the dominant species, as inferred from the peaks at 6.1 and 
6.5 ppm, characteristic for complexed DB24C8. Proton d shifts ~0.4 ppm downfield, due 
to the hydrogen bonding interactions with the DB24C8.  
 
Figure 2.16 – 1H NMR spectra of [Pt2(BPE)2(dppp)2][OTf]8 at 1 mM with 0, 5, 10, 
and 20 equivalents of DB24C8 added. 
 
The MORP that is formed upon addition of DB24C8 is either a [4] or [5]MN. It 
is not possible to distinguish between the two possibilities using 1D 1H NMR 
spectroscopy as both cyclic species would result in very similar spectra. It is possible to 
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identify the nature of the MORP formed using pulsed field gradient difusion NMR 
techniques, the results of which wil be discussed later in this chapter. 
 
Figure 2.17 – 1H NMR spectra of [Pt2(BPE)2(PEt3)4][OTf]8 at 1 mM with 0, 2, and 5 
equivalents of DB24C8 added. 
 
The addition of DB24C8 to MOP [Pt2(BPE)2(PEt3)4][OTf]8 generates the 1H 
NMR spectra shown in Figure 2.17. The addition of 5 equivalents of DB24C8 generates 
a single interlocked species with the characteristic peaks for complexed DB24C8 at 6.1 
and 6.6 ppm. Hydrogen bonding interactions causes the shift of the peaks for protons d, 
~0.4 ppm, and e, ~0.1 ppm upfield.  It is again not possible to distinguish between the 
possible species ([4] or [5]MN) using 1D 1H NMR spectroscopy. 
The addition of DB24C8 to MOP [Pd2(BPE)2(en)2][OTf]8 is ilustrated in the 1H 
NMR spectra shown in Figure 2.18.  At dilute concentrations (1 mM), the result is two 
major interlocked species with the characteristic DB24C8 peaks from 6.1-6.7 ppm. 
Increasing the concentration to 100 mM simplifies the spectrum to only one of these 
interlocked species. It is not possible to distinguish between these two possible species 
using 1D 1H NMR spectroscopy as both cyclic species would result in very similar 
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spectra. It is possible to prove that both are larger interlocked species using pulsed field 
gradient difusion NMR spectroscopy. 
 
Figure 2.18 – 1H NMR spectra of [Pd2(BPE)2(en)2][OTf]8 at 1 mM with 0, and 10, 
equivalents of DB24C8 added, and at 100 mM with 5 equivalents added. 
 
2.5 DIFFUSION ORDERED SPECTROSCOPY 
Pulsed field gradient NMR spectroscopy techniques determine self-difusion 
coeficients, which scale inversely with mass or size of a molecule.  Difusion ordered 
spectroscopy (DOSY) can be very useful for the determination of the size of a compound 
in solution that cannot be determined by conventional methods such as mass 
spectroscopy or X-ray crystalography because of its large size or dificulties in growing 
high-quality crystals. 
2.5.1 Introduction to DOSY 
Difusion coeficients depend on the molecular weight, size, and shape of a 
molecule, as wel as the experimental conditions, such as solvent and temperature.  The 
difusion coefficient is related to molecular size by the Stokes-Einstein equation; 
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𝐷 =
𝑘𝑇
𝑓
 
where D is the diffusion coefficient, k is the Boltzmann constant, T is the temperature, 
and f is the friction coefficient.  For the simplest possible shape, that of a sphere, the 
friction coefficient, f, is given by; 
𝑓 = 6𝜋𝜂𝑟𝑠 
where η is the viscosity of the solution, and rs is the effective hydrodynamic or stokes 
radius.  For more complicated shapes the friction factor must be modified.109,110 
 
Figure 2.19 – Standards of known size and shape for the determination of diffusion 
coefficients. 
 
To determine the size of a species that is not spherical, standards with similar 
shapes/structures are required.  This is because diffusion coefficients are not directly 
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related to molecular weight, but rather reflect the effective hydrodynamic radius.  Thus, it 
is not only the size, but also the shape that determines the diffusion coefficient.109,111 
The standards used in this study consists of the dimeric MOPs discussed 
previously, [Pt2(BPE)2(dppp)2][OTf]8, [Pt2(BPE)2(PEt3)4][OTf]8, and 
[Pd2(BPE)2(en)2][OTf]8, as well as similarly shaped extended corner compounds 
[Pt(DM)2(dppp)][OTf]4, [Pt(DM)2(PEt3)2][OTf]4, [Pd(DM)2(en)][OTf]4, 
[Pt(DPM)2(dppp)][OTf]4, [Pt(DPM)2(PEt3)2][OTf]4, and [Pd(DPM)2(en)][OTf]4, and 
uncoordinated ligands [DM][OTf], and [DPM][OTf], (Figure 2.19). 
2.5.2 Synthesis of DOSY Standards 
 
Scheme 2.6 – Synthesis of DOSY standard precursors. 
 
The compounds synthesized as precursors to the DOSY standards consist of two 
linear ligands (Scheme 2.6).  DP is synthesized via a Suzuki reaction.  The combination 
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of 1,4-dibromobenzene with a small excess of 4-pyridineboronic acid in the presence of 
sodium carbonate and a [Pd(PPh3)4] catalyst, in a DMF and water mixture, gives the 
product after refluxing for seven days. 
The syntheses of the final ligands proceed via an SN2 reaction.  The combination 
of DP or 4,4’-bipyridine with methyl iodide, refluxing under a nitrogen atmosphere for 
two hours, and recrystallizing from methanol, produces [DM][Br], and [DPM][Br], 
respectively.  Simple two layer aqueous NaOTf/MeNO2 extractions yield the anion 
exchanged ligands, [DM][OTf], and [DPM][OTf]. 
 
Scheme 2.7 – Synthesis of extended corner DOSY standards. 
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Final assembly of the extended corner standards involve the combination of the 
three cis-protected metal complexes, [Pt(dppp)(OTf)2], cis-[Pt(PEt3)2(OTf)2], or 
[Pd(en)(OH2)2][OTf]2 with two equivalents of the appropriate monopositive ligand as 
ilustrated in Scheme 2.7. 
2.5.3 DOSY Analysis 
To determine the sizes of MORPs it was first necessary to create a calibration 
curve using the eleven standards described above.  The sizes of the standards were 
modeled using their space-filed representations generated through molecular mechanics 
(MM3) geometry optimization calculations using the Scigress Explorer 7.7 software. A 
representative example of the structures is shown in Figure 2.20. 
 
Figure 2.20 – Molecular Mechanics (MM3) geometry optimized structures of left: 
extended corner [Pd(DM)2(en)]4+, center: extended corner [Pd(DPM)2(en)]4+ and 
right: dimer [Pd2(BPE)2(en)2]8+. 
 
The hydrodynamic radius, r, for each standard was approximated as half of the 
longest distance in the space-filed representation of the calculated structure of the 
molecule (represented as the large gray-blue circles in Figure 2.2). The radi determined 
for the extended corner and uncoordinated ligand standards are listed in Tables 2.1. 
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Table 2.2 lists the radii determined for the three dimeric molecular squares.  For each 
MORP the radii for both of the possible structures ([4] and [5]MN) were modelled using 
the same methodology as the standards (Table 2.3).     
Table 2.1 – Measured Diffusion Coefficients and Modeled Radii of Standards. 
Molecule 
Measured 
Diffusion 
Coefficients D 
(x 10-10 m2/s) 
Average 
Diffusion 
Coefficient D (x 
10-10 m2/s) 
Radius r 
(Å) 
[Pt(DM)2(dppp)]4+ 
4.5699 
4.5259 
4.5357 
4.54 (± 0.02) 5.5 
Pt(DM)2(PEt3)2]4+ 
4.7263 
4.7312 
4.7312 
4.73 (± 0.00) 5.2 
[Pd(DM)2(en)]4+ 
5.1662 
5.0831 
5.1320 
5.13 (± 0.04) 5.1 
[Pt(DPM)2(dppp)]4+ 
3.8856 
4.1984 
3.8856 
3.99 (± 0.18) 6.9 
Pt(DPM)2(PEt3)2]4+ 
4.2620 
4.2864 
4.2816 
4.28 (± 0.01) 6.7 
[Pd(DPM)2(en)]4+ 
4.4624 
4.4380 
4.4502 
4.45 (± 0.01) 6.6 
[DM]+ 
9.3451 
9.2766 
9.2180 
9.28 (± 0.06) 3.1 
[DPM]+ 
6.5689 
6.5591 
6.5738 
6.5200 
6.6178 
6.5507 
6.57 (± 0.01) 4.1 
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Table 2.2 – Measured Diffusion Coefficients and Modeled Radii of Dimers. 
Molecule 
Measured 
Diffusion 
Coefficients D 
(x 10-10 m2/s) 
Average 
Diffusion 
Coefficient D 
(x 10-10 m2/s) 
Radius r 
(Å) 
[Pt2(BPE)2(dppp)2]8+ 
3.2014 
3.1672 
3.2258 
3.20 (± 0.03) 8.2 
[Pt2(BPE)2(PEt3)4]8+ 
3.3333 
3.3529 
3.3920 
3.36 (± 0.03) 7.7 
[Pd2(BPE)2(en)2]8+ 
3.4213 
3.3529 
3.3871 
3.39 (± 0.03) 7.1 
 
Table 2.3 – Measured Diffusion Coefficients and Modeled Radii of MORPs. 
MORP 
Constructed 
with: 
Measured 
Diffusion 
Coefficients 
D (x 10-10 
m2/s) 
Average 
Diffusion 
Coefficient 
D (x 10-10 
m2/s) 
Radius r (Å) 
Calculated 
from 
calibration 
curve 
Radius r 
(Å) 
modelled 
[4]MN 
Radius r 
(Å) 
modelled 
[5]MN 
[Pt(dppp)]2+ 
2.4340 
2.4438 
2.3851 
2.42 (± 0.03) 11.1 10.1 11.7 
[Pt(PEt3)2]2+ 
2.4145 
2.4145 
2.5513 
2.46 (± 0.08) 10.9 9.7 11.2 
[Pd(en)]2+ 
dilute 
species 
2.2581 
2.3069 
2.2434 
2.27 (± 0.03) 11.9 8.9 10.6 
[Pd(en)]2+ 
conc. species 
1.8866 
1.8866 
1.8768 
1.88 (± 0.01) 14.3 8.9 10.6 
 
DOSY spectra for all the standards as well as the MORPs were collected in 
CD3NO2 solvent, at 10 mM concentration, and 21±0.5 °C.  The raw DOSY data was 
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processed using the DOSY toolbox software.112  The extracted diffusion coefficients, 
listed in Tables 2.1 for the non-dimeric standards, Table 2.2 for the three dimer standards, 
and Table 2.3 for the MORPs, are the average of at least three trials with the reported 
error being the standard deviation. 
The calibration curve (Figure 2.21) consists of a plot of the measured D values of 
the standards plotted against the inverse of their modelled hydrodynamic radii, 1/r.  The 
line of best fit is forced through zero.  The measured diffusion coefficients for MORPs 
and the line of best fit from the calibration curve was used to determine their 
hydrodynamic radii, listed in Table 2.3.  
Figure 2.21 – Diffusion coefficients vs. the reciprocal of the modeled radii for the 
standards. 
 
Comparing the calculated r value (11.1 Å) with the modelled values for the [4], 
and  [5]MN (10.1 and 11.7 Å, respectively),  for  the  MORP  utilizing  the  [Pt(dppp)]2+  
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Figure 2.22 – Diffusion coefficient vs. the reciprocal of the modeled radii for the [4] 
and [5]MN possibilities, for the MORP assembled from the [Pt(dppp)]2+ corner. 
 
Figure 2.23 – Diffusion coefficient vs. the reciprocal of the modeled radii for the [4] 
and [5]MN possibilities, for the MORP assembled from the [Pt(PEt3)2]2+ corner. 
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metal fragment, shows that the experimental r value is closer to the modelled value for 
the tetrameric [5]MN (Table 2.3, Figure 2.22).  The identity of this MORP was therefore 
determined to be [Pt4(BPE⊂DB24C8)4(dppp)4][OTf]16. 
Similarly, when comparing the calculated (10.9 Å) and modelled (9.7 and 11.2 Å) 
r values for the MORP assembled with the [Pt(PEt3)2]2+ metal fragment (Table 2.3, 
Figure 2.23), it is evident that the structure was again the square [5]MN, or 
[Pt4(BPE⊂DB24C8)4(PEt3)8][OTf]16, and not the triangular [4]MN. 
 
Figure 2.24 – Diffusion coefficient vs. the reciprocal of the modeled radii for the [4] 
and [5]MN, and catenated [5]MN possibilities, for the MORPs assembled from the 
[Pd(en)]2+ corner. 
 
Comparing the calculated r value of 11.9 Å with the modelled values for the [4], 
and [5]MN (8.9 and 10.6 Å, respectively), for the two MORP species utilizing the 
[Pd(en)]2+ metal fragment, the data shows that the experimental r value for the first 
species that is more abundant at dilute concentrations is much closer to the modelled 
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value for the tetrameric [5]MN (Table 2.3, Figure 2.24).  Therefore the structure of the 
MORP that appears at lower concentration is [Pd4(BPE⊂DB24C8)4(en)4][OTf]16. 
The calculated r value for the second species that dominates at higher 
concentration is even larger (14.3 Å), and correlates well with the modelled radius for a 
catenated version of the [5]MN, [Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32, where the 
tetrameric square is interpenetrated by another square as depicted in cartoon form in 
Figure 2.25.   
 
Figure 2.25 – Cartoon of the catenated structure of 
[Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32 with macrocyclic wheels omitted for clarity. 
 
Figure 2.26 depicts the MM3 optimized structure of the catenated square 
MORPs, which shows the interpenetrated MORPs are perfectly sized to mutually fill 
each other’s cavities.  Such a catenated MORP would be entropically favorable over the 
uninterpenetrated [5]MN where the cavity is filled with a mix of anions and solvent.  The 
greater steric bulk of the [Pt(dppp)]2+ and [Pt(PEt3)2]2+ corner units in comparison to the 
[Pd(en)]2+ unit likely prevents catenated MORPs from forming.   
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Figure 2.26 – The catenated structure of [Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32, 
generated using MM3 calculations. 
 
2.6 SUMMARY AND CONCLUSIONS 
 A series of dimeric MOPs were synthesized using a set of cis-protected metal 
fragments in combination with the [BPE]2+ naked axle as the divergent ligand.  The 
structures of the dimeric MOPs were confirmed by means of single crystal X-ray 
crystallography.  The addition of the DB24C8 macrocyclic wheel resulted in the 
conversion of the MOPs into larger [5]MN and catenated [5]MN, with 
[2]pseudorotaxanes as the ligands.  These MOPs and MORPs are self-assembled from 
commercially available or easily synthesized components.  The presence or absence of 
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pseudorotaxane formation controls the self-assembly process.  Thus, by including or 
excluding the DB24C8 crown ether, the size and shape of the product of the reaction is 
controlled.  The absence of structural confirmation by means of single crystal X-ray 
crystallography meant that an alternate was necessary.  DOSY analysis was used to 
determine the size and shape of the MORPs. 
 The only drawback to this system is that the structures of the MNs cannot be 
determined by X-ray crystallography.  This could be solved by using permanently 
interlocked [2]rotaxanes as the ligands instead of [2]pseudorotaxanes.  [2]Rotaxane 
ligands would be much more likely to produce MNs that can be crystallized and 
subjected to single crystal X-ray analysis.  Reducing the number of anions by the design 
of a neutral or a negatively charged [2]rotaxane linker would also simplify and improve 
the system. 
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2.7 EXPERIMENTAL 
2.7.1 General Comments 
[Pt(dppp)(OTf)2],22,105 cis-[Pt(PEt3)2(OTf)2],22 and [Pd(en)(OH2)][OTf]2106 were 
synthesized using slightly modified literature methods.  Sodium 
trifluoromethanesulfonate, [Pt(en)Cl2], 4,4’-bipyridine, 1,2-dibromomethane, 
iodomethane, pyrazine, 1,4-dibromobenzene, 4-pyridineboronic acid, [Pd(PPh3)4], 
sodium carbonate, potassium carbonate and DB24C8 were purchased from Aldrich and 
used as received.  Deuterated solvents were obtained from Cambridge Isotope 
Laboratories or Aldrich and used as received.  Solvents were dried using an Innovative 
Technologies Solvent Purification System.  Thin layer chromatography (TLC) was 
performed using Teledyne Silica gel 60 F254 plates and viewed under UV light.  Column 
chromatography was performed using Silicycle Ultra Pure Silica Gel (230 – 400 mesh).  
1H NMR, 13C NMR and 2-D NMR experiments were performed on a Bruker Avance 500 
instrument, with a working frequency of 500.13 MHz for 1H nuclei, 125.7 MHz for 13C 
nuclei, and 202 MHz for 31P nuclei.  1H and 13C chemical shifts are quoted in ppm 
relative to tetramethylsilane, using the residual solvent peak as a reference standard.  31P 
chemical shifts were referenced vs. external 85% H3PO4 (0.00 ppm).  Conventional 2-D 
NMR experiments 1H-1H COSY and 1H-13C HMQC were conducted and used to help 
assign all peaks.  1H-DOSY experiments were carried out using the longitudinal eddy-
current delay with bipolar gradient pulse pair and two spoil gradients (ledbpgp2s) pulse 
program, at 21±0.5 °C, 10 mM concentration, and 4 cm sample height in a 5 mm tube.  
Experiments were performed with a diffusion time, Δ, of 0.2 s, a gradient recovery delay 
of 100 μs, a longitudinal eddy-current delay of 2.5 ms, a gradient pulse duration, δ/2, of 1 
A [2]Pseudorotaxane Ligand for the Self-Assembly of MORPs 
 
63 
ms.  A series of 32 linear increments in gradient strength were used with 8 scans per 
increment.  The data was processed using the DOSY toolbox software using the standard 
high resolution DOSY fitting.112  Infrared (IR) experiments were performed on a Bruker 
Alpha FT-IR spectrometer.  Melting points were recorded using a Fischer-Johns melting 
point apparatus.   
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2.7.2 Synthesis of [DE][Br] 
4,4’-Bipyridine (5.23 g, 0.0335 mol) was dissolved in 1,2-dibromoethane (40 mL) and 
refluxed for 3 h. The light brown precipitate was filtered off and washed with diethyl 
ether. Yield: 11.51 g, 99 %. 
 
Table 2.4 - 1H NMR data of [DE][Br] in D2O. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.81 d  2 3Jab = 6.2 
b 7.95 d  2 3Jba = 6.2 
c 8.49 d  2 3Jcd = 6.7 
d 9.07 d 2 3Jdc = 6.7 
e 5.15 t 2 3Jef = 5.7 
f 4.08 t 2 3Jfe = 5.7  
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2.7.3 Synthesis of [BPE][OTf]2 
[DE][Br] (2.00 g, 0.00581 mol) and 4,4′-bipyridine (2.72 g, 0.0174 mol) were dissolved 
in 1-BuOH (40 mL) and refluxed for 12 h. The solution was filtered hot and the resulting 
precipitate washed with MeOH and MeNO2. The light brown precipitate was collected 
(Yield: 1.47 g, 56 %) and anion exchanged to the triflate salt by way of a two layer 
NaOTf (aq)/MeNO2 extraction. Yield: 1.05g, 56 %. 
 
Table 2.5 - 1H NMR data of [BPE][Br]2 in D2O. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.80 d  4 3Jab = 6.3 
b 7.97 d  4 3Jba = 6.3 
c 8.51 d  4 3Jcd = 6.8 
d 9.03 d 4 3Jdc = 6.8 
e 4.44 s 4 - 
 
Table 2.6 - 1H NMR data of [BPE][OTf]2 in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.81 d  4 3Jab = 5.6 
b 7.83 d  4 3Jba = 5.6 
c 8.40 d  4 3Jcd = 5.4 
d 8.88 d 4 3Jdc = 5.4 
e 5.19 s 4 - 
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Table 2.7 - 1H NMR data of [BPE][OTf]2 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.86 d  4 3Jab = 6.1 
b 7.88 d  4 3Jba = 6.1 
c 8.67 d  4 3Jcd = 6.9 
d 9.09 d 4 3Jdc = 6.9 
e 5.50 s 4 - 
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2.7.4 Synthesis of [Pt2(BPE)2(dppp)2][OTf]8 
[BPE][OTf]2 (0.032 g, 0.05 mmol) and [Pt(dppp)(OTf)2] (0.045 g, 0.05 mmol) were 
dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Slow diffusion of isopropyl 
ether into the filtrate produces colourless crystals.  Yield: 0.076 g, 99 %.  MP: 255-260 
°C (decomp).  31P NMR (202 MHz, CD3NO2, 298 K) δ = -13.24 (1JP-Pt = 3026 Hz).  IR 
(ATR) ν/cm-1 = 3526, 3104, 3059, 3028, 2967, 2927, 1644, 1619, 1437, 1246, 1223, 
1154, 1103, 1075, 1025, 975, 828, 755, 708, 694, 635, 573, 515.  Diffusion Coefficient 
(1H NMR, 500 MHz, CD3NO2, 294 K): 3.20 (± 0.03) x 10-10 m2/s. 
 
Table 2.8 - 1H NMR data of [Pt2(BPE)2(dppp)2][OTf]8 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.99 d  8 3Jab = 5.8 
b 7.58 d  8 3Jba = 5.8 
c 8.07 d  8 3Jcd = 7.0 
d 8.82 d 8 3Jdc = 7.0 
e 5.49 s 8 - 
f 2.41 broad t 4 - 
g 3.35 broad s 8 - 
h 7.41 m 16 3Jhi = 7.1 
i 7.70 dd 16 3Jhi, ij = 8.0 
j 7.48 t 8 3Jji = 7.4 
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Table 2.9 – 13C NMR data of [Pt2(BPE)2(dppp)2][OTf]8 in CD3NO2. 
Carbon δ (ppm) # Carbons (J (Hz)) 
1 152.75 8 
2 127.22 8 
3 146.82 4 
4 154.77 4 
5 129.05 8 
6 147.02 8 
7 61.99 4 
8 22.51 2 
9 18.66 4 
10 125.56 8 (1JC-P = 65.4) 
11 130.92 16 
12 134.43 16 
13 134.03 8 
OTf- 122.22 8 (1JC-F = 318.3) 
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DOSY of [Pt2(BPE)2(dppp)2][OTf]8 in CD3NO2. 
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2.7.5 Synthesis of [Pt2(BPE)2(PEt3)4][OTf]8 
[BPE][OTf]2 (0.032 g, 0.05 mmol) and cis-[Pt(PEt3)2(OTf)2] (0.036 g, 0.05 mmol) were 
dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Slow diffusion of isopropyl 
ether into the filtrate produces colourless microcrystals.  Yield: 0.068 g, 99 %.  MP: >300 
°C.  31P NMR (202 MHz, CD3NO2, 298 K) δ = 1.72 (1JP-Pt = 3077 Hz).  IR (ATR) ν/cm-1 
= 3549, 3103, 3056, 3025, 2980, 2943, 2884, 1646, 1619, 1428, 1248, 1222, 1153, 1076, 
1026, 831, 757, 736, 723, 635, 573, 516.  Diffusion Coefficient (1H NMR, 500 MHz, 
CD3NO2, 294 K): 3.36 (± 0.02) x 10-10 m2/s. 
 
Table 2.10 - 1H NMR data of [Pt2(BPE)2(PEt3)4][OTf]8 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.20 d  8 3Jab = 5.7 
b 8.14 d  8 3Jba = 5.7 
c 8.36 d  8 3Jcd = 7.0 
d 8.90 d 8 3Jdc = 7.0 
e 5.52 s 8 - 
f 1.33 m 36 - 
g 1.98 m 24 - 
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Table 2.11 – 13C NMR data of [Pt2(BPE)2(PEt3)4][OTf]8 in CD3NO2. 
Carbon δ (ppm) # Carbons (J (Hz)) 
1 152.70 8 
2 128.59 8 
3 148.13 4 
4 154.83 4 
5 129.31 8 
6 147.08 8 
7 62.07 4 
8 8.36 12 
9 16.16 12 (1JC-P = 38.2) 
OTf- 122.21 8 (1JC-F = 318.2) 
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DOSY of [Pt2(BPE)2(PEt3)4][OTf]8 in CD3NO2. 
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2.7.6 Synthesis of [Pd2(BPE)2(en)2][OTf]8 
[BPE][OTf]2 (0.032 g, 0.05 mmol) and [Pd(en)(OH2)][OTf]2 (0.025g, 0.05 mmol) were 
dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Slow diffusion of isopropyl 
ether into the filtrate produces light yellow crystals.  Yield: 0.055g, 99 %.  MP: 250-260 
°C (decomp).  IR (ATR) ν/cm-1 = 3515, 3230, 3133, 3115, 3061, 1645, 1620, 1546, 1499, 
1468, 1242, 1221, 1152, 1024, 826, 759, 725, 632, 572, 535.  Diffusion Coefficient (1H 
NMR, 500 MHz, CD3NO2, 294 K): 3.39 (± 0.03) x 10-10 m2/s. 
 
Table 2.12 - 1H NMR data of [Pd2(BPE)2(en)2][OTf]8 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.11 d  8 3Jab = 6.8 
b 8.04 d  8 3Jba = 6.8 
c 8.39 d  8 3Jcd = 7.0 
d 8.87 d 8 3Jdc = 7.0 
e 5.55 s 8 - 
f 3.12 broad s 8 - 
g 4.69 s 8 - 
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Table 2.13 – 13C NMR data of [Pd2(BPE)2(en)2][OTf]8 in CD3NO2. 
Carbon δ (ppm) # Carbons (J (Hz)) 
1 154.28 8 
2 126.76 8 
3 147.34 4 
4 155.28 4 
5 129.22 8 
6 146.98 8 
7 62.15 4 
8 47.82 4 
OTf- 122.13 8 (1JC-F = 318.0) 
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DOSY of [Pd2(BPE)2(en)2][OTf]8 in CD3NO2. 
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2.7.7 Synthesis of [Pt4(BPE⊂DB24C8)4(dppp)4][OTf]16 
[Pt2(BPE)2(dppp)2][OTf]8 (1.5 mg, 0.0005 mmol) was dissolved in MeNO2 (1 mL) to 
produce a 1 mM solution.  The addition of DB24C8 (20 eq. 9.0 mg, 0.020 mmol) and 
stirring at RT for 10 min produces a yellow solution.  31P NMR (202 MHz, CD3NO2, 298 
K) δ = -13.01 (1JP-Pt = 3042 Hz).  Diffusion Coefficient (1H NMR, 500 MHz, CD3NO2, 
294 K): 2.42 (± 0.03) x 10-10 m2/s. 
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Table 2.14 - 1H NMR data of [Pt4(BPE⊂DB24C8)4(dppp)4][OTf]16 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.00 d  16  3Jab = 5.3 
b 7.49 overlapped m  16 - 
c 7.95 d  16 3Jcd = 6.9 
d 9.21 d 16 3Jdc = 6.9 
e 5.53 s 16 - 
f 6.09 m 16 - 
g 6.49 m 16 - 
h-j 3.85 – 4.05 overlapped m 96 - 
k 2.44 broad m 8 - 
l 3.38 broad s 16 - 
m 7.48 overlapped m 32 - 
n 7.79 m 32 3Jnm,no = 7.2 
o 7.53 t 16 3Jon = 7.4 
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Table 2.15 – 13C NMR data of [Pt4(BPE⊂DB24C8)4(dppp)4][OTf]16 in CD3NO2. 
Carbon δ (ppm) # Carbons (J (Hz)) 
1 152.60 16 
2 126.39 16 
3 145.48 8 
4 151.88 8 
5 126.77 16 
6 147.98 16 
7 59.55 8 
8 122.37 16 
9 113.55 16 
10 148.12 16 
11 68.91 16 
12 71.34 16 
13 71.92 16 
14 18.59 4 
15 22.50 8 
16 125.66 16 (1JC-P = 67.7) 
17 130.96 32 
18 134.52 32 
19 134.17 16 
OTf- 122.44 16 (1JC-F = 318.6) 
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DOSY of [Pt4(BPE⊂DB24C8)4(dppp)4][OTf]16 in CD3NO2. 
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2.7.8 Synthesis of [Pt4(BPE⊂DB24C8)4(PEt3)8][OTf]16 
[Pt2(BPE)2(PEt3)4][OTf]8 (1.4 mg, 0.0005 mmol) was dissolved in MeNO2 (1 mL) to 
produce a 1 mM solution.  The addition of DB24C8 (5 eq. 2.2 mg, 0.005 mmol) and 
stirring at RT for 10 min produces a yellow solution.  31P NMR (202 MHz, CD3NO2, 298 
K) δ = 1.55 (1JP-Pt = 3083 Hz).  Diffusion Coefficient (1H NMR, 500 MHz, CD3NO2, 294 
K): 2.46 (± 0.06) x 10-10 m2/s. 
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Table 2.16 - 1H NMR data of [Pt4(BPE⊂DB24C8)4(PEt3)8][OTf]16 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.24 d  16 3Jab = 5.6 
b 8.06 d  16 3Jba = 5.6 
c 8.24 d  16 3Jcd = 6.8 
d 9.27 d 16 3Jdc = 6.8 
e 5.62 s 16 - 
f 6.05 m 16 - 
g 6.56 m 16 - 
h 4.00 broad s 32 - 
i 3.95 broad s 32 - 
j 3.92 broad s 32 - 
k 1.40 m 72 - 
l 2.04 m 48 - 
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Table 2.17 – 13C NMR data of [Pt4(BPE⊂DB24C8)4(PEt3)8][OTf]16 in CD3NO2. 
Carbon δ (ppm) # Carbons 
1 152.76 16 
2 128.13 16 
3 146.25 8 
4 151.37 8 
5 126.54 16 
6 147.92 16 
7 59.62 8 
8 122.41 16 
9 113.85 16 
10 150.30 16 
11 68.87 16 
12 71.59 16 
13 71.78 16 
14 8.40 24 
15 16.22 24 (1JC-P = 38.5) 
OTf- 122.41 16 (1JC-F = 318.7) 
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DOSY of [Pt4(BPE⊂DB24C8)4(PEt3)8][OTf]16 in CD3NO2. 
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2.7.9 Synthesis of [Pd4(BPE⊂DB24C8)4(en)4][OTf]16 and 
[Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32 
[Pd2(BPE)2(en)2][OTf]8 (1.1 mg, 0.0005 mmol) and DB24C8 (10 eq. 4.5 mg, 0.010 
mmol)  were dissolved in MeNO2 (1 mL) and stirred at RT for 10 min to produce a 1 mM 
yellow solution consisting of a mixture of [Pd4(BPE⊂DB24C8)4(en)4][OTf]16 and 
[Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32.   
To produce exclusively [Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32, [Pd2(BPE)2(en)2][OTf]8 
(0.055g, 0.025 mmol) and DB24C8 (5 eq. 0.112 g, 0.250 mmol) were dissolved in 
MeNO2 (1 mL) and stirred at RT for 10 min to produce a darker yellow 50 mM solution. 
 
[Pd4(BPE⊂DB24C8)4(en)4][OTf]16 Diffusion Coefficient (1H NMR, 500 MHz, 
CD3NO2, 294 K): 2.27 (± 0.03) x 10-10 m2/s. 
[Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32 Diffusion Coefficient (1H NMR, 500 MHz, 
CD3NO2, 294 K): 1.88 (± 0.00) x 10-10 m2/s. 
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Table 2.18 - 1H NMR data of [Pd4(BPE⊂DB24C8)4(en)4][OTf]16 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.10 d  16 3Jab = 7.1 
b 7.78 d  16 3Jba = 7.1 
c 8.10 d  16 3Jcd = 6.9 
d 9.24 d 16 3Jdc = 6.9 
e 5.58 s 16 - 
f 6.10 m 16 - 
g 6.56 m 16 - 
h-j 3.90-4.15 m 96 - 
k 3.19 broad s 16 - 
l 4.99 broad s 16 - 
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Table 2.19 - 1H NMR data of [Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.12 d  32 3Jab = 7.0 
b 7.80 d  32 3Jba = 7.0 
c 8.15 d  32 3Jcd = 7.0 
d 9.36 d 32 3Jdc = 7.0 
e 5.69 s 32 - 
f 6.18 m 32 - 
g 6.63 m 32 - 
h-j 3.70-4.30 m 192 - 
k 3.19 broad s 32 - 
l 4.86 broad s 32 - 
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Table 2.20 – 13C NMR data of [Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32 in CD3NO2. 
Carbon δ (ppm) # Carbons 
1 154.46 32 
2 126.32 32 
3 145.78 16 
4 152.58 16 
5 126.52 32 
6 148.03 32 
7 59.59 16 
8 122.74 32 
9 113.71 32 
10 148.35 32 
11 69.04 32 
12 71.60 32 
13 71.72 32 
14 48.69 16 
OTf- 122.30 32 (1JC-F = 318.4) 
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DOSY of [Pd4(BPE⊂DB24C8)4(en)4][OTf]16 and [Pd4(BPE⊂DB24C8)4(en)4]2[OTf]32 
in CD3NO2. 
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2.7.10 Synthesis of DP 
1,4-Dibromobenzene (3.84 g, 0.0163 mol) and 4-pyridineboronic acid (5.00 g, 0.0407 
mol) were dissolved in DMF (200 mL) under N2.  Tetrakis(triphenylphosphine) 
palladium (0) (0.94 g, 0.813 mmol) was added to the mixture, followed by sodium 
carbonate (8.62 g, 0.0814 mol) dissolved in water (min) under N2.  The solution was then 
refluxed for 7 days, concentrated to dryness, and the resulting residue dissolved in 
CH2Cl2 (200-300 mL) and H2O (100-200 mL).  This mixture was filtered, and the organic 
and aqueous layers separated.  The organic layer was then washed with water (3 x 50 
mL), dried over K2CO3, filtered, and concentrated to dryness.  The residue was 
recrystallized by dissolving in acetone (min), filtering, cooling in freezer for 12 h, and 
filtering again to isolate an off-white solid.  Yield: 3.30 g, 87 %. 
 
Table 2.21 - 1H NMR data of DP in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.71 d  4 3Jab = 6.1 
b 7.57 d  4 3Jba = 6.1 
c 7.79 s 4 - 
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2.7.11 Synthesis of [DM][OTf] 
4,4’-Bipyridine (1.80 g, 0.0115 mol) and methyl iodide (0.80 mL, 0.0140 mol) were 
refluxed in CH2Cl2 (min.) under N2 for 2 h.  The solution was allowed to cool to RT, the 
precipitate filtered off, washed with EtOAc, recrystallized from MeOH (Yield: 1.72 g, 50 
%), and anion exchanged to the triflate salt by way of a two layer NaOTf (aq)/MeNO2 
extraction.  Yield: 1.38 g, 75 %.  Diffusion Coefficient (1H NMR, 500 MHz, CD3NO2, 
294 K): 9.28 (± 0.05) x 10-10 m2/s. 
 
Table 2.22 - 1H NMR data of [DM][I] in CD3SO. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.86 d  2 3Jab = 6.0 
b 8.03 d  2 3Jba = 6.0 
c 8.61 d 2 3Jcd = 6.7 
d 9.13 d 2 3Jdc = 6.7 
e 4.38 s 3 - 
 
Table 2.23 - 1H NMR data of [DM][OTf] in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.84 d  2 3Jab = 6.1 
b 7.86 d  2 3Jba = 6.1 
c 8.42 d 2 3Jcd = 6.6 
d 8.88 d 2 3Jdc = 6.6 
e 4.53 s 3 - 
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2.7.12 Synthesis of [DPM][OTf] 
DP (0.89 g, 0.00383 mol) and methyl iodide (0.27 mL, 0.00456 mol) were refluxed in 
CH2Cl2 (min.) under N2 at for 2 h.  The solution was allowed to cool to RT, the 
precipitate filtered off, washed with EtOAc, recrystallized from MeOH, and purified by 
column chromatography on silica gel using a 7:1:2 mixture of MeOH, 2M NH4Cl (aq) 
and MeNO2.  The product was anion exchanged to the triflate salt by way of a two layer 
NaOTf (aq)/MeNO2 extraction.  Yield: 0.66 g, 43 %.  Diffusion Coefficient (1H NMR, 
500 MHz, CD3NO2, 294 K): 6.57 (± 0.03) x 10-10 m2/s. 
 
Table 2.24 - 1H NMR data of [DPM][OTf] in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.71 d  2 3Jab = 5.2 
b 7.74 d  2 3Jba = 5.2 
c 8.00 d 2 3Jcd = 8.4 
d 8.07 d 2 3Jdc = 8.4 
e 8.30 d 2 3Jef = 6.6 
f 8.64 d 2 3Jdc = 6.6 
e 4.29 s 3 - 
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Table 2.25 - 1H NMR data of [DPM][OTf] in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.71 d  2 3Jab = 4.8 
b 7.79 d  2 3Jba = 4.8 
c 8.05 d 2 3Jcd = 6.8 
d 8.15 d 2 3Jdc = 6.8 
e 8.41 d 2 3Jef = 6.8 
f 8.80 d 2 3Jdc = 6.8 
e 4.49 s 3 - 
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2.7.13 Synthesis of [Pt(DM)2(dppp)][OTf]4 
[DM][OTf] (0.032 g, 0.0999 mmol) and [Pt(dppp)(OTf)2]  (0.045 g, 0.0497 mmol) were 
dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Removal of the solvent 
produces a yellow glass.  Yield: 0.075 g, 97%.  MP: >300 °C.  31P NMR (202 MHz, 
CD3NO2, 298 K) δ = -13.26 (1JP-Pt = 3020 Hz).  IR (ATR) ν/cm-1 = 3511, 3125, 3103, 
3057, 2996, 2967, 2930, 2866, 1648, 1619, 1548, 1528, 1497, 1585, 1467, 1437, 1250, 
1224, 1155, 1102, 1076, 1028, 999, 978, 822, 756, 735, 707, 695, 674, 636, 574, 517.  
Diffusion Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 4.54 (± 0.02) x 10-10 m2/s. 
 
Table 2.26 - 1H NMR data of [Pt(DM)2(dppp)][OTf]4 in CD3NO2 (partially 
dissociates). 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.09 d  4 3Jab = 5.9 
b 7.68 d  4 3Jba = 5.9 
c 8.19 d 4 3Jcd = 6.8 
d 8.85 d 4 3Jdc = 6.8 
e 4.50 s 6 - 
f 2.42 broad m  2 - 
g 3.39 broad m  4 - 
h 7.42 m 8 3Jhi = 7.2 
i 7.75 dd  8 3Jih,ij = 7.8 
j 7.49 t  4 3Jji = 7.4 
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Table 2.27 – 13C NMR data of [Pt(DM)2(dppp)][OTf]4 in CD3NO2 (partially 
dissociates). 
Carbon δ (ppm) # Carbons 
1 152.86 4 
2 126.92 4 
3 146.63 2 
4 152.46 2 
5 127.48 4 
6 147.45 4 
7 49.59 2 
8 18.69 1 
9 22.55 2 
10 125.89 4 (1JC-P = 51.9) 
11 130.92 8 
12 134.48 8 
13 134.00 4 
OTf- 122.37 4 (1JC-F = 318.4) 
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DOSY of [Pt(DM)2(dppp)][OTf]4 in CD3NO2 (partially dissociates). 
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2.7.14 Synthesis of [Pt(DM)2(PEt3)2][OTf]4 
[DM][OTf] (0.032 g, 0.0999 mmol) and [Pt(PEt3)2(OTf)2]  (0.036 g, 0.0493 mmol) were 
dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Removal of the solvent 
produces a yellow glass.  Yield: 0.067 g, 99 %.  MP: >300 °C.  31P NMR (202 MHz, 
CD3NO2, 298 K) δ = 1.47 (1JP-Pt = 3070 Hz).  IR (ATR) ν/cm-1 = 3505, 3103, 3058, 
2974, 2945, 2886, 1647, 1619, 1580, 1541, 1498, 1463, 1424, 1393, 1252, 1224, 1195, 
1153, 1075, 1028, 976, 873, 827, 757, 734, 719, 636, 574, 517.  Diffusion Coefficient 
(1H NMR, 500 MHz, CD3NO2, 294 K): 4.73 (± 0.00) x 10-10 m2/s. 
 
Table 2.28 - 1H NMR data of [Pt(DM)2(PEt3)2][OTf]4 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.23 d  4 3Jab = 6.7 
b 8.20 d  4 3Jba = 6.7 
c 8.40 d 4 3Jcd = 6.9 
d 8.91 d 4 3Jdc = 6.9 
e 4.51 s 6 - 
f 1.34 m  18 - 
g 1.97 m  12 - 
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Table 2.29 – 13C NMR data of [Pt(DM)2(PEt3)2][OTf]4 in CD3NO2. 
Carbon δ (ppm) # Carbons 
1 152.78 4 
2 128.26 4 
3 147.73 2 
4 152.32 2 
5 127.63 4 
6 147.54 4 
7 49.69 2 
8 8.34 6 
9 16.11 6 (1JC-P = 38.9) 
OTf- 122.32 4 (1JC-F = 318.5) 
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DOSY of [Pt(DM)2(PEt3)2][OTf]4 in CD3NO2. 
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2.7.15 Synthesis of [Pd(DM)2(en)][OTf]4 
[DM][OTf] (0.032 g, 0.0999 mmol) and [Pt(en)2(OH2)2][OTf]2  (0.025 g, 0.0499 mmol) 
were dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Removal of the 
solvent produces an orange yellow glass.  Yield: 0.054 g, 98 %.  MP: 235-245 °C 
(decomp).  IR (ATR) ν/cm-1 = 3510, 3231, 3130, 3110, 3059, 3029, 2966, 1644, 1620, 
1582, 1544, 1499, 1467, 1427, 1247, 1223, 1156, 1080, 1058, 1026, 869, 824, 758, 737, 
718636, 574, 544.  Diffusion Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 5.13 (± 
0.03) x 10-10 m2/s. 
 
Table 2.30 - 1H NMR data of [Pd(DM)2(en)][OTf]4 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.21 d  4 3Jab = 6.9 
b 8.08 d  4 3Jba = 6.9 
c 8.39 d 4 3Jcd = 6.9 
d 8.91 d 4 3Jdc = 6.9 
e 4.53 s 6 - 
f 3.12 broad s  4 - 
g 4.69 broad s 4 - 
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Table 2.31 – 13C NMR data of [Pd(DM)2(en)][OTf]4 in CD3NO2. 
Carbon δ (ppm) # Carbons 
1 154.36 4 
2 126.48 4 
3 147.09 2 
4 153.09 2 
5 127.67 4 
6 147.44 4 
7 49.62 2 
8 48.67 2 
OTf- 122.27 4 (1JC-F = 318.2) 
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DOSY of [Pd(DM)2(en)][OTf]4 in CD3NO2. 
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2.7.16 Synthesis of [Pt(DPM)2(dppp)][OTf]4 
[DPM][OTf] (0.040 g, 0.0.1009 mmol) and [Pt(dppp)(OTf)2]  (0.045 g, 0.0497 mmol) 
were dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Removal of the 
solvent produced a yellow glass.  Yield: 0.083 g, 99 %.  MP: >300 °C.  31P NMR (202 
MHz, CD3NO2, 298 K) δ = -12.92 (1JP-Pt = 3007 Hz).  IR (ATR) ν/cm-1 = 3507, 3124, 
3100, 3059, 2919, 1643, 1615, 1540, 1491, 1437, 1393, 1251, 1223, 1193, 1152, 1102, 
1073, 1027, 1010, 999, 977, 841, 817, 755, 707, 694, 676, 635, 573, 515.  Diffusion 
Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 3.99 (± 0.15) x 10-10 m2/s. 
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Table 2.32 - 1H NMR data of [Pt(DPM)2(dppp)][OTf]4 in CD3NO2 (partially 
dissociated). 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.85 d  4 3Jab = 5.3 
b 7.58 d  4 3Jba = 5.3 
c 7.84 d 4 3Jcd = 8.8 
d 8.08 d 4 3Jdc = 8.8 
e 8.36 d 4 3Jef = 7.1 
f 8.79 d 4 3Jfe = 7.1 
g 4.47 s 6 - 
h 2.39 broad m  2 - 
i 3.36 broad s  4 - 
j 7.44 m 8 3Jjk = 7.1 
k 7.76 dd  8 3Jkj,kl = 7.9 
l 7.51 t  4 3Jlk = 7.3 
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Table 2.33 – 13C NMR data of [Pt(DPM)2(dppp)][OTf]4 in CD3NO2 (partially 
dissociated). 
Carbon δ (ppm) # Carbons 
1 151.78 4 
2 126.50 4 
3 151.96 2 
4 137.34 2 
5 129.90 4 
6 130.30 4 
7 140.03 2 
8 156.53 2 
9 126.76 4 
10 146.62 4 
11 48.94 2 
12 18.76 1 
13 22.80 2 
14 125.64 4 (1JC-P = 35.0) 
15 130.88 8 
16 134.48 8 
17 133.90 4 
OTf- 122.41 4 (1JC-F = 318.6) 
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DOSY of [Pt(DPM)2(dppp)][OTf]4 in CD3NO2 (partially dissociated). 
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2.7.17 Synthesis of [Pt(DPM)2(PEt3)2][OTf]4 
[DPM][OTf] (0.040 g, 0.1009 mmol) and [Pt(PEt3)2(OTf)2]  (0.036 g, 0.0493 mmol) 
were dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Removal of the 
solvent produces a yellow glass.  Yield: 0.074 g, 99 %.  MP: >300 °C.  31P NMR (202 
MHz, CD3NO2, 298 K) δ = 1.38 (1JP-Pt = 3062 Hz).  IR (ATR) ν/cm-1 = 3507, 3132, 
3104, 3058, 3974, 2945, 2885, 1645, 1615, 1541, 1492, 1464, 1432, 1406, 1394, 1253, 
1223, 1194, 1153, 1072, 1028, 1009, 818, 770, 757, 732, 636, 573, 517.  Diffusion 
Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 4.28 (± 0.01) x 10-10 m2/s. 
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Table 2.34 - 1H NMR data of [Pt(DPM)2(PEt3)2][OTf]4 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.03 d  4 3Jab = 6.6 
b 8.09 d  4 3Jba = 6.6 
c 8.04 d 4 3Jcd = 8.7 
d 8.14 d 4 3Jdc = 8.7 
e 8.38 d 4 3Jef = 7.0 
f 8.79 d 4 3Jfe = 7.0 
g 4.47 s 6 - 
h 1.36 m  18 - 
i 2.00 m  12 - 
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Table 2.35 – 13C NMR data of [Pt(DPM)2(PEt3)2][OTf]4 in CD3NO2. 
Carbon δ (ppm) # Carbons 
1 151.85 4 
2 127.13 4 
3 152.64 2 
4 137.64 2 
5 129.98 4 
6 130.39 4 
7 139.62 2 
8 156.47 2 
9 126.52 4 
10 146.65 4 
11 48.96 2 
12 8.38 6 
13 16.10 6 (1JC-P = 38.5) 
OTf- 122.39 4 (1JC-F = 318.5) 
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DOSY of [Pt(DPM)2(PEt3)2][OTf]4 in CD3NO2. 
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2.7.18 Synthesis of [Pd(DPM)2(en)][OTf]4 
[DPM][OTf] (0.040 g, 0.1009 mmol) and [Pt(en)2(OH2)2][OTf]2  (0.025 g, 0.0499 mmol) 
were dissolved in MeNO2 (1 mL), stirred for 10 min, and filtered.  Removal of solvent 
produces a light yellow waxy solid.  Yield: 0.062 g, 98 %.  MP: 195-205 °C (decomp).  
IR (ATR) ν/cm-1 = 3510, 3231, 3130, 3110, 3059, 3029, 2966, 1644, 1620, 1582, 1544, 
1499, 1467, 1427, 1247, 1223, 1156, 1080, 1058, 1026, 869, 824, 758, 737, 718, 636, 
574, 517.  Diffusion Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 4.45 (± 0.01) x 
10-10 m2/s. 
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Table 2.36 - 1H NMR data of [Pd(DPM)2(en)][OTf]4 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 9.03 d  4 3Jab = 6.7 
b 7.99 d  4 3Jba = 6.7 
c 8.05 d 4 3Jcd = 8.5 
d 8.15 d 4 3Jdc = 8.5 
e 8.39 d 4 3Jef = 6.3 
f 8.80 d 4 3Jfe = 6.3 
g 4.48 s  6 - 
h 3.12 broad s  4 - 
i 4.62 broad s  4 - 
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Table 2.37 – 13C NMR data of [Pd(DPM)2(en)][OTf]4 in CD3NO2. 
Carbon δ (ppm) # Carbons 
1 153.42 4 
2 125.75 4 
3 152.01 2 
4 137.34 2 
5 129.98 4 
6 130.36 4 
7 140.32 2 
8 156.61 2 
9 126.52 4 
10 146.61 4 
11 48.94 2 
12 48.56 2 
OTf- 122.31 4 (1JC-F = 318.1) 
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DOSY of [Pd(DPM)2(en)][OTf]4 in CD3NO2. 
 
 
 
CHAPTER 3 
 
An Interlocked [2]Rotaxane Ligand for the Self-Assembly of 
MORPs 
 
3.1 INTRODUCTION 
 Dibenzo-24-crown-8 (DB24C8) has been used in conjunction with a variety of 
linear cationic molecules for the formation of [2]pseudorotaxanes.113  The first system 
reported, discovered by Stoddart, used secondary ammonium cations 
(N,N-dibenzylammonium, Figure 3.1) as the axle.114-118  The dibenzylammonium cation 
and DB24C8 macrocycle are held together by strong NH···O hydrogen bonds as well as 
N+···O ion-dipole interactions (Figure 3.1 left) 
 
Figure 3.1 – N,N-Dibenzylammonium (left), N-benzylanilinium (middle), and 
bis(pyridinium)ethane (right) [2]pseudorotaxanes with DB24C8. 
 
A second system, studied by the Loeb group, uses 1,2-bis(pyridinium)ethane 
(BPE) cations as the axles (as introduced in Chapter 2).  These [2]pseudorotaxanes are 
held together via a series of weaker CH···O hydrogen bonds, two sets of N+···O ion-
dipole interactions and significant π-stacking between the electron poor pyridinium rings 
of BPE and the electron rich catechol rings of DB24C8 (Figure 3.1). 
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A third type of axle consisting of an N-benzylanilinium (NBA) cation, also 
studied in the Loeb group, combines favourable features of the two above systems.119-121  
This system is held together by N+···O ion-dipole interactions, strong NH···O hydrogen 
bonding, weaker CH···O hydrogen bonding, and π-stacking interactions between 
relatively electron poor aromatic rings of the axle and the electron rich catechol rings of 
the crown ether. 
 
Figure 3.2 – Protonated (left) and neutral (right) N-benzylanilinium recognition 
sites. 
 
A useful feature of this axle is that the recognition site can be turned partially ON 
and OFF via acid-base chemistry (Figure 3.2).  Deprotonation of the N-benzylanilinium 
cation disrupts the N+···O ion-dipole interactions, and weakens the NH···O hydrogen 
bonding, the CH···O hydrogen bonding, and the π-stacking interactions as the axle is less 
electron poor when neutral.  It also eliminates the accompanying anion.  
 
Figure 3.3 – Design of the [2]rotaxane linker. 
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This chapter describes the incorporation of an N-benzylanilinium (NBA) and 
DB24C8 based [2]rotaxane into a MORP.  The linker design (Figure 3.3) is of a 
[2]rotaxane of the same general size and shape as the [2]pseudorotaxane employed as the 
linker in Chapter 2.  The design features the NBA recognition site instead of BPE, 24C6 
instead of DB24C8, as well as two methyl groups on each of the inner aromatic rings that 
act as stoppers. 
3.2 SYNTHESIS AND CHARACTERIZATION 
3.2.1 Synthesis of [2]Rotaxane 
 The synthesis of the NBA containing [2]rotaxane first necessitates the synthesis 
of a pre-axle building block containing the recognition site via a six-step synthetic 
sequence as outlined in Schemes 3.1 and 3.2. 
 
Scheme 3.1 – Synthesis of NBA containing pre-axle building block components. 
 
The first step is the bromination of 3,5-dimethylaniline with N-bromosuccinimide 
in acetonitrile to produce 4-bromo-3,5-dimethylaniline after extraction with ethyl 
acetate and purification by column chromatography.  The amine is then converted to an 
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iodo-group via the diazonium salt.  This is accomplished by reacting 
4-bromo-3,5-dimethylaniline with sodium nitrite in sulfuric acid, followed by addition 
to potassium iodide in water, neutralization, extraction, and concentration to generate 
2-bromo-5-iodo-m-xylene.  The third step consists of the conversion of the iodo-group 
to an aldehyde by the combination of 2-bromo-5-iodo-m-xylene with n-butyllithium in 
tetrahydrofuran, followed by the addition of dimethylformamide, acidification, extraction 
with ethyl acetate, to produce 4-bromo-3,5-dimethylbenzaldehyde after purification by 
column chromatography. 
 
Scheme 3.2 – Synthesis of NBA containing pre-axle building block. 
 
The axle is assembled by means of the combination of the products produced in 
the first and third steps using a Schiff base reaction.  The reaction of 
4-bromo-3,5-dimethylaniline with 4-bromo-3,5-dimethylbenzaldehyde in the presence 
of magnesium sulfate in chloroform produces Br(Me)2PhN=CPh(Me)2Br, after 
filtration, concentration, and recrystallization from methanol.  This is followed by a 
reduction with sodium borohydride in a mixture of ethanol and tetrahydrofuran.  The 
crude product was purified by redissolving in chloroform, washing with water, and 
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concentrating to generate the corresponding amine, Br(Me)2PhN-CPh(Me)2Br.  
Protonation of the amine with tetrafluoroboric acid in diethyl ether generates the pre-axle 
with recognition site, [Br(Me)2PhNH2-CPh(Me)2Br][BF4]. 
The second building block, the pre-wheel, is synthesized by the double alkylation 
of pentaethylene glycol with 5-bromo-1-pentene using sodium hydride and sodium iodide 
in tetrahydrofuran (Scheme 3.3).  After neutralization, organic workup and purification 
by column chromatography this produces the pre-wheel, pentaethylene glycol 
di-pent-4-enyl ether. 
 
Scheme 3.3 – Synthesis of pre-wheel building block. 
 
The desired [2]rotaxane linker can be synthesized by the four step sequence laid 
out in Scheme 3.4.  The first step involves the synthesis of the [2]rotaxane via the 
clipping method.  This is accomplished by means of ring closing olefin metathesis, by 
reacting the protonated pre-axle, [Br(Me)2PhNH2-CPh(Me)2Br][BF4], with 
pentaethylene glycol di-pent-4-enyl ether, held together by NH···O hydrogen bonds, 
using the Grubbs I catalyst in dichloromethane.  The resulting solution was concentrated 
to yield a mixture of the trans-isomer, [Br(Me)2PhNH2-CPh(Me)2Br⊂(E)-24C6][BF4] 
and the cis-isomer, [Br(Me)2PhNH2-CPh(Me)2Br⊂(Z)-24C6][BF4].  The crude product 
was neutralized by dissolving in methanol, and treating with triethylamine.  The resulting 
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mixture was concentrated and purified by column chromatography to give a mixture of 
Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6. 
Scheme 3.4 – Synthesis of NBA containing [2]rotaxane. 
 
The next step consists of attaching the coordinating pyridines onto the axle by 
means of a double Suzuki coupling reaction.  The [2]rotaxane is reacted with 4-
pyridineboronic acid, with the palladium tetrakis triphenylphosphine catalyst and cesium 
carbonate in a mixture of dimethylformamide and toluene at 120 °C for eighteen hours.  
An organic workup and recrystallization from acetonitrile, afforded the product, a 
mixture of Py(Me)2PhN-CPh(Me)2Py⊂(E)-24C6 and Py(Me)2PhN-CPh(Me)2Py⊂(Z)-
24C6. 
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 The last step is the hydrogenation of the double bond remaining from the clipping 
reaction.  This is accomplished by the reaction of the mixture of 
Py(Me)2PhN-CPh(Me)2Py⊂(E)-24C6 and Py(Me)2PhN-CPh(Me)2Py⊂(Z)-24C6 with 
hydrogen gas and palladium on carbon in methanol.  Filtration, concentration, and 
recrystallization from hexanes produces the [2]rotaxane ligand, 
Py(Me)2PhN-CPh(Me)2Py⊂24C6. 
3.2.2 Synthesis of Naked Axle 
The corresponding naked axle was also synthesized for use as a ligand as depicted 
in Scheme 3.5.  The reaction of Br(Me)2PhN-CPh(Me)2Br with 4-pyridineboronic acid, 
palladium tetrakis triphenylphosphine, and cesium carbonate in a mixture of 
dimethylformamide and toluene, followed by filtration, concentration and 
recrystallization from acetonitrile produced the naked axle, Py(Me)2PhN-CPh(Me)2Py 
in high yield.  
 
Scheme 3.5 – Synthesis of naked axle ligand, Py(Me)2PhN-CPh(Me)2Py. 
 
3.2.3 1H NMR Analysis 
 Depicted in Figure 3.4 are the 1H NMR spectra for the macrocyclic wheel, 24C6, 
the [2]rotaxane ligand, Py(Me)2PhN-CPh(Me)2Py⊂24C6, and the naked axle ligand, 
Py(Me)2PhN-CPh(Me)2Py.  Comparing 24C6 with Py(Me)2PhN-CPh(Me)2Py⊂24C6, 
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shows that the signals from protons k-p become broader and shift slightly upfield. The 
efect of [2]rotaxane formation on protons q-s from the alkyl chain portion of 24C6 is 
similar.  When comparing the Py(Me)2PhN-CPh(Me)2Py naked axle with the 
Py(Me)2PhN-CPh(Me)2Py⊂24C6 [2]rotaxane it can be seen the signals from the protons 
that are on the ends of the axle removed from the influence of the wheel, a, b, c, h, i, and 
j, do not shift markedly. 
 
 
Figure 3.4 – Structure of Py(Me)2PhN-CPh(Me)2Py⊂24C6 with labeling scheme, 
and 1H NMR spectra of 24C6 (top), the Py(Me)2PhN-CPh(Me)2Py⊂24C6 
[2]rotaxane (middle), and the Py(Me)2PhN-CPh(Me)2Py naked axle (botom) in 
CDCl3. 
 
The aromatic protons from the inner ring, d, and g shift downfield by ~0.2 and 0.3 
ppm, respectively, and proton f shifts ~0.2 ppm downfield, due to hydrogen bonding 
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interactions with the oxygen atoms of the wheel.  The largest shift is experienced by 
proton e, which shifts ~1.2 ppm downfield due to hydrogen bonding between the amine 
and the oxygen atoms of the wheel. 
3.2.4 X-Ray Crystallography of [2]Rotaxane Ligand 
 From the single crystal X-ray structure of the [2]rotaxane ligand, 
Py(Me)2PhN-CPh(Me)2Py⊂24C6, shown in Figure 3.5, it is possible to discern that the 
wheel does not sit perfectly perpendicular to the axle, but rather at an angle of about 45°. 
 
Figure 3.5 – Single crystal structure of Py(Me)2PhN-CPh(Me)2Py⊂24C6, ball and 
stick side view with hydrogen atoms omitted for clarity. 
 
The length of the [2]rotaxane ligand from pyridyl nitrogen atom to pyridyl 
nitrogen atom measures 17.7 Å, while the distance between the two furthest apart atoms 
of the crown ether macrocyclic wheel measures 9.8 Å.  Three of the six oxygen atoms of 
the crown ether are within hydrogen bonding distance of the amine group of the axle with 
N···O distances of 3.30, 3.44, and 3.63 Å and N-H···O angles of 99.0, 159.2 and 136.2°.  
The torsion angles between the outer pyridine and inner phenyl rings are close to 
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perpendicular at 81.4 and 77.6°, and the two inner phenyl rings are close to parallel with 
a torsion angle of 5.9°.   
 
Figure 3.6 – Single crystal structure of Py(Me)2PhN-CPh(Me)2Py⊂24C6, space 
filling side view (top), and top-down view (bottom). 
 
The space filling side view and top down view (Figure 3.6) shows the interlocked 
nature of the [2]rotaxane ligand, with the atoms of the crown ether macrocyclic wheel 
behind the methyl group stoppers on the axle, keeping the crown ether on the axle as a 
permanently interlocked [2]rotaxane. 
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3.3 SYNTHESIS AND CHARACTERIZATION OF MOP 
3.3.1 Synthesis of MOP with Naked Axle Linker.  
The naked axle, Py(Me)2PhN-CPh(Me)2Py, was combined with one of the cis-
protected metal complexes used in the previous chapter, [Pt(dppp)(OTf)2], in equimolar 
amounts in nitromethane solvent to produce dimeric MOP, 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 (Scheme 3.6). 
 
Scheme 3.6 – Synthesis of dimer [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4.  
 
The dimer was characterized using 1H NMR spectroscopy, as well as single 
crystal X-ray crystallography to determine the structure. 
3.3.2 1H NMR Analysis 
 The 1H NMR spectra for the naked axle, Py(Me)2PhN-CPh(Me)2Py, and the 
result of combining the naked axle ligand with [Pt(dppp)(OTf)2] are depicted in Figure 
3.6.  When the two components are combined at 10 mM in CD3NO2, the result is one 
major product and a number of other species.  After recrystallization the spectrum 
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simplifies somewhat with the major species remaining and most of the minor species 
disappearing. 
 
Figure 3.7 – 1H NMR spectra of Py(Me)2PhN-CPh(Me)2Py (top), [Pt2(Py(Me)2PhN-
CPh(Me)2Py)2(dppp)2][OTf]4 and impurities at 10 mM (middle), and 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 after recrystalization (botom) in 
CD3NO2. 
 
When comparing the spectrum from the naked axle linker and the spectra 
resulting from combination with the corner unit, it can be seen that protons a, j, and f, do 
not shift much upon coordination to the metal center.  The protons ortho- to the 
coordinating nitrogen atoms, a and j, would be expected to shift downfield upon 
coordination, however, this is canceled out by an upfield shift due to π-π stacking 
interactions with the aromatic rings on the Pt(dppp) corner units. Protons b and i, meta- 
to the coordinating nitrogen atoms, shift ~0.1 and 0.2 ppm upfield due to π-π stacking 
interactions with the aromatic rings of the corner units. Protons d and g from the inner 
aromatic rings shift ~0.2 and 0.1 ppm upfield, respectively. The amine proton, e, shifts 
~0.5 ppm downfield. 
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 From the 1H NMR spectra it can be concluded that coordination did occur due to 
the general broadening of all of the signals, especially the broadening of protons a and j 
ortho- to the coordinating nitrogen atoms.  It is not possible to determine the size and 
shape of the resulting MOP from 1H NMR spectroscopy, however, the structure was 
determined using single crystal X-ray crystallography. 
3.3.3 X-Ray Crystallography of Dimeric MOP  
Crystals suitable for single crystal X-ray structural determination of the dimeric 
MOP were grown by slow diffusion of isopropyl ether into a solution of 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 in a nitromethane/dichloromethane 
mixture.  The single crystal X-ray structure (Figure 3.7) confirms the dimeric formulation 
and square-like structure of the [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+ cation, as 
well as the π-π stacking interaction observed in the 1H NMR spectrum.  The atoms of the 
aromatic ring on the corner and the coordinating pyridine ring range between 3.17 and 
4.19 Å, which is very similar to what was observed in the [Pt2(BPE)2(dppp)2]8+ dimer 
from the previous chapter. 
The Pt···Pt distance measures 15.9 Å, and the distance between aniline nitrogen 
atoms across the other diagonal is 12.9 Å, which means that the 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+ dimer is less square-like than the 
[Pt2(BPE)2(dppp)2]8+ dimer (15.3 and 15.7 Å).  The dihedral angle between the outside 
pyridine ring and the inside phenyl ring is ranges between 64.2 and 72.4°, which is much 
larger than the comparable angle in the [Pt2(BPE)2(dppp)2]8+ dimer.  The N···Pt···N 
angles are both 80.3° which is further from 90° than the BPE containing dimer (87.1 and 
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85.0°).  The complementary P···Pt···P angles measure 94.3° which is towards the higher 
end of what was observed in the BPE containing dimer (90.5 and 93.7°).   
 
 
Figure 3.8 – Single crystal X-ray structure of 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4, ball and stick top view along b-axis 
(top), and side view along c-axis (bottom) with anions, solvent, and H-atoms omitted 
for clarity. 
 
The side view of the [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+ dimer reveals 
that the dimer adopts a puckered or bowl-like shape.  This is quite different from the 
[Pt2(BPE)2(dppp)2]8+ dimer which was perfectly planar.   
The packing diagram (Figure 3.8) shows the dimers stacked along the b-axis, 
again creating channel-like cavities.  [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+ dimer 
units are 10.9 Å apart which is much closer than the BPE containing dimer at 13.4 Å. 
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Figure 3.9 – Packing diagram of [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+, viewing 
along the b-axis, wireframe view omitting anions, solvent, and H-atoms for clarity. 
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3.4 SYNTHESIS AND CHARACTERIZATION OF MORP 
3.4.1 Synthesis of MORP 
The combination of cis-protected corner, [Pt(dppp)(OTf)2], with the [2]rotaxane 
ligand, Py(Me)2PhN-CPh(Me)2Py⊂24C6, ought to result in the synthesis of a MN, 
similar to those in Chapter 2, the only difference being a permanently interlocked 
[2]rotaxane ligand instead of the [2]pseudorotaxane ligand as illustrated in Scheme 3.7. 
Scheme 3.7 – Synthesis of [4]MN or [5]MN from Py(Me)2PhN-CPh(Me)2Py⊂24C6 
[2]rotaxane. 
 
3.4.2 1H NMR Analysis 
The 1H NMR spectra for the [2]rotaxane ligand, 
Py(Me)2PhN-CPh(Me)2Py⊂24C6, and the result of combination with [Pt(dppp)(OTf)2] 
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are depicted in Figure 3.9.  At 10 mM in CD3NO2, the combination of the two 
components produces one major product and some impurities.  Recrystalization 
simplifies the spectrum.  
 
Figure 3.10 – 1H NMR spectra of Py(Me)2PhN-CPh(Me)2Py⊂24C6 (top), resulting 
MORP at 10 mM (middle), and after recrystalization (botom) in CD3NO2. 
 
Al signals in the spectrum of the MORP, especialy protons a and j, ortho- to the 
coordinating nitrogen atoms, are broader than that of the [2]rotaxane, indicating that the 
ligand is coordinated to metal centers.  Protons a and j would be expected to be 
deshielded due to coordination, and shielded due to π-π stacking interactions with the 
aromatic rings on the Pt(dppp) corner units. Thus, proton a does not shift significantly, 
while j shifts ~0.1 ppm downfield. The protons meta- to the coordinating nitrogen atoms, 
b and i, both shift ~0.1 ppm upfield. The aromatic protons on the inner rings, d and g, 
both shift upfield, d by ~0.1 ppm, while the signal for proton g becomes obscured by the 
signals from the aromatic rings of the dppp unit of the corner. The amine proton e, shifts 
~0.1 ppm downfield, while methylene proton f does not shift significantly. 
An Interlocked [2]Rotaxane Ligand for the Self-Assembly of MORPs 
 
132 
Similar to the dimeric MOP it is not possible to determine the shape and size of 
the MORP from the 1H NMR spectra.  The structure was determined using single crystal 
X-ray crystallography. 
3.4.3 X-ray Crystallography of MORP  
Crystals fit for single crystal X-ray structural determination were grown by slow 
diffusion of isopropyl ether into a dichloromethane solution of the MORP. 
 
Figure 3.11 – Single crystal structure of triangular MORP 
[Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3]4+. 
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The structure (Figure 3.10) of the MORP was determined to be the trimeric 
[4]MN, a triangle in shape.  The crystal structure also confirms the π-π stacking 
interaction observed in the 1H NMR spectrum.  The distances between the atoms of the 
coordinating pyridine ring and the aromatic ring on the corner range between 3.20 and 
4.73 Å, which is further apart than what was observed in the 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+ MOP (between 3.17 and 4.19 Å). 
 
Figure 3.12 – Space-filling view of [Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3]4+ 
MORP.  
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Figure 3.13 – Packing diagram of [Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3]4+, 
viewing along the b-axis, wireframe view omitting 24C6 macrocycles, anions, 
solvent, and H-atoms for clarity. 
 
The Pt···Pt distance ranges from ~21.6 to 21.9 Å, which as expected is 
significantly further apart than in the MOP (15.9 Å), while the N···Pt···N angles range 
between 82.3 and 84.0°, less distorted from 90° than was observed in the MOP at 80.3°.  
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The P···Pt···P angles range between 88.4 and 92.9 °, which is smaller than in the MOP 
(94.3°).  The lengths of the [2]rotaxane ligands between pyridyl nitrogen atoms range 
from 17.6 to 17.8Å, which is about the same as what was measured in the crystal 
structure of the [2]rotaxane ligand (17.7Å).  This indicates that the 
Py(Me)2PhN-CPh(Me)2Py⊂24C6 ligands are close to linear, and do not bend 
significantly.  This observation combined with the observed N···Pt···N angles show that 
most of the accommodation of the strain inherent in the triangular shape happens at the 
metal centers. 
The space-filling view (Figure 3.11) illustrates that the 24C6 macrocycles fill the 
space inside the MORP perfectly.  
The packing diagram (Figure 3.12) illustrates that the triangular MORPs are 
arranged in a hexagonal pattern parallel to the ac plane, and stacked along the b-axis, 
creating channels filled with 24C6 macrocycles.  Stacking units of 
[Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3]4+ triangles are ~17.2 Å apart, with 
anions and solvent in between layers. 
3.5 DOSY ANALYSIS 
DOSY data were collected for both the dimeric MOP, 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4, and the trimeric MORP, 
[Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3][OTf]6, in CD3NO2 at 10 mM 
concentration and 21±0.5 °C, the same conditions as utilized in the previous chapter 
(Table 3.1).  The Diffusion coefficients were again extracted using DOSY toolbox and 
plotted on the calibration curve from the previous chapter. 
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Table 3.1 – Diffusion Coefficients and Modeled Radii of MOP and MORP. 
Assembly 
Diffusion 
Coefficients D 
(x 10-10 m2/s) 
Average 
Diffusion 
Coefficient D 
(x 10-10 m2/s) 
Radius r (Å) 
Calculated from 
calibration curve 
Radius r (Å) 
modelled 
Dimeric 
MOP 
3.4946 
3.6168 
3.6657 
3.59 (± 0.09) 7.5 8.2 
[4]MN 
2.7370 
2.7615 
2.8348 
2.78 (± 0.05) 9.7 9.2 
[5]MN - - - 11.0 
 
 
Figure 3.14 – Diffusion coefficient vs. the reciprocal of the modeled radius for the 
dimer, [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+. 
 
The sizes of the MOP and MORP were again modeled using their space-filled 
representations generated through molecular mechanics (MM3) geometry optimization 
from Scigress Explorer 7.7.  The hydrodynamic radius, r, for each was again 
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approximated as half of the longest distance in the space-filled representation of the 
calculated structure of the molecule. 
Comparing the calculated r value (7.5 Å) with the modelled values for the dimer, 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2]4+ (8.2 Å), shows that the experimental r value 
is in the range of the dimers from the previous chapter (Figure 3.13).  This result 
confirms the results from the solid state structure. 
 
Figure 3.15 – Diffusion coefficient vs. the reciprocal of the modeled radii for the 
[4]MN triangle, and [5]MN square possibilities for the MORP assembled from the 
Py(Me)2PhN-CPh(Me)2Py⊂24C6 [2]rotaxane linker and the [Pt(dppp)]2+ corner. 
 
Similarly, comparing the radius calculated using the calibration curve and the 
experimentally measured diffusion coefficient (9.7 Å) and modelled radii for the [4] and 
[5]MN (9.2 and 11.0 Å, respectively) possibilities, shows that the experimental r value is 
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closer to the modelled value for the [4]MN (Figure 3.14), which again agrees with the 
solid state results. 
3.6 SUMMARY AND CONCLUSIONS 
 A complementary naked axle and [2]rotaxane pair were successfully synthesized, 
and employed as the divergent linkers in the synthesis of both a dimeric MOP and a 
trimeric [4]MN MORP.  The absence or presence of the 24C6 macrocycle is the only 
difference between the two self-assembled metallomacrocycles, and thus controls the 
self-assembly process, and the size and shape of the product.  
 This system was an improvement upon that employed in chapter 2 as both the 
dimeric MOP and the [4]MN were crystallized allowing the shape and structure to be 
confirmed using single crystal X-ray crystallography.  Both species were also analyzed 
with DOSY, which confirmed the solid state results. 
 The length of the Py(Me)2PhN-CPh(Me)2Py⊂24C6 [2]rotaxane and its 
flexibility in combination with the [Pt(dppp)]2+ metal fragment results in the formation of 
the entropically favored triangular [4]MN and not the square [5]MN.  The synthesis of a 
[5]MN could possibly then achieved by the design of a shorter, more rigid [2]rotaxane 
ligand which would increase the strain of the entropically favored triangle as well as 
decrease the size of the cavity to not allow room for three 24C6 or similar macrocycles 
inside.  Alternatively, a more bulky crown ether macrocycle such as DB24C8 could also 
be expected to discourage the formation of the triangular [4]MN.  A more rigid corner 
unit less able to deviate from 90° at the metal center might also be a strategy toward the 
synthesis of [5]MNs over [4]MNs. 
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3.7 EXPERIMENTAL 
3.7.1 General Comments 
3,5-Dimethylaniline,122 and [Pt(dppp)(OTf)2],22,105 were synthesized using slightly 
modified literature methods.  N-Bromosuccinimide, MgSO4, H2SO4, sodium nitrite, 
potassium iodide, Na2SO3, N-butyllithium, HCl, NaCl, sodium Borohydride, HBF4·Et2O, 
sodium hydride, pentaethylene glycol, 5-bromopentene, sodium iodide, Grubbs I, Et3N, 
4-pyridineboronic acid, palladium tetrakis triphenylphosphine, Cs2CO3, palladium on 
carbon, H2, were purchased from Aldrich or TCI America and used as received.  
Deuterated solvents were obtained from Cambridge Isotope Laboratories or Aldrich and 
used as received.  Solvents were dried using an Innovative Technologies Solvent 
Purification System.  Thin layer chromatography (TLC) was performed using Teledyne 
Silica gel 60 F254 plates and viewed under UV light.  Column chromatography was 
performed using Silicycle Ultra Pure Silica Gel (230 – 400 mesh).  1H NMR, 13C NMR 
and 2-D NMR experiments were performed on a Bruker Avance 500 instrument, with a 
working frequency of 500.13 MHz for 1H nuclei, 125.7 MHz for 13C nuclei, and 202 
MHz for 31P nuclei.  1H and 13C chemical shifts are quoted in ppm relative to 
tetramethylsilane, using the residual solvent peak as a reference standard.  31P chemical 
shifts were referenced vs. external 85% H3PO4 (0.00 ppm).  Conventional 2-D NMR 
experiments 1H-1H COSY and 1H-13C HMQC were conducted and used to help assign all 
peaks.  1H-DOSY experiments were carried out using the longitudinal eddy-current delay 
with bipolar gradient pulse pair and two spoil gradients (ledbpgp2s) pulse program, at 
21±0.5 °C, 10 mM concentration, and 4 cm sample height in a 5 mm tube.  Experiments 
were performed with a diffusion time, Δ, of 0.2 s, a gradient recovery delay of 100 μs, a 
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longitudinal eddy-current delay of 2.5 ms, a gradient pulse duration, δ/2, of 1 ms.  A 
series of 32 linear increments in gradient strength were used with 8 scans per increment.  
The data was processed using the DOSY toolbox software using the standard high 
resolution DOSY fitting.112  High resolution mass spectrometry (HR-MS) experiments 
were performed on a Micromass LCT electrospray (ESI) time-of-flight (TOF) mass 
spectrometer.  Solutions of 50-100 ng/µL were prepared and injected for analysis at a rate 
of 5 µL/min, using a syringe pump.  Infrared (IR) experiments were performed on a 
Bruker Alpha FT-IR spectrometer.  Melting points were recorded using a Fischer-Johns 
melting point apparatus.   
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3.7.2 Synthesis of 4-bromo-3,5-dimethylaniline 
3,5-dimethylaniline (12.0 g, 0.0990 mol) was dissolved in MeCN (75 mL), and the 
solution cooled to 0 °C.  A solution of N-bromosuccinimide (17.6 g, 0.0990 mol) in 
MeCN (75 mL) was added dropwise, and the solution stirred and warmed to RT 
overnight.  An additional 200 mL of MeCN was added, and the solution stirred for an 
addition 30 min, extracted with EtOAc (2 x 200 mL), dried over MgSO4, filtered, and 
concentrated.  The crude product was purified by flash column chromatography (SiO2, 
EtOAc/hexanes, 1:4 v/v) to give a beige solid.  Yield: 16.6 g, 84% 
 
Table 3.2 - 1H NMR data of 4-bromo-3,5-dimethylaniline in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.34 s  6 - 
d 6.43 s  2 - 
e 3.60 s 2 - 
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3.7.3 Synthesis of 2-bromo-5-iodo-m-xylene 
4-Bromo-3,5-dimethylaniline (5.00 g, 0.0250 mol) was dissolved in H2O (60 mL) and 
conc. H2SO4 (4 mL), and the solution cooled to 0 °C.  Sodium nitrite (17.24 g, 0.250 mol) 
was dissolved in H2O (30 mL), and added dropwise.  Potassium iodide (6.22 g, 0.0375 
mol) was dissolved in H2O (15 mL) and heated to 50 °C.  The diazonium salt solution 
was added to the potassium iodide solution under vigorous stirring.  The resulting 
mixture was stirred at 50 °C for 30 min, then cooled to RT, neutralized with Na2SO3 (aq.) 
until no further colour change, and extracted with Et2O (3 x 50 mL).  The combined 
organic extracts were dried over MgSO4, filtered, and concentrated to give an orange oil.  
Yield: 7.04 g, 91%    
 
Table 3.3 - 1H NMR data of 2-bromo-5-iodo-m-xylene in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.37 s  6 - 
d 7.41 s 2 - 
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3.7.4 Synthesis of 4-bromo-3,5-dimethylbenzaldehyde 
2-Bromo-5-iodo-m-xylene (2.00 g, 6.43 mmol) was dissolved in THF (15 mL) under N2, 
and cooled to -78 °C.  N-butyllithium (4.02 mL, 6.43 mmol, 1.6 M in hexanes) was added 
dropwise, and the resulting solution stirred for 45 min.  DMF (1.52 mL, 0.0197 mol) was 
added dropwise and the solution warmed to RT.  An HCl aq. solution (15 mL, 5%) was 
added, the mixture extracted with Et2O (3 x 20 mL), and the combined organic phase 
washed with H2O (2 x 10 mL) and sat. NaCl (aq.) (10 mL), dried over MgSO4, filtered 
and concentrated.  The crude product was purified by flash column chromatography 
(SiO2, EtOAc/hexanes, 1:10 v/v) to give an orange crystalline solid.  Yield: 1.02 g, 74%. 
 
Table 3.4 - 1H NMR data of 4-bromo-3,5-dimethylbenzaldehyde in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.50 s  6 - 
d 7.56 s  2 - 
f 9.93 s 1 - 
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3.7.5 Synthesis of Br(Me)2PhN=CPh(Me)2Br 
(N-(4-bromo-3,5-dimethylbenzylidene)-4-bromo-3,5-dimethylaniline) 
4-Bromo-3,5-dimethylaniline (1.00 g, 5.00 mmol) and 
4-Bromo-3,5-dimethylbenzaldehyde (1.12 g, 5.25 mmol) were dissolved in CHCl3 
(min), and MgSO4 was added to create a slurry.  The mixture was stirred until the 
reaction was complete by 1H NMR (~12 h).  The reaction mixture was filtered, and 
concentrated.  The crude product was purified by dissolving impurities in MeOH (5 mL), 
and filtering to isolate an off-white solid.  Yield: 1.90 g, 96 %.  MP: 166-167 °C.  IR 
(ATR) ν/cm-1 = 2972, 2949, 2916, 2855, 1701, 1621, 1570, 1461, 1449, 1432, 1378, 
1357, 1288, 1148, 1023, 1008, 968, 879, 867, 850, 766, 704, 616, 568, 554.  HR-MS 
(ESI): calcd for [M+H] +, [C17H18Br2N]+, m/z = 395.9786, found m/z = 395.9781, error 
1.3 ppm. 
 
Table 3.5 - 1H NMR data of Br(Me)2PhN=CPh(Me)2Br in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.45 s  6 - 
d 6.95 s  2 - 
f 8.35 s 1 - 
g 7.59 s  2 - 
h 2.49 s  6 - 
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Table 3.6 – 13C NMR data of Br(Me)2PhN=CPh(Me)2Br in CDCl3. 
Carbon δ (ppm) # Carbons 
4 124.87 1 
5 139.22 2 
6 24.06 2 
7 120.75 2 
8 150.54 1 
9 159.73 1 
10 134.68 1 
11 128.36 2 
12 139.26 2 
13 24.13 2 
14 131.44 1 
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3.7.6 Synthesis of Br(Me)2PhN-CPh(Me)2Br  
(N-(4-bromo-3,5-dimethylbenzyl)-4-bromo-3,5-dimethylaniline) 
Br(Me)2PhN=CPh(Me)2Br (1.98 g, 5.00 mmol) and sodium borohydride (0.21 g, 5.50 
mmol) were dissolved in THF (15 mL) and EtOH (15 mL), and stirred until the reaction 
was complete by 1H NMR (~12 h).  The reaction mixture was concentrated and the 
residue dissolved in CHCl3 (100 mL).  The resulting solution was washed with H2O (2 x 
25 mL), dried over MgSO4, filtered, and concentrated to give an off-white solid.  Yield: 
1.47 g, 89 %.  MP: 133-135 °C.  IR (ATR) ν/cm-1 = 3428, 2964, 2919, 2850, 1594, 1498, 
1465, 1435, 1411, 1399, 1381, 1329, 1259, 1202, 1088, 1010, 843, 828, 793, 695, 686, 
563.  HR-MS (ESI): calcd for [M+H] +, [C17H20Br2N]+, m/z = 397.9942, found m/z = 
397.9947, error 1.3 ppm.   
 
Table 3.7 - 1H NMR data of Br(Me)2PhN-CPh(Me)2Br in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.33 s  6 - 
d 6.38 s  2 - 
e 3.88 broad s  1 - 
f 4.18 broad s 2 - 
g 7.06 s  2 - 
h 2.41 s  6 - 
 
 
 
 
An Interlocked [2]Rotaxane Ligand for the Self-Assembly of MORPs 
 
147 
Table 3.8 - 1H NMR data of Br(Me)2PhN-CPh(Me)2Br in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.24 s  6 - 
d 6.40 s  2 - 
e 4.89 broad s  1 - 
f 4.17 d 2 3Jfe = 6.1 
g 7.12 s  2 - 
h 2.36 s  6 - 
 
 
Table 3.9 – 13C NMR data of Br(Me)2PhN-CPh(Me)2Br in CDCl3. 
Carbon δ (ppm) # Carbons 
4 115.31 1 
5 138.79 2 
6 24.09 2 
7 113.07 2 
8 146.85 1 
9 47.95 1 
10 137.94 1 
11 127.40 2 
12 138.96 2 
13 24.22 2 
14 126.39 1 
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3.7.7 Synthesis of [Br(Me)2PhNH2-CPh(Me)2Br][BF4]  
(N-(4-bromo-3,5-dimethylbenzyl)-4-bromo-3,5-dimethylanilinium 
tetrafluoroborate) 
Br(Me)2PhN-CPh(Me)2Br (0.40 g, 1.01 mmol) was dissolved in Et2O (15 mL).  
HBF4·Et2O (0.18 g, 1.11 mmol) was added and the resulting mixture stirred for 10 min, 
and filtered to isolate a white powder.  Yield: 0.45 g, 91 %.  MP: 174-176 °C.  IR (ATR) 
ν/cm-1 = 3176, 3095, 2988, 2956, 2923, 1603, 1589, 1467, 1439, 1418, 1346, 1297, 1134, 
1054, 1030, 960, 884, 818, 760, 705, 597, 573, 550.  HR-MS (ESI): calcd for [M+H] +, 
[C17H20Br2N]+, m/z = 397.9942, found m/z =397.9947, error 1.3 ppm. 
 
Table 3.10 - 1H NMR data of [Br(Me)2PhNH2-CPh(Me)2Br][BF4] in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.42 s  6 - 
d 7.13 s  2 - 
e 8.60 broad s  2 - 
f 4.46 s 2 - 
g 7.15 s  2 - 
h 2.39 s  6 - 
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Table 3.11 – 13C NMR data of [Br(Me)2PhNH2-CPh(Me)2Br][BF4] in CD3CN. 
Carbon δ (ppm) # Carbons 
4 129.63 1 
5 141.98 2 
6 24.01 2 
7 118.37 2 
8 133.66 1 
9 56.71 1 
10 129.49 1 
11 131.34 2 
12 140.31 2 
13 24.18 2 
14 129.86 1 
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3.7.8 Synthesis of pentaethylene glycol di-pent-4-enyl ether 
Sodium hydride (2.65 g, 67.23 mmol, 60% in mineral oil) was suspended in THF (100 
mL) under N2, and the mixture cooled to 0 °C.  Pentaethylene glycol (5.34 g, 22.41 
mmol) was slowly, and stirred until H2 evolution ceased. 5-Bromopentene (10.00 g, 
67.10 mmol) dissolved in THF (25 mL) was added dropwise, NaI (0.20 g, 1.34 mmol) 
added slowly, and the mixture warmed to RT, and stirred for 5 days, after which the 
reaction was quenched with H2O, and the solvent removed in vacuo.  The residue was 
dissolved in EtOAc, and the solution washed with sat. NaCl solution, dried over MgSO4, 
filtered, and the concentrated.  The crude product was purified by flash column 
chromatography (SiO2, EtOAc/hexanes, 1:1 v/v, increasing EtOAc % once product starts 
to elute) to give a colorless oil.  Yield: 5.01 g, 60 %. 
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Table 3.12 - 1H NMR data of pentaethylene glycol di-pent-4-enyl ether in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
k-m 3.61 s  12 - 
n 3.59 m  4 3Jno = 5.3 
o 3.53 m  4 3Jon = 5.3 
p 3.42 t 4 3Jpq = 6.7 
q 1.63 quintet  4 3Jqp,qr = 7.1 
r 2.06 q  4 3Jrq,rs = 7.2 
s 5.76 m 2 - 
t 4.90 d 2 3Jts = 9.9 
u 4.96 dd 2 3Jus = 17.2, 2Jut = 1.5  
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 3.7.9 Synthesis of Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and 
Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 
[Br(Me)2PhNH2-CPh(Me)2Br][BF4] (0.40 g, 0.82 mmol) and pentaethylene glycol 
di-pent-4-enyl ether (0.46 g, 1.24 mmol) were dissolved in CH2Cl2 under N2.  Grubbs I 
(0.07 g, 0.08 mmol) was added and the resulting solution heated to 41 °C for 24 h.  The 
solution was concentrated, redissolved in MeOH, a few drops Et3N added, and the 
neutralized solution concentrated.  The crude product was purified by flash column 
chromatography (SiO2, EtOAc/hexanes, 1:3 v/v) to give the product (E/Z mixture, 62/38) 
as an off-white waxy solid.  Yield: 0.52 g, 85 %.  MP: 199-201 °C.  IR (ATR) ν/cm-1 = 
3372, 2937, 2870, 1596, 1516, 1466, 1448, 1349, 1265, 1246, 1101, 1016, 957, 850, 737, 
701, 601, 566.  HR-MS (ESI): calcd for [M+H] +, [C35H54Br2NO6]+, m/z =744.2297, 
found m/z = 744.2305, error 1.1 ppm. 
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Table 3.13 - 1H NMR data of Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.35 s  6 - 
d 6.65 s  2 - 
e 5.17 broad t  1 3Jef = 4.8 
f 4.30 d 2 3Jfe = 4.8 
g 7.46 s  2 - 
h 2.42 s  6 - 
k-p 3.19-3.58 m 24 - 
q 1.62, 1.54 2 m 2, 2 3Jqp,qr = 6.8 
r 1.98 m 4 - 
s 5.28 t 2 3Jsr = 3.4 
 
Table 3.14 – 1H NMR data of Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 2.33 s  6 - 
d 6.70 s  2 - 
e, s 5.21 m 3 - 
f 4.39 d 2 3Jfe = 4.9 
g 7.44 s  2 - 
h 2.41 s  6 - 
k-p 3.19-3.58 m 24 - 
q 1.41, 1.47 m 4 3Jqp,qr = 6.2 
r 1.89, 2.11 2 m 2, 2 - 
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Table 3.15 – 13C NMR data of Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
4 112.68 1 
5 137.50 2 
6 23.85 2 
7 113.79 2 
8 148.65 1 
9 47.17 1 
10 139.04 1 
11 130.21 2 
12 137.28 2 
13 24.17 2 
14 125.45 1 
18-23 
70.40 
70.44 
70.56 
70.76 
70.96 
71.04 
12 
24 29.33 2 
25 28.81 2 
26 130.27 2 
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Table 3.16 – 13C NMR data of Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
4 112.58 1 
5 137.28 2 
6 23.90 2 
7 114.07 2 
8 148.72 1 
9 46.93 1 
10 139.51 1 
11 129.99 2 
12 137.24 2 
13 24.13 2 
14 125.27 1 
18-22 
70.67 
70.74 
70.85 
71.12 
71.18 
10 
23 72.23 2 
24 30.58 2 
25 25.25 2 
26 129.86 2 
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3.7.10 Synthesis of Py(Me)2PhN-CPh(Me)2Py⊂(E)-24C6 and 
Py(Me)2PhN-CPh(Me)2Py⊂(Z)-24C6 
Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 
(0.100 g, 0.1345 mmol), 4-pyridineboronic acid (0.050 g, 0.4068 mmol), palladium 
tetrakis triphenylphosphine (0.017 g, 0.0147 mmol), and Cs2CO3 (0.180 g, 0.5525 mmol) 
were dissolved in DMF (2.5 mL) and toluene (2.5 mL) under N2, and heated to 120 °C 
overnight.  The reaction mixture was cooled to RT and filtered (washed with CH2Cl2).  
The filtrate was concentrated, the residue dissolved in CH2Cl2 (10 mL) and the resulting 
solution washed with H2O (5 mL), and concentrated.  The crude product was 
recrystallized from MeCN to produce a light yellow crystalline solid.  Yield: 0.091 g, 91 
%.  MP: 208-210 °C.  IR (ATR) ν/cm-1 = 3372, 3028, 2868, 1606, 1595, 1539, 1513, 
1468, 1449, 1408, 1349, 1338, 1262, 1188, 1101, 1035, 989, 954, 875, 828, 803, 718, 
697, 595, 546.  HR-MS (ESI): calcd for [M+H]+, [C45H62N3O6]+, m/z =740.4639, found 
m/z = 740.4665, error 3.5 ppm. 
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Table 3.17 - 1H NMR data of Py(Me)2PhN-CPh(Me)2Py⊂(E)-24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.61 d 2 3Jab = 4.3 
b 7.16 d 2 3Jba = 4.3 
c 2.01 s  6 - 
d 6.68 s  2 - 
e ~ 5.25 overlapped m 1 -  
f 4.46 d 2 3Jfe = 4.8 
g 7.51 s  2 - 
h 2.05 s  6 - 
i 7.11 d 2 3Jij = 4.4 
j 8.68 d 2 3Jij = 4.4 
k-p 3.64-3.24 m 24 - 
q 1.62, 1.69 2 m 2, 2 3Jqp,qr = 7.0 
r ~ 2.03 overlapped m 2, 2 -  
s 5.33 t 2 3Jsr = 3.5 
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Table 3.18 - 1H NMR data of Py(Me)2PhN-CPh(Me)2Py⊂(Z)-24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a ~ 8.59 overlapped d 2 - 
b 7.14 d 2 3Jba = 4.4 
c 2.00 s  6 - 
d 6.74 s  2 - 
e 5.31 t 1 3Jef = 4.9 
f 4.44 d 2 3Jfe = 4.9 
g 7.49 s  2 - 
h 2.03 s  6 - 
i 7.10 overlapped d 2 3Jij = 4.2 
j 8.67 overlapped d 2 - 
k-p 3.64-3.24 m 24 - 
q 1.51 m 4 3Jqp,qr = 6.5 
r 2.19, 1.94 2 m 2, 2 - 
s ~ 5.25 overlapped m 2 -  
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Table 3.19 – 13C NMR data of Py(Me)2PhN-CPh(Me)2Py⊂(E)-24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1 149.69 2 
2 126.33 2 
3 151.09 1 
4 126.52 1 
5 134.91 2 
6 21.23 2 
7 112.89 2 
8 149.48 1 
9 47.55 1 
10 140.26 1 
11 129.52 2 
12 134.25 2 
13 20.77 2 
14 137.36 1 
15, 17 150.19 1, 2 
16 125.03 2 
18-23 
70.42 
70.45 
70.60 
70.80 
71.06 
12 
24 29.41 2 
25 28.89 2 
26 130.39 2 
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Table 3.20 – 13C NMR data of Py(Me)2PhN-CPh(Me)2Py⊂(Z)-24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1 149.62 2 
2 126.36 2 
3 151.22 1 
4 126.41 1 
5 134.70 2 
6 21.20 2 
7 113.10 2 
8 149.53 1 
9 47.33 1 
10 140.69 1 
11 129.28 2 
12 134.23 2 
13 20.81 2 
14 137.20 1 
15 150.25 1 
16 125.05 2 
17 150.16 2 
18-22 
70.70 
70.78 
70.87 
71.17 
71.25 
 
10 
23 72.24 2 
24 30.63 2 
25 25.36 2 
26 129.93 2 
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3.7.11 Synthesis of Py(Me)2PhN-CPh(Me)2Py⊂24C6 
Palladium on carbon (10 %, 0.120 g, 0.113 mmol) was suspended in MeOH (30 mL) 
under N2. The mixture of Py(Me)2PhN-CPh(Me)2Py⊂(E)-24C6 and 
Py(Me)2PhN-CPh(Me)2Py⊂(Z)-24C6 (0.300 g, 0.405 mmol) was dissolved in MeOH 
(min), and added to the suspension.  H2 was introduced via a balloon, and the suspension 
stirred until the reaction was complete by 1H NMR (3 h).  The reaction mixture was 
filtered through Celite, concentrated, and recrystallized from hexanes to give an off-white 
powder.  Yield: 0.280 g, 93 %.  MP: 229-232 °C.  IR (ATR) ν/cm-1 = 3351, 3050, 3028, 
2919, 2858, 1606, 1596, 1540, 1513, 1455, 1409, 1349, 1264, 1184, 1100, 989, 956, 904, 
854, 828, 733, 718, 701, 595, 547.  HR-MS (ESI): calcd for [M+H]+, [C45H64N3O6]+, m/z 
=742.4795, found m/z = 742.4794, error 0.1 ppm. 
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Table 3.21 - 1H NMR data of Py(Me)2PhN-CPh(Me)2Py⊂24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.61 d 2 3Jab = 4.4 
b 7.15 d 2 3Jba = 4.4 
c 2.00 s  6 - 
d 6.71 s  2 - 
e 5.22 broad t  1 3Jef = 4.7 
f 4.50 d 2 3Jfe =  4.7 
g 7.51 s  2 - 
h 2.05 s  6 - 
i 7.11 d 2 3Jij = 4.4 
j 8.68 d 2 3Jji = 4.4 
k-p 3.70-3.27 m 24 - 
q 1.47  broad m 4 - 
r 1.30 broad m 4 - 
s 1.16 broad m 4 - 
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Table 3.22 – 13C NMR data of Py(Me)2PhN-CPh(Me)2Py⊂24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1 149.63 2 
2 126.38 2 
3 151.28 1 
4 126.45 1 
5 134.74 2 
6 21.18 2 
7 117.07 2 
8 149.41 1 
9 47.40 1 
10 140.54 1 
11 129.42 2 
12 134.26 2 
13 20.79 2 
14 137.31 1 
15 150.27 1 
16 125.06 2 
17 150.17 2 
18-22 
70.56 
70.69 
70.80 
70.88 
71.27 
10 
23 71.94 2 
24 30.02 2 
25 26.01 2 
26 29.17 2 
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3.7.12 Synthesis of Py(Me)2PhN-CPh(Me)2Py 
Br(Me)2PhN-CPh(Me)2Br (0.220 g, 0.554 mmol), 4-pyridineboronic acid (0.0.280 g, 
1.37 mmol), palladium tetrakis triphenylphosphine (0.060 g, 0.0519 mmol), and Cs2CO3 
(0.450 g, 1.38 mmol) were dissolved in DMF (10 mL) and toluene (10 mL) under N2, and 
heated to 110 °C overnight.  The reaction mixture was cooled to RT and filtered (washed 
with CHCl3).  The filtrate was concentrated, and the crude product was recrystallized 
from MeCN to produce a off-white solid.  Yield: 0.200 g, 92 %.  MP: 168-172 °C.  IR 
(ATR) ν/cm-1 = 3291, 3027, 2973, 2951, 2918, 1606, 1596, 1540, 1508, 1478, 1438, 
1407, 1378, 1331, 1278, 1265, 1215, 1187, 1068, 990, 826, 732, 718, 696, 591, 542, 511.  
HR-MS (ESI): calcd for [M+H] +, [C27H28N3]+, m/z = 394.2283, found m/z = 394.2283, 
error 0.0 ppm. 
 
Table 3.23 - 1H NMR data of Py(Me)2PhN-CPh(Me)2Py in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.64 d 2 3Jab = 5.1 
b, i 7.12 overlapped d 4 3Jba,ij = 5.7 
c 1.99 s  6 - 
d 6.47 s  2 - 
e 4.06 broad s  1 - 
f 4.32 s 2 - 
g 7.17 s  2 - 
h 2.04 s  6 - 
j 8.69 d 2 3Jji = 5.5 
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Table 3.24 - 1H NMR data of Py(Me)2PhN-CPh(Me)2Py in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.57 d 2 3Jab = 5.9 
b 7.18 d 2 3Jba = 5.9 
c 1.94 s  6 - 
d 6.50 s  2 - 
e 4.76 broad s  1 - 
f 4.36 s 2 - 
g 7.22 s  2 - 
h 2.03 s  6 - 
i 7.15  2 3Jij = 5.9 
j 8.63 d 2 3Jji = 5.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
An Interlocked [2]Rotaxane Ligand for the Self-Assembly of MORPs 
 
166 
 
Table 3.25 – 13C NMR data of Py(Me)2PhN-CPh(Me)2Py in CDCl3. 
Carbon δ (ppm) # Carbons 
1 150.03 2 
2 125.71 2 
3 149.91 1 
4 129.02 1 
5 136.58 2 
6 21.17 2 
7 112.00 2 
8 147.95 1 
9 48.24 1 
10 139.24 1 
11 126.97 2 
12 135.85 2 
13 20.90 2 
14 138.32 1 
15 149.38 1 
16 124.72 2 
17 150.33 2 
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3.7.13 Synthesis of [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 
Py(Me)2PhN-CPh(Me)2Py (3.9 mg, 0.01 mmol) and [Pt(dppp)(OTf)2]  (9.1 mg, 0.01 
mmol) were dissolved in MeNO2 (2 mL), stirred for 30 min, and filtered.  Removal of the 
solvent produces a yellow powder.  Yield:  0.013 g. 100 %.  MP: 251-254 °C.  31P NMR 
(202 MHz, CD3NO2, 298 K) δ = -12.89 (1JP-Pt = 3008 Hz).  IR (ATR) ν/cm-1 = 3373, 
3096, 3057, 2953, 2923, 2857, 1603, 1500, 1483, 1436, 1332, 1252, 1223, 1188, 1153, 
1103, 1068, 1028, 999, 976, 838, 798, 748, 707, 693, 674, 636, 572, 515.  Diffusion 
Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 3.59 (± 0.07) x 10-10 m2/s. 
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Table 3.26 - 1H NMR data of [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 in 
CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.61 m 4 - 
b, i 6.97 m 8 - 
c 1.81 s  12 - 
d 6.33 s  4 - 
e 5.24 broad s  1 - 
f 4.22 m 4 - 
g 7.13 s  4 - 
h 1.88 s  6 - 
j 8.68 m 4 - 
t 2.44 br t 4 - 
u 3.35 br s 8 - 
v 7.47 m 16 - 
w 7.79 m 16 - 
x 7.51 t 8 3Jxw = 7.8 
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An Interlocked [2]Rotaxane Ligand for the Self-Assembly of MORPs 
 
170 
Table 3.27 – 13C NMR data of [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 in 
CD3NO2 from HMQC/HMBC. 
Carbon δ (ppm) # Carbons 
1 150.4 4 
2 129.7 4 
3 155.8 2 
4 126.8 2 
5 137.2 4 
6 20.7 4 
7 113.1 4 
8 150.0 2 
9 47.6 2 
10 141.8 2 
11 129.2 4 
12 136.6 4 
13 21.2 4 
14 138.3 2 
15 154.8 2 
16 130.1 4 
17 150.7 4 
27 18.7 2 
28 22.8 4 
29 125.8 8 
30 130.6 16 
31 134.3 16 
32 133.7 8 
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DOSY of [Pt2(Py(Me)2PhN-CPh(Me)2Py)2(dppp)2][OTf]4 in CD3NO2. 
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3.7.13 Synthesis of [Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3][OTf]6 
Py(Me)2PhN-CPh(Me)2Py⊂24C6 (7.4 mg, 0.01 mmol) and [Pt(dppp)(OTf)2]  (9.1 mg, 
0.01 mmol) were dissolved in MeNO2 (2 mL), stirred for 30 min, and filtered.  Removal 
of the solvent produces a yellow glass.  Yield: 0.016 g. 100 %.  MP: 251-254 °C.  31P 
NMR (202 MHz, CD3NO2, 298 K) δ = -12.88 (1JP-Pt = 3020 Hz).  IR (ATR) ν/cm-1 = 
3511, 3372, 3059, 2919, 2864, 1603, 1504, 1484, 1452, 1348, 1556, 1223, 1190, 1155, 
1102, 1069, 1030, 999, 977, 874, 798, 752, 707, 694, 674, 637, 572, 517.  Diffusion 
Coefficient (1H NMR, 500 MHz, CD3NO2, 294 K): 2.78 (± 0.04) x 10-10 m2/s. 
 
 
 
 
 
 
An Interlocked [2]Rotaxane Ligand for the Self-Assembly of MORPs 
 
173 
Table 3.28 - 1H NMR data of [Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3][OTf]6 
in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.73 br d 6 - 
b, i 7.08 m 12 - 
c 1.76 s  6 - 
d 6.69 br s  6 - 
e 5.51 br s  3 - 
f 4.56 s 6 - 
g, x 7.53 m  20 3Jxw = 6.1 
h 2.19 s  6 - 
j 8.59 br d 6 - 
k-p 3.61-3.30 m 72 - 
q 1.37  br m 12 - 
r 1.29 br m 12 - 
s 1.16 br m 12 - 
t 3.24 br s 6 - 
u 2.45 br m 12 - 
v 7.48 t 24 3Jvw = 7.0 
w 7.82 br s 24 - 
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Table 3.29 – 13C NMR data of [Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3][OTf]6 
in CD3NO2 from HMQC/HMBC. 
Carbon δ (ppm) # Carbons 
1 150.2 6 
2 130.4 6 
3 156.4 3 
4 126.8 3 
5 136.5 3 
6 21.3 6 
7 114.1 6 
8 150.0 3 
9 47.6 3 
10 142.7 3 
11 130.5 6 
12 136.7 6 
13 20.7 6 
14 140.9  
15 156.0 3 
16 129.6 6 
17 151.0 6 
18-22 
71.8 
71.9 
72.1 
72.4 
30 
23 72.9 6 
24 31.0 6 
25 26.8 6 
26 30.0 6 
27 18.8 3 
28 22.8 6 
29 125.2 12 
30 130.6 24 
31 134.3 24 
32 133.8 12 
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DOSY of [Pt3(Py(Me)2PhN-CPh(Me)2Py⊂24C6)3(dppp)3][OTf]6 in CD3NO2. 
 
 
 
 
CHAPTER 4 
 
A Compact [2]Rotaxane Ligand with Pyrazole Donors 
 
4.1 INTRODUCTION 
 The NBA containing [2]rotaxane described in Chapter 3 can be modified by 
switching out the pyridine coordinating group.  The design described in this chapter was 
inspired by a series of studies carried out by Yu and coworkers, utilizing bipyrazolate 
linkers and bipyridine based palladium dimetallic corner units in the assembly of MOPs.  
The first two studies utilized a series of tertramethyl-substituted bipyrazolate and 
hexamethyl-substituted tripyrazolate linkers, which when combined with 
[Pd(bipy)(NO3)2] or [Pd(phen)(NO3)2] self-assemble into various MOPs.123,124   
 
Figure 4.1 – Representative example of bipyrazolate linker containing MOP with 
bipy ligands omitted for clarity.125 
 
Steric repulsion of the methyl groups was found to cause distortion in the 
resulting MOPs, thus a third study used unsubstituted bipyrazolate linkers (Figure 4.1).125  
Further studies explored host-guest interactions,126,127 luminescence,126,128 anion-
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sensing,127-129 self-assembly of hetero-metallacycles,130 redox chemistry,129 and the 
creation of deeper cavities within the MOPs.127 
 
Figure 4.2 – Design of the [2]rotaxane linker. 
 
The linker design consists of the NBA [2]rotaxane core from the previous chapter 
with two pyrazole moieties replacing the pyridine coordinating groups (Figure 4.2).  This 
should produce a [2]rotaxane chelating ligand that is slightly more compact than the 
pyridine based ligand, and leads to the synthesis of a more rigid MORP. 
4.2 SYNTHESIS AND CHARACTERIZATION 
4.2.1 Synthesis of [2]Rotaxane  
The synthesis of the pyrazole containing [2]rotaxane linker follows the same 
synthetic sequence as the Py(Me)2PhN-CPh(Me)2Py⊂24C6 [2]rotaxane linker described 
in chapter 3 up to the mixture of Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and 
Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6.  From that point it diverges (Figure 4.3). 
The first step involves the reaction of the mixture of the 
Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 
[2]rotaxanes with 1-benzylpyrazole-4-boronic acid pinacol ester, a catalyst formed from 
tris(dibenzylideneacetone)dipalladium and tricyclohexylphosphine, and potassium 
phosphate in a mixture of dioxane and water at 100 °C in a double Suzuki reaction.  The 
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product, consisting of a mixture of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(E)-24C6 and 
BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(Z)-24C6, was recovered after an organic workup 
and purification by column chromatography.  
 
Scheme 4.1 – Synthesis of pyrazole containing [2]rotaxane. 
   
The second to last step is the hydrogenation of the double bond on the 24C6 
macrocycle through the reaction of the mixture of the cis- and trans-isomers of the 
benzyl-protected [2]rotaxane, BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(E)-24C6 and 
BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(Z)-24C6, with hydrogen gas and palladium on 
carbon in methanol.  Pure BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂24C6 was recovered after 
removal of the solvent.  
 Lastly, the benzyl protecting groups were removed via the reaction of 
BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂24C6 with sodium in liquid ammonia and 
tetrahydrofuran.  Standard organic workup yielded the [2]rotaxane ligand, 
Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6. 
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4.2.2 Synthesis of Naked Axle 
 The matching naked axle was also synthesized for comparison to the [2]rotaxane 
ligand as depicted in Scheme 4.2.  The synthesis follows the same sequence as that of the 
pyridine version from the previous chapter up to the dibromo axle.  From there the 
synthesis diverges.  The first step is the reaction of Br(Me)2PhN-CPh(Me)2Br with 
1-benzyl-4-boronic acid pinacol ester, tris(dibenzylideneacetone)dipalladium and 
tricyclohexylphosphine as catalyst, and potassium phosphate in a mixture of dioxane and 
water.  After filtration, extraction, and flash chromatography, the product of 
BzPyr(Me)2PhN-CPh(Me)2PyrBz was isolated in nearly quantitative yield.  
 
Scheme 4.2 – Synthesis of naked axle ligand, Pyr(Me)2PhN-CPh(Me)2Pyr. 
 
 Removal of the benzyl protecting groups by means of the reaction of sodium in 
ammonia with BzPyr(Me)2PhN-CPh(Me)2PyrBz in tetrahydrofuran, followed by 
extraction, and concentration produced the naked axle linker, 
Pyr(Me)2PhN-CPh(Me)2Pyr. 
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4.2.3 1H NMR Analysis 
  The 1H NMR spectra for the empty macrocyclic wheel, 24C6, the [2]rotaxane, 
Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6, and the naked axle, Pyr(Me)2PhN-CPh(Me)2Pyr 
are presented in Figure 4.3.  
 
 
Figure 4.3 – Structure of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 with labeling scheme, 
and 1H NMR spectra of 24C6 (top), the Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 
[2]rotaxane (middle), and the Pyr(Me)2PhN-CPh(Me)2Pyr naked axle (botom) in 
CD3CN. 
 
When the 24C6 macrocyclic wheel and the Py(Me)2PhN-CPh(Me)2Py⊂24C6 
[2]rotaxane are compared the signals from protons k-p broaden and shift slightly upfield. 
Protons q-s from the 24C6 alkyl chain also shift slightly upfield. 
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When the [2]rotaxane is compared with the naked axle, 
Pyr(Me)2PhN-CPh(Me)2Pyr, the protons that are removed from the influence of the 
wheel, a, b, h-j, t, and t’, do not shift noticeably.  Methyl group protons labelled c shift 
~0.1 ppm upfield.  Protons d and g, from the inner aromatic rings shift ~0.3 and 0.4 ppm 
downfield, respectively.  The aniline proton, e, shifts ~0.4 ppm downfield, while 
methylene protons, f, shift ~0.2 ppm downfield.  The downfield shifts are due to 
hydrogen bonding with the oxygen atoms of the crown ether. 
4.2.4 X-Ray Crystallography of [2]Rotaxane Ligand  
 The single crystal X-ray structure of the Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 
[2]rotaxane is illustrated in Figures 4.4 and 4.5. 
 
Figure 4.4 – Single crystal structure of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6, ball and 
stick side view. 
 
 From the ball and stick view in Figure 4.4, it is possible to determine that the 
wheel sits much closer to perpendicular to the axle as opposed to the close to 45° angle 
observed in the pyridine based [2]rotaxane described in the previous chapter. 
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Figure 4.5 – Single crystal structure of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6, space 
filling side view (top), and top-down view (bottom). 
 
The Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 is shorter than the pyridine containing 
[2]rotaxane at 16.4 Å (vs. 17.7 Å).  Two of the oxygen atoms of the 24C6 macrocycle are 
within hydrogen bonding distance of the amine group of the axle, with N···O distances of 
3.21, and 3.58 Å, and N-H···O angles 133.6, and 157.7°, respectively.  The torsion angles 
between the inner phenyl rings and outer pyrazole rings are 56.1 and 71.6°, which is 
closer to parallel than the comparable torsion angles in the pyridine based [2]rotaxane 
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(81.4 and 77.6°).  The torsion angle between the two inner aromatic rings is more 
perpendicular in the pyrazole containing [2]rotaxane at 54.4°, vs. a close to parallel 5.9° 
in the pyridine analog. 
The top down view (Figure 4.5, bottom) again demonstrates that the methyl 
groups on the inner phenyl rings of the axles are in front of the atoms of the crown ether, 
keeping the wheel on the axle as a permanently interlocked [2]rotaxane. 
The presence of the pyrazole moiety in the [2]rotaxane linker enables the 
organization of the [2]rotaxane in 2D sheets in the solid state via a hydrogen bonded 
network (Figure 4.6).  Each Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 [2]rotaxane is 
connected to another on either side through NH···N hydrogen bonds between adjacent 
pyrazole rings.  Each [2]rotaxane is also connected to the next row through an NH···O 
hydrogen bond to a water molecule, which is in turn connected to a methanol molecule 
through an OH···O hydrogen bond, which connects to the next row of [2]rotaxanes via an 
OH···N hydrogen bond, resulting in an 2D hydrogen bonded network. 
 
Figure 4.6 – Single crystal structure of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 packing, 
ball and stick side view, with 24C6 macrocycles omitted from top two rows for 
clarity. 
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 The pyrazole-pyrazole NH···N hydrogen bond is distance is 2.82 Å and the N-
H···N angle is 171.3°, indicating a strong hydrogen bond.  The pyrazole to water NH···O 
hydrogen bond distance is 2.88 Å with an N-H···O angle of 165.7°, again indicating a 
strong hydrogen bond.  The water to methanol OH···O hydrogen bond distance is 2.77 Å, 
while the methanol to pyrazole OH···N hydrogen bond distance is 2.81 Å, both being 
strong hydrogen bonds.   
4.3 SYNTHESIS AND CHARACTERIZATION OF MOP 
4.3.1 Synthesis of MOP with Naked Axle Linker. 
 The combination of the naked axle, Pyr(Me)2PhN-CPh(Me)2Pyr, with 
[Pd(bipy)(NO3)2] or as it exists in the solid state, [Pd2(bipy)2(NO3)2][NO3]2·H2O,131 in 
equimolar amounts produces a MOP, [Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2]6+, of 
dimeric structure, as illustrated in Scheme 4.3. 
 
Scheme 4.3 – Synthesis of [Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2][NO3]6 dimer 
from naked axle ligand. 
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4.3.2 1H NMR Analysis 
Depicted in Figure 4.7 are the 1H NMR spectra for the naked axle, 
Pyr(Me)2PhN-CPh(Me)2Pyr, and the result of the combination of the naked axle with 
[Pd2(bipy)2(NO3)2][NO3]2·H2O, as described in the previous section.  The result is one 
major species.  When the spectra for the naked axle and MOP are compared protons a 
and b, and i and j, on the coordinating pyrazole rings shift downfield due to coordination 
by ~0.5 and 0.4 ppm, respectively.  The protons from the stoppering methyl groups 
labeled c and h, shift ~0.1 ppm downfield.  
 
Figure 4.7 – 1H NMR spectra of Pyr(Me)2PhN-CPh(Me)2Pyr naked axle (top), and 
dimeric MOP, [Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2][NO3]6 (botom) in 
CD3OD/CD2Cl2 1:1. 
 
Protons d and g from the inner phenyl rings shift ~0.2 ppm upfield and ~0.5 ppm 
downfield, respectively. The methylene proton f shifts ~0.2 ppm downfield. 
4.4 SYNTHESIS AND CHARACTERIZATION OF MORP 
4.4.1 Synthesis of MORP with [2]Rotaxane Linker 
 Combining the [2]rotaxane Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 ligand with the 
[Pd2(bipy)2(NO3)2][NO3]2·H2O corner would be expected to result in the synthesis of a 
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MN.  Since the pyrazole containing linker is slightly shorter than the pyridine base linker 
employed in the previous chapter, and also bonds to two palladium atoms at each end as 
opposed to one platinum, the resulting MORP would be less likely to be a trimeric 
4[MN] due to higher strain, and more likely to be a square 5[MN].  Both possibilities are 
illustrated in Scheme 4.4. 
 
Scheme 4.4 – Synthesis of [4]MN or 5[MN] from Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 
with bipy ligands omitted on MORPs for clarity. 
 
4.4.2 1H NMR Analysis 
 The 1H NMR spectra for the [2]rotaxane ligand, 
Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6, and the result of the combination of the 
[2]rotaxane with [Pd2(bipy)2(NO3)2][NO3]2·H2O as shown in Scheme 4.4, are depicted in 
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Figure 4.8. The result is two species, the identities of which cannot be determined by 1H 
NMR spectroscopy.  After recrystalization by slow difusion of isopropyl ether into an 
acetonitrile solution of the products, only the major species remains, but some 
decomposition also occurs. 
The signals in the spectra of the MORP are broader than those in the spectrum of 
the Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 [2]rotaxane, indicating that coordination did 
occur. Protons a and b, and i and j, on the coordinating pyrazole rings, deshielded due to 
coordination to the paladium metal centers, shift ~0.4 ppm downfield.  
 
Figure 4.8 – 1H NMR spectra of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 [2]rotaxane 
(top), after combination with [Pd2(bipy)2]4+ corner unit (middle), and after 
recrystalization (botom) in CD3CN. 
 
 The protons on the inner aromatic rings, d, and g, both shift downfield, by ~0.7 
and 0.1 ppm, respectively.  The amine proton e shifts ~4.2 ppm downfield, as it is 
protonated during the self-assembly process. This is due to the pyrazole moieties of the 
[2]rotaxane ligand deprotonating upon coordination.  The methylene protons labeled f 
shift ~0.4 ppm downfield. 
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Unfortunately it was not possible to grow X-ray quality single crystals of this 
assembly.  Therefore, it was necessary to analyze its size and shape by a DOSY NMR 
analysis. 
4.5 DOSY ANALYSIS 
Diffusion NMR data was collected for the pyrazole-based MORP in CD3NO2 at 
10 mM concentration and 21±0.5 °C, the same conditions as employed for the previous 
two chapters.  The DOSY toolbox software was again used to extract the diffusion 
coefficients, listed in Table 4.1.  
Table 4.1 – Diffusion Coefficients and Modeled Radii of MOP and MORP. 
Assembly 
Diffusion 
Coefficients D 
(x 10-10 m2/s) 
Average 
Diffusion 
Coefficient D 
(x 10-10 m2/s) 
Radius r (Å) 
Calculated from 
calibration curve 
Radius r (Å) 
modelled 
[4]MN -  - - 8.4 
[5]MN - - - 9.8 
catenane 
1.9961 
2.0367 
2.1039 
2.05 (± 0.05) 13.2 12.4 
 
The sizes of the possible [4] and [5]MN MORP species were modelled using their space-
filled representations generated through molecular mechanics (MM3) geometry 
optimization calculations using Scigress Explorer 7.7 in the same fashion as the 
assemblies from Chapter 2 and 3.  The effective hydrodynamic radius, r, for the trimeric 
[4] and tetrameric [5]MN possibilities were approximated as half of the longest distance 
in the space-filled representation of the calculated structures of the molecules using the 
same methodology as the two previous chapters (Table 4.1).   
A Compact [2]Rotaxane Ligand with Pyrazole Donors 
 
190 
 
Figure 4.9 – Diffusion coefficient vs. the reciprocal of the modeled radii for the 
[4]MN triangle, [5]MN square, and catenated [5]MNs possibilities for the MORP 
assembled from the Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 [2]rotaxane linker and the 
[Pd2(bipy)2]4+ metal fragment. 
 
The radius calculated using the experimentally measured diffusion coefficient and 
the calibration curve (13.2 Å), is much larger than both the modelled radii for the [4] and 
[5]MN (8.4 and 9.8 Å, respectively) possibilities.  It does however correlate well (Figure 
4.9) with the modelled radius (12.4 Å) for catenated version of the [5]MN.  Thus, the 
assembly is identified as [Pd8(bipy)8(Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6)4]2[NO3]24. 
4.6 MOLECULAR MODELLING 
 As it was not possible to obtain crystals of sufficient quality for single crystal X-
ray structural determination of either the dimeric MOP or the catenated MORP to date, 
the modelled structures are presented.  Both structures were modelled with Scigress 
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Explorer 7.7 using the crystal structure of a similar self-assembled compound utilizing 
the same corner unit as a starting point to more accurately model the most likely 
molecular structure.125   
 
 
Figure 4.10 – MM3 calculated structure for the dimeric MOP, 
[Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2]6+, ball and stick view with hydrogen 
atoms omitted (top), and space-filling view (bottom). 
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Figure 4.10 shows the MM3 optimized structure of the 
[Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2]6+ dimer.  The space-filling view shows how 
the contracted length of the naked axle shrinks the cavity to where the methyl groups fill 
the majority of the available space. 
 The MM3 modelled structure for the catenated tetrameric MORP, 
[Pd8(bipy)8(Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6)4]224+ shows the doubly interpenetrated 
structure with two [5]MN mutually filling each other’s cavities. 
 
Figure 4.11 – The MM3 optimized structure of the catenated, tetrameric [5]MN, 
[Pd8(bipy)8(Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6)4]224+. 
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4.7 SUMMARY AND CONCLUSIONS 
 A [2]rotaxane ligand incorporating pyrazole donor groups was successfully 
synthesized.  The matching naked axle ligand was also synthesized and employed as a 
divergent tetradentate ligand in the synthesis of a dimeric MOP.  The combination of the 
[2]rotaxane ligand with the appropriate dimeric cis-protected metal fragment as corner 
unit, produced the desired tetrameric [5]MN, as a interpenetrated [2]catenane consisting 
of two square MORPs.  The presence or absence of the 24C6 macrocyclic wheel is again 
the only difference between the two supramolecular assemblies, influencing the self-
assembly process and directing the size and shape of the product.  The compact design of 
the [2]rotaxane ligand along with the use of a more rigid corner unit prevented the 
formation of the trimeric [4]MN, as intended.  Unfortunately, crystals suitable for single 
crystal X-ray crystallography have not been obtained as yet.  Thus, the structure of the 
catenated MORP was determined by means of a DOSY analysis.  One strategy towards 
the synthesis of a uninterpenetrated non-catenated tetrameric [5]MN would be the 
incorporation of bulkier crown ether macrocycles as the wheel component.  Alternatively, 
a suitably sized guest could be found to fill the cavity. 
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4.8 EXPERIMENTAL 
4.8.1 General Comments 
The Br(Me)2PhN-CPh(Me)2Br axle, and isomeric mixture of [2]rotaxanes,  
Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 were 
synthesized as outlined in the previous chapter.  [Pd2(bipy)2(NO3)2][NO3]2·H2O was 
synthesized using a literature preparation.131  1-Benzylpyrazole-4-boronic acid pinacol 
ester, tricyclohexylphosphine, tris(dibenzylideneacetone)dipalladium(0), potassium 
phosphate, MgSO4, palladium on carbon, H2, sodium metal, NH3, NH4Cl, were purchased 
from Aldrich or TCI America and used as received.  Deuterated solvents were obtained 
from Cambridge Isotope Laboratories or Aldrich and used as received.  Solvents were 
dried using an Innovative Technologies Solvent Purification System.  Thin layer 
chromatography (TLC) was performed using Teledyne Silica gel 60 F254 plates and 
viewed under UV light.  Column chromatography was performed using Silicycle Ultra 
Pure Silica Gel (230 – 400 mesh).  1H NMR, 13C NMR and 2-D NMR experiments were 
performed on a Bruker Avance 500 instrument, with a working frequency of 500.13 MHz 
for 1H nuclei, 125.7 MHz for 13C nuclei, and 202 MHz for 31P nuclei.  1H and 13C 
chemical shifts are quoted in ppm relative to tetramethylsilane, using the residual solvent 
peak as a reference standard.  Conventional 2-D NMR experiments 1H-1H COSY and 1H-
13C HMQC were conducted and used to help assign all peaks.  1H-DOSY experiments 
were carried out using the longitudinal eddy-current delay with bipolar gradient pulse 
pair and two spoil gradients (ledbpgp2s) pulse program, at 21±0.5 °C, 10 mM 
concentration, and 4 cm sample height in a 5 mm tube.  Experiments were performed 
with a diffusion time, Δ, of 0.2 s, a gradient recovery delay of 100 μs, a longitudinal 
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eddy-current delay of 2.5 ms, a gradient pulse duration, δ/2, of 1 ms.  A series of 32 
linear increments in gradient strength were used with 8 scans per increment.  The data 
was processed using the DOSY toolbox software using the standard high resolution 
DOSY fitting.112  High resolution mass spectrometry (HR-MS) experiments were 
performed on a Micromass LCT electrospray (ESI) time-of-flight (TOF) mass 
spectrometer.  Solutions of 50-100 ng/µL were prepared and injected for analysis at a rate 
of 5 µL/min, using a syringe pump.  Infrared (IR) experiments were performed on a 
Bruker Alpha FT-IR spectrometer.  Melting points were recorded using a Fischer-Johns 
melting point apparatus.  
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4.8.2 Synthesis of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(E)-24C6 and 
BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(Z)-24C6 
Br(Me)2PhN-CPh(Me)2Br⊂(E)-24C6 and Br(Me)2PhN-CPh(Me)2Br⊂(Z)-24C6 (0.39 
g, 0.52 mmol), 1-benzylpyrazole-4-boronic acid pinacol ester (0.33 g, 1.15 mmol), 
tris(dibenzylideneacetone)dipalladium(0) (0.01 g, 0.01 mmol),  tricyclohexylphosphine 
(7.0 mg, 0.03 mmol), and potassium phosphate (0.38 g, 1.77 mmol) were dissolved in 
dioxane (1.4 mL) and H2O (0.7 mL) under N2, and heated to 100 °C for 18 h.  The 
reaction mixture was cooled to RT, and filtered through a pad of silica (washing with 
EtOAc), and the filtrate concentrated.  The residue was dissolved in EtOAc (15 mL) and 
H2O (5 mL), the layers separated, and the H2O layer extracted with EtOAc (2 x 15 mL).  
The combined organic extracts were dried over MgSO4, filtered, and concentrated.  The 
crude product was purified by flash column chromatography (SiO2, 7 % MeOH in 
CH2Cl2, increasing MeOH % once product starts to elute) to give the product (E/Z 
mixture, 62/38) as an off-white greasy solid.  Yield: 0.45 g, 95 %.  MP: 162-165 °C.  IR 
(ATR) ν/cm-1 = 3368, 2914, 2869, 1608, 1565, 1513, 1497, 1454, 1350, 1331, 1260, 
1216, 1190, 1100, 1029, 1017, 995, 939, 855, 799, 724, 693.  HR-MS (ESI): calcd for 
[M+H] +, [C55H72N5O6]+, m/z = 898.5483, found m/z = 898.5484, error 0.1 ppm. 
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Table 4.2 - 1H NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(E)-24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 7.26 s 1 - 
b 7.44 s 1 - 
c 2.10 s  6 - 
d 6.64 s  2 - 
e 5.15 broad t  1 - 
f 4.38 d 2 3Jfe = 4.3 
g 7.46 s  2 - 
h 2.16 s  6 - 
i 7.44 s 1 - 
j 7.28 s 1 - 
k-p 3.26-3.58 m 24 - 
q 1.59, 1.67 2 m 4 3Jqr = 6.8 
r 2.00 m 4 - 
s 5.32 t 2 3Jsr = 3.4 
t 5.37 s 3 - 
t’ 5.39 s 3 - 
u, u’ 7.23 m 4 3Juv = 5.8 
v, v’ 7.36 m 4 3Jvu,vw = 7.0 
w, w’ 7.31 t 2 3Jwv = 7.3 
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Table 4.3 - 1H NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(Z)-24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 7.26 s 1 - 
b 7.43 s 1 - 
c 2.08 s  6 - 
d 6.68 s  2 - 
e, s 5.22 m  1 - 
f 4.46 d 2 3Jfe = 4.8 
g 7.42 s  2 - 
h 2.15 s  6 - 
i 7.44 s 1 - 
j 7.28 s 1 - 
k-p 3.20-3.59 m 24 - 
q 1.45, 1.51 2 m 4 3Jqr = 7.0 
r 2.19, 1.84 2 broad s 4 - 
t 5.31 s 3 - 
t’ 5.32 s 3 - 
u, u’ 7.21 m 4 3Juv = 6.1 
v, v’ 7.36 m 4 3Jvu,vw = 7.0 
w, w’ 7.31 t 2 3Jwv = 7.3 
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Table 4.4 – 13C NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(E)-24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1 129.20 1 
2 140.98 1 
3 121.52 1 
4 118.86 1 
5 137.02 2 
6 21.78 2 
7 112.81 2 
8 148.88 1 
9 47.62 1 
10 139.36 1 
11, 30 129.02 4 
12 136.50 2 
13 21.42 2 
14 130.12 1 
15 120.80 1 
16 140.98 1 
17 128.95 1 
18-23 
70.19 
70.41 
70.43 
70.68 
70.99 
71.07 
12 
24 29.40 2 
25 28.89 2 
26 130.40 2 
27 56.07 1 
27’ 56.15 1 
28 137.50 1 
28’ 137.25 1 
29, 29’ 127.53 4 
30’ 128.93 2 
31 128.00 1 
31’ 128.13 1 
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Table 4.5 – 13C NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(Z)-24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1 129.30 1 
2 140.22 1 
3 121.63 1 
4 118.71 1 
5 136.79 2 
6 21.76 2 
7 113.07 2 
8 148.96 1 
9 47.42 1 
10 139.80 1 
11 128.86 2 
12 136.48 2 
13 21.50 2 
14 129.96 1 
15 120.85 1 
16 140.24 1 
17, 30 129.02  3 
18-22 
70.51 
70.60 
70.76 
71.10 
71.16 
10 
23 72.21 2 
24 30.63 2 
25 25.34 2 
26 129.93  
27 56.07 1 
27’ 56.15 1 
28 137.54 1 
28’ 137.27 1 
29, 29’ 127.55 4 
30’ 128.95 2 
31 127.98 1 
31’ 128.12 1 
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4.8.3 Synthesis of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂24C6 
Palladium on carbon (10 %, 0.11 g, 0.10 mmol) was suspended in MeOH (15 mL) under 
N2.  The mixture of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(E)-24C6 and 
BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂(Z)-24C6 (0.33 g, 0.37 mmol) was dissolved in 
MeOH (min), and added to the suspension.  H2 was introduced via a balloon, and the 
suspension stirred until the reaction was complete by 1H NMR (3 h).  The reaction 
mixture was filtered through Celite, and concentrated to give an off-white greasy solid.  
Yield: 0.31 g, 90 %.  MP: 164-166 °C.  IR (ATR) ν/cm-1 = 3367, 2917, 2858, 1608, 
1568, 1514, 1496, 1455, 1446, 1411, 1349, 1330, 1189, 1101, 1030, 995, 950, 939, 910, 
727, 693.  HR-MS (ESI): calcd for [M+H]+, [C55H74N5O6]+, m/z = 900.5639, found m/z = 
900.5651, error 1.3 ppm. 
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Table 4.6 - 1H NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 7.27 s 1 - 
b, i 7.44 s 2 - 
c 2.10 s  6 - 
d 6.67 s  2 - 
e 5.12 broad t  1 3Jef = 4.5 
f 4.43 d 2 3Jfe = 4.5 
g 7.47 s  2 - 
h 2.16 s  6 - 
j 7.29 s 1 - 
k-p 3.27-3.60 m 24 - 
q 1.48 m 4 3Jqp,qr = 5.6 
r 1.30 m 4 - 
s 1.15 m 4 3Jsr = 6.6  
t 5.38 s 3 - 
t’ 5.41 s 3 - 
u, u’ 7.24 m 4 3Juv = 6.0 
v, v’ 7.37 m 4 3Jvu,vw = 7.1 
w, w’ 7.33 t 2 3Jwv = 7.5 
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Table 4.7 – 13C NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1 129.22 1 
2 140.79 1 
3 121.48 1 
4 118.56 1 
5 136.68 2 
6 21.59 2 
7 112.85 2 
8 148.70 1 
9 47.32 1 
10 139.44 1 
11 128.92 2 
12 136.33 2 
13 21.25 2 
14 129.88 1 
15 120.67 1 
16 140.02 1 
17, 30 128.86 3 
18-23 
70.18 
70.34 
70.56 
71.00 
71.69 
12 
24 29.78 2 
25 25.83 2 
26 29.00 2 
27 55.85 1 
27’ 55.95 1 
28 137.37 1 
28’ 137.10 1 
29, 29’ 127.35 4 
30’ 128.79 4 
31 127.83 1 
31’ 127.97 1 
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4.8.4 Synthesis of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 
BzPyr(Me)2PhN-CPh(Me)2PyrBz⊂24C6 (0.087 g, 0.0966 mmol) was dissolved in 
anhydrous THF, and added dropwise to a solution of sodium (0.018 g, 0.783 mmol) in 
liquid NH3 (~15 mL) at -78 °C.  A second batch of sodium (0.018 g, 0.783 mmol) was 
added and the resulting mixture stirred until the blue colour faded (1.5 – 2 h).  NH4Cl 
(0.052 g, 0.972 mmol) in H2O (min.) was slowly added, and the NH3 evaporated.  The 
mixture was extracted with CH2Cl2 (2 x 15 mL).  The combined organic phase was dried 
over MgSO4, filtered, and concentrated to produce a light yellow waxy solid.  Yield: 
0.050 g, 71 %.  MP: 279-282 °C.  IR (ATR) ν/cm-1 = 3363, 3180, 2921, 2858, 1725, 
1608, 1571, 1558, 1511, 1460, 1454, 1410, 1365, 1348, 1288, 1259, 1217, 1189, 1098, 
1027, 946, 934, 909, 864, 803, 754, 734, 689, 666.  HR-MS (ESI): calcd for [M+H] +, 
[C41H62N5O6]+, m/z = 720.4700, found m/z = 720.4704, error 0.6 ppm. 
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Table 4.8 - 1H NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b, i, j 7.50 s 4 - 
c 2.10 s  6 - 
d 6.70 s  2 - 
e 5.15 broad t  1 - 
f 4.47 d 2 3Jfe = 4.6 
g 7.48 s  2 - 
h 2.17 s  6 - 
k-p 3.28-3.62 m 24 - 
q 1.50 m 4 3Jqp,qr = 6.7 
r 1.32 m 4 - 
s 1.17 broad t 4 -  
t, t’ - - - - 
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Table 4.9 - 1H NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b 7.41 s 2 - 
c 2.05 s  6 - 
d 6.68 s  2 - 
e 5.22 broad t  1 3Jef = 4.6 
f 4.45 d 2 3Jfe = 4.6 
g 7.48 s  2 - 
h 2.13 s  6 - 
i, j 7.47 s 2 - 
k-p 3.22-3.59 m 24 - 
q 1.45 m 4 3Jqp,qr = 6.2 
r 1.31 m 4 3Jrq,rs = 6.8 
s 1.15 broad t 4 3Jsr = 6.9 
t, t’ 11.11 broad s 1 - 
 
Table 4.10 - 1H NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 in CD3NO2. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b 7.48 s 2 - 
c 2.11 s  6 - 
d 6.79 s  2 - 
e 5.35 broad t  1 3Jef = 4.8 
f 4.54 broad s 2 - 
g 7.57 s  2 - 
h 2.19 s  6 - 
i, j 7.54 s 2 - 
k-p 3.33-3.66 m 24 - 
q 1.51 m 4 3Jqp,qr = 5.6 
r 1.35 m 4 - 
s 1.20 broad t 4 3Jsr = 6.8 
t, t’ - - - - 
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Table 4.11 – 13C NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 in CDCl3. 
Carbon δ (ppm) # Carbons 
1, 2 134.53 2 
3 120.60 1 
4 118.53 1 
5 137.06 2 
6 21.73 2 
7 113.04 2 
8 148.98 1 
9 47.51 1 
10 139.72 1 
11 129.07 2 
12 136.72 2 
13 21.40 2 
14 129.92 1 
15 119.86 1 
16, 17 133.93 2 
18-23 
70.41 
70.60 
70.74 
70.77 
71.22 
71.92 
12 
24 29.94 2 
25 25.98 2 
26 29.14 2 
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4.8.5 Synthesis of BzPyr(Me)2PhN-CPh(Me)2PyrBz 
Br(Me)2PhN-CPh(Me)2Br (0.21 g, 0.53 mmol), 1-benzylpyrazole-4-boronic acid 
pinacol ester (0.33 g, 1.16 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.01 g, 0.01 
mmol),  tricyclohexylphosphine (7.1 mg, 0.03 mmol), and potassium phosphate (0.38 g, 
1.80 mmol) were dissolved in dioxane (4 mL) and H2O (4 mL) under N2, and heated to 
100 °C for 18 h.  The reaction mixture was cooled to RT, and filtered through a pad of 
silica (washing with EtOAc), and the filtrate concentrated.  The residue was dissolved in 
EtOAc (15 mL) and H2O (5 mL), the layers separated, and the H2O layer extracted with 
EtOAc (2 x 15 mL).  The combined organic extracts were dried over MgSO4, filtered, 
and concentrated.  The crude product was purified by flash column chromatography 
((SiO2, EtOac/hexanes, starting at 2:3 v/v, and increasing the % EtOAc) to give an off-
white waxy solid.  Yield: 0.29 g, 98 %.  MP: 146-148 °C.  IR (ATR) ν/cm-1 = 3332, 
3089, 3030, 2965, 2912, 1608, 1567, 1496, 1454, 1443, 1407, 1358, 1326, 1261, 1215, 
1189, 1156, 1101, 1077, 1062, 1029, 995, 937, 853, 805, 721, 693, 582, 568.  HR-MS 
(ESI): calcd for [M+H] +, [C37H38N5]+, m/z = 552.3127, found m/z = 552.3134, error 1.3 
ppm.  
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Table 4.12 - 1H NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 7.23 s 1 - 
b 7.41 s 1 - 
c 2.07 s  6 - 
d 6.42 s  2 - 
e 4.03 broad s  1 - 
f 4.25 s 2 - 
g 7.11 s  2 - 
h 2.14 s  6 - 
i 7.44 s 1 - 
j 7.27 s 1 - 
t 5.36 s 3 - 
t’ 5.38 s 3 - 
u, u’ 7.21 m 4 3Juv = 7.7 
v, v’ 7.35 m 4 3Jvu,vw = 6.8 
w, w’ 7.31 t 2 3Jwv = 6.8 
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Table 4.13 – 13C NMR data of BzPyr(Me)2PhN-CPh(Me)2PyrBz in CDCl3. 
Carbon δ (ppm) # Carbons 
1 129.07 1 
2 140.56 1 
3 120.50 1 
4 121.66 1 
5 138.73 2 
6 21.69 2 
7 111.99 2 
8 147.49 1 
9 48.36 1 
10 138.55 1 
11 126.77 2 
12 138.07 2 
13 21.48 2 
14 131.44 1 
15 120.12 1 
16 139.96 1 
17 128.73 1 
27 56.08 1 
27’ 56.17 1 
28 137.25 1 
28’ 137.04 1 
29 127.49 2 
29’ 127.55 2 
30 129.02 2 
30’ 128.96 2 
31 128.05 1 
31’ 128.17 1 
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4.8.6 Synthesis of Pyr(Me)2PhN-CPh(Me)2Pyr 
BzPyr(Me)2PhN-CPh(Me)2PyrBz (0.100 g, 0.181 mmol) was dissolved in anhydrous 
THF, and added dropwise to a solution of sodium (0.033 g, 1.44 mmol) in liquid NH3 
(~15 mL) at -78 °C.  A second batch of sodium (0.033 g, 1.44 mmol) was added and the 
resulting mixture stirred until the blue colour faded (1.5 – 2 h).  NH4Cl (0.102 g, 1.91 
mmol) dissolved in H2O (min.) was slowly added, and the NH3 evaporated.  The layers 
were separated and the aqueous phase extracted with CH2Cl2 (3 x 8 mL).  The combined 
organic phase was dried over MgSO4, filtered, and concentrated.  The crude product was 
dissolved in MeCN, filtered, and concentrated to produce a yellow glassy solid.  Yield: 
0.037 g, 55 %.  MP: >300 °C.  IR (ATR) ν/cm-1 = 3367, 3167, 3070, 2948, 2924, 2855, 
1685, 1608, 1572, 1495, 1453, 1438, 1405, 1366, 1337, 1261, 1185, 1141, 1087, 948, 
932, 906, 865, 802, 728, 688, 648.  HR-MS (ESI): calcd for [M+H] +, [C23H26N5]+, m/z = 
372.2188, found m/z = 372.2188, error 0.0 ppm. 
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Table 4.14 - 1H NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b 7.37 s 2 - 
c 1.98 s  6 - 
d 6.40 s  2 - 
e 4.79 broad s  1 - 
f 4.25 d 2 3Jfe = 4.8 
g 7.11 s  2 - 
h 2.09 s  6 - 
i, j 7.46 s 2 - 
t, t’ 11.09 broad s 2 - 
 
Table 4.15 - 1H NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b 7.50 s 2 - 
c 2.10 s  6 - 
d 6.48 s  2 - 
e - -  - - 
f 4.30 s 2 - 
g 7.16 s  2 - 
h 2.17 s  6 - 
i, j 7.54 s 2 - 
t, t’ - - - - 
 
 
 
 
A Compact [2]Rotaxane Ligand with Pyrazole Donors 
 
214 
Table 4.16 - 1H NMR data of Pyr(Me)2PhN-CPh(Me)2Pyr in MeOD/CD2Cl2 1:1. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b 7.40 s 2 - 
c 2.02 s  6 - 
d 6.44 s  2 - 
e - -  - - 
f 4.26 s 2 - 
g 7.11 s  2 - 
h 2.11 s  6 - 
i, j 7.46 s 2 - 
t, t’  - - - 
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4.8.7 Synthesis of [Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2][NO3]6 
Pyr(Me)2PhN-CPh(Me)2Pyr (3.7 mg, 0.010 mmol) and [Pd2(bipy)2(NO3)2][NO3]2·H2O 
(7.9 mg, 0.010 mmol) were dissolved in MeNO2 (2 mL) and stirred for 10 min.  The 
resulting clear yellow solution was filtered and the solvent evaporated to produce a 
yellow solid.  Yield: 8.1 mg, 74 %. 
 
Table 4.17 - 1H NMR data of [Pd4(bipy)4(Pyr(Me)2PhN-CPh(Me)2Pyr)2][NO3]6 in 
CD2Cl2/MeOD 1:1. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a, b 7.87 2 s 4 - 
c 2.15 s  12 - 
d 6.89 s  4 - 
e - -  - - 
f 4.46 s 4 - 
g 6.94 s  4 - 
h 2.13 s  12 - 
i, j 7.88 2 s 4 - 
t 8.50 d 8 3Jtu = 7.9 
u 8.35 t 8 3Jut,uv = 8.1 
v 7.76 overlapped m 8 - 
w 8.31 overlapped m 8 - 
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4.8.8 Synthesis of [Pd8(bipy)8(Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6)4]2[NO3]24 
Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6 (7.2 mg, 0.010 mmol) and 
[Pd2(bipy)2(NO3)2][NO3]2·H2O (7.9 mg, 0.010 mmol) were suspended in H2O (1.0 mL) 
and acetone (0.5 mL), and stirred at 60 °C for 2 h.  The resulting clear yellow solution 
was filtered, and the solvent evaporated.  The product was anion exchanged to the OTf 
salt through the addition of a saturated H2O solution of NaOTf, followed by an extraction 
with MeNO2.  The organic layer was washed with H2O, dried over MgSO4, filtered, and 
the solvent evaporated to yield a yellow solid.  Yield: 14.3 mg, 85 %.  MP: 182-189 °C 
(decomp.).  IR (ATR) ν/cm-1 = 3509, 3116, 3094, 2923, 2855, 1606, 1564, 1472, 1452, 
1256, 1224, 1158, 1110, 1093, 1030, 771, 725, 637, 574, 517.  Diffusion Coefficient (1H 
NMR, 500 MHz, CD3NO2, 294 K): 2.05 (± 0.04) x 10-10 m2/s. 
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Table 4.18 - 1H NMR data of [Pd8(bipy)8(Pyr(Me)2PhN-
CPh(Me)2Pyr⊂24C6)4]2[NO3]24 in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a,b,i,j 7.84  broad m 32 - 
c,h 2.24 broad m  96 - 
d 7.37 broad s  16 - 
e 9.41  broad s 16 - 
f 4.86 broad s 16 - 
g 7.53 broad s  16 - 
k-p 3.31-3.56 m 192 - 
q 1.34 broad s 32 - 
r 1.26 broad s 32 - 
s 1.23 broad s 32 - 
t,v,w 8.29-8.45 overlapped m 96 - 
u 7.74 broad m 32 - 
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DOSY of [Pd8(bipy)8(Pyr(Me)2PhN-CPh(Me)2Pyr⊂24C6)4]2[NO3]24 in CD3NO2. 
 
 
 
 
CHAPTER 5 
 
An Unsymmetrical Benzimidazole [2]Rotaxane Ligand 
 
3.1 INTRODUCTION 
 In addition to the 1,2-bis(dipyridinium)ethane (BPE) and N-benzylanilinium 
(NBA) axles utilized in the previous chapters, a third axle used for the formation of 
[2]pseudorotaxanes and [2]rotaxanes in conjunction with DB24C8 has also been studied 
in the Loeb group.  This design utilizes a triphenylbenzimidazolium cation in conjunction 
with the DB24C8 macrocycle to form a [2]pseudorotaxane in which the macrocycle 
adopts a C configuration as illustrated in Figure 5.1.132-134  
 
Figure 5.1 – [2]Pseudorotaxane consisting of the 2,4,7-triphenylbenzimidazolium 
cation complexed with DB24C8.133 
 
The [2]pseudorotaxane is held together by strong NH···O hydrogen bonds and 
N+···O ion-dipole interactions between the NH groups of the benzimidazolium cation and 
the oxygen atoms of the macrocycle, as well as weaker CH···O hydrogen bonds between 
aromatic protons of the cation and oxygen atoms on the macrocycle.  It is also held 
together by substantial π-stacking between the electron poor benzimidazolium ring and 
the electron rich catechol rings of the macrocycle.  
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 This motif can also be employed in the synthesis of [2]rotaxanes by using a 
second triphenylbenzimidazolium group as a stopper to produce an H-shaped molecular 
shuttle (Figure 5.2).   
Figure 5.2 – Neutral, cationic, and dicationic forms of the benzimidazole based 
[2]rotaxane.132,134 
 
 This system can exist in three different states (neutral, cationic, and dicationic) 
due to the presence of two benzimidazole (BzIm) recognition sites on the axle.  In the 
dicationic species there are two identical strongly binding recognition sites while in the 
neutral state the ion-dipole and π-stacking interactions are absent, the hydrogen bonding 
reduced, and the anion eliminated. 
 The relatively compact size, rigidity, right angle (90°) turns, and straightforward 
synthetic modification of the [2]rotaxane molecular shuttle allows for the modification of 
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the basic design to incorporate a variety of functional groups, such as pyridine moieties 
for coordination to metals. 
 The ligand design described in this chapter takes inspiration from the M2L4 cages 
(Figure 5.3) utilizing palladium ions and pyridine containing 180° bridging ligands 
published over the last two decades. 
 
Figure 5.3 – Cartoon of M2L4 cage general structure. 
 
 The first pyridine-palladium based M2L4 system, also one of the first quadruply 
stranded helicates, was discovered by McMorran and Steel,135 who reported that the 
combination of 1,4-bis(3-pyridyloxy)benzene (Figure 5.4a) with [PdI2(Py)2] in the 
presence of silver triflate, followed by the addition of ammonium hexafluorophosphate, 
produced a M2L4 helical cage with two square-planar palladium atoms, each coordinated 
to the four bridging ligands, with one hexafluorophosphate anion encapsulated within the 
cage in the solid state. 
This was followed a few years later by a study by Fujita and coworkers which 
monitored the synthesis of a M2L4 cage by NMR spectroscopy.136  The combination of 
the rigid 1,3-bisphenylbenzene core containing ligand depicted in Figure 5.4b and 
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Pd(NO3)2 in dimethyl sulphoxide produced the M2L4 cage, which encapsulates a nitrate 
anion in the solid state. 
A set of amide-based flexible ligands (Figure 5.4c) which can adopt different 
conformations were used to synthesize a series of M2L4 cages.137-139  These cages change 
conformation to accommodate a variety of guests, electrophilic or nucleophilic, by 
changing the nature of the cavity of the cage.  A quadruply stranded helicate was 
synthesized using 4,4’-bis(3-pyridinemethoxy)-benzophenone as a flexible ligand (Figure 
5.4d) that allows the resulting cage to dimerize into an interlocked [M2L4]2 
structure.140,141  The same system can also encapsulate a series of anions, including chiral 
d- or l-camphor sulphonate and a first generation sulphonate dendrimer. 
The banana-shaped ligand pictured in Figure 5.4e reacts with 
[Pd(CH3CN)4][BF4]2 to produce a versatile M2L4 cage which can bind 1,1’-ferrocene 
bis(sulfonate) and other anionic guests,142-144 and act as the wheel to a bis-anionic axle to 
form a [2]pseudorotaxane.145  The solubility of the cage can be controlled through the 
addition of different guests,146 and it can be used to create a stacked pentanuclear 
platinum compound consisting of the cage containing three alternating positively and 
negatively charged platinum centred ions.147  An extended version of the ligand has also 
been used to synthesize a larger version of the cage.148 
The cage formed by a rigid ligand with a phenyl-alkyne backbone (Figure 5.4f) 
acts as host to anions as well as neutral organic guests with donor groups.149  
Modification of the ligand with endohedral functional groups allows for the formation of 
heteroclusters composed of two different ligands which self-sort according to non-
covalent and space-filling interactions.150,151  A very similar ligand with the central 
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aromatic ring exchanged for a pyridine ring has been used to host two cisplatin 
molecules, which are released when a competitive ligand is added.152 
Quadruply stranded helicates were synthesized from a series of easily synthesized 
di-1.4-substituted-1,2,3-triazole “click” ligands (Figure 5.4g),153,154 as well as 
N,N’-bis(3-pyridylformyl)piperazine (Figure 5.4h).155 
 
Figure 5.4 – Ligands leading to the self-assembly of M2L4 cages in combination with 
Pd(II) ions.135-162 
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  The unique anthracene containing ligand pictured in Figure 5.4i was found to 
form a M2L4 cage when reacted with PdCl2(DMSO)2 in the presence of AgNO3 which 
encapsulates both spherical ([2,2]paracyclophane) and planar (1-methylpyrene) organic 
guests, as well as the fullerene, C60.156 
 The dibenzosuberone based ligand shown in Figure 5.4j forms a small cage while 
a larger analogue with an alkyne spacer forms a dimerized interpenetrated [M2L4]2 
structure which encapsulate halide anions strongly enough to dissolve AgCl.157,158  
Endohedrally functionalizing the larger ligand prevents the dimerization unless a chloride 
anion is added, which restores the [M2L4]2 structure creating two pockets which 
encapsulate two larger perrhenate anions.159  Replacing the dibenzosuberone core with 
phenothiazine creates an interpenetrated [M2L4]2 double cage incorporating redox 
centers,160 while replacing it with a dithienylethene photoswitch allows the size and shape 
of the resulting self-assembled cage to be controlled by means of irradiation with ultra-
violet or white light.161  The analogous chiral 2,2’-bis(methoxymethyl)-1,1’-binaphthyl 
ligand was shown to self-sort and exclusively form homochiral cages from racemic 
mixtures.162 
 
Figure 5.5 – Design of the [2]rotaxane ligand. 
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This chapter describes the design and synthesis of a [2]rotaxane ligand suitable 
for incorporation into a M2L4 cage.  The design is a modification of the H-shaped 
[2]rotaxane introduced at the start of this chapter to incorporate two pyridine moieties for 
coordination to palladium metal centers as well as tert-butylphenyl groups to improve 
solubility as illustrated in Figure 5.5.    
5.2 SYNTHESIS AND CHARACTERIZATION 
5.2.1 Synthesis of [2]Rotaxane 
 The synthesis of the [2]rotaxane molecular shuttle starts with the synthesis of the 
T-shaped recognition site (Scheme 5.1).  First, by means of a Suzuki reaction, 
4,7-dibromo-2,1,3-benzthiadiazole is coupled with 4-tert-butylphenylboronic acid, using 
a tetrakis(triphenylphosphine)palladium(0) catalyst and sodium carbonate in a mixture of 
toluene, tetrahydrofuran and water under nitrogen.  The product of 
4-bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole was purified by flash column 
chromatography.  The second step is a sulfur extrusion using a cobalt (II) chloride 
catalyst and sodium borohydride as reducing agent which produces 1,2-diamino-3-
bromo-6-(4-t-butylphenyl)-benzene after organic workup.  
The next step is a condensation reaction with terephthaldehyde in the presence of 
a zirconium (IV) chloride catalyst and acetonitrile solvent.  Removal of the solvent and 
recrystallization from acetonitrile produced the axle, 
4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-benzimidazole.  The addition of 
tetrafluoroboric acid to an diethyl ether solution of the product precipitates the 
4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-benzimidazolium T-shaped axle 
with recognition site as the tetrafluoroborate salt, [Br(tBuPh)BzImPhC=O][BF4]. 
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Scheme 5.1 – Synthesis of benzimidazolium recognition site. 
 
The synthesis of the [2]rotaxane starts with the combination of the protonated axle 
[Br(tBuPh)BzImPhC=O][BF4] and DB24C8 macrocyclic wheel in chloroform to form 
the [2]pseudorotaxane.  The 1,2-diamino-3-bromo-6-(4-t-butylphenyl)benzene stopper 
was then added along with zirconium chloride.  The (Br(tBuPh)BzIm)2Ph⊂DB24C8 
[2]rotaxane was recovered after neutralization with triethylamine.  The final step involves 
a Suzuki reaction to add the pyridine coordinating moieties by the reaction of the 
[2]rotaxane with 4-pyridineboronic acid in the presence of the PEPPSI-IPr catalyst and 
potassium carbonate in a dioxane and water solution.   Purification involved the 
protonation of the [2]rotaxane with tetrafluoroboric acid, followed by extraction, removal 
of the solvent, dissolving of the residue in acetonitrile, and the addition of triethylamine 
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to deprotonate and precipitate the (Py(tBuPh)BzIm)2Ph⊂DB24C8 H-shaped [2]rotaxane 
molecular shuttle.  
 
Scheme 5.2 – Synthesis of H-shaped [2]rotaxane molecular shuttle, 
(Py(tBuPh)BzIm)2Ph⊂DB24C8. 
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5.2.2 Synthesis of Naked Axle 
 The related H-shaped naked axle was also synthesized as a comparison to the 
[2]rotaxane ligand, as well as an interesting ligand in its own right.  The synthetic 
sequence necessary is depicted in Scheme 5.3. 
 
Scheme 5.3 – Synthesis of H-shaped naked axle ligand, (Py(tBuPh)BzIm)2Ph. 
 
The first step is the attachment of the pyridine coordinating group using a Suzuki 
coupling reaction.  4-Bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole synthesized as 
described in the previous section is dissolved in a dioxane and water mixture, and 4-
pyridineboronic acid, the PEPPSI-IPr catalyst, and potassium carbonate added.  Flash 
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column chromatography produces pure 4-(4-pyridine)-7-(4-t-butylphenyl)-
2,1,3-benzthiadiazole.  Next is the sulfur extrusion, which involves the addition of cobalt 
(II) chloride and sodium borohydride to an ethanol/tetrahydrofuran solution of 
4-(4-pyridine)-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole, which produces the desired 
product, 1,2-diamino-3-(4-pyridine)-6-(4-t-butylphenyl)benzene.  The last step is the 
construction of the naked axle through a double condensation reaction, combining the 
1,2-diamino-3-(4-pyridine)-6-(4-t-butylphenyl)-benzene stopper with terephthaldehyde 
and a zirconium (IV) chloride in chloroform.  Purification by boiling in diethyl ether 
produces the (Py(tBuPh)BzIm)2Ph H-shaped naked axle. 
5.2.3 1H NMR Analysis 
 The 1H NMR spectra for the uncomplexed macrocyclic wheel, DB24C8, the 
H-shaped [2]rotaxane ligand, [(Py(tBuPh)BzIm)2Ph⊂DB24C8][HBF4]4, and the naked 
axle ligand, [(Py(tBuPh)BzIm)2Ph][HBF4]4, are displayed in Figures 5.6 and 5.7.  Both 
the [2]rotaxane and naked axle are tetraprotonated, which gives two equal strongly 
binding recognition sites.  There is slow exchange on the NMR timescale of the 
macrocycle between ends of the axle of the [2]rotaxane, which gives rise to two sets of 
peaks, complexed and uncomplexed. 
When the uncomplexed DB24C8 macrocycle and [2]rotaxane are compared 
(Figure 5.6), it can be seen that all signals shift upfield when the macrocycle is 
interpenetrated by the axle.  Protons j and k shift ~0.3 and ~0.6 ppm upfield, 
respectively, due to π-stacking between the electron rich catechol rings of the macrocycle 
and the electron poor benzimidazolium ring.     
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Figure 5.6 – Structure of [(Py(tBuPh)BzIm)2Ph⊂DB24C8]4+ with labeling scheme. 
 
 Protons l, m, both shift upfield by ~0.4 ppm while n splits into two mutiplets, 
~0.1, and 0.8 ppm upfield from the parent peak, due to proximity to the oxygen atoms of 
the macrocycle that are hydrogen bonded to the NH groups and center aromatic ring of 
the protonated axle.  
 
Figure  5.7  – 1H NMR spectra  of  DB24C8 (top), the 
[(Py(tBuPh)BzIm)2Ph⊂DB24C8][HBF4]4 [2]rotaxane (middle),  and the 
[(Py(tBuPh)BzIm)2Ph][HBF4]4 naked axle (botom) in CD3CN. 
  
The NH protons of the benzimidazolium ring labeled h appear between 12.81 
and 13.37 ppm, the two sharper peaks being from the complexed end, experiencing 
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hydrogen bonding, and the broader two from the uncomplexed end.  Figure 5.6 also 
shows the tBu group protons, g, which splits into two singlets both slightly downfield 
from the parent peak. 
Comparing the aromatic regions of the 1H NMR spectra of the [2]rotaxane and 
naked axle reveals that each aromatic proton on the axle splits into two peaks, corelating 
to the complexed and uncomplexed ends.  Pyridine protons labeled a shift ~0.1 ppm 
downfield and barely upfield, and change from a doublet to two triplets as a now couples 
to the protonated pyridine in addition to protons b, which shift ~0.5 and 0.1 ppm upfield 
due to the presence or absence of π-stacking with the macrocycle.  Central aromatic 
protons c, and d, both split into two doublets, with c shifting ~0.6 ppm upfield and 
slightly downfield and d shifting ~0.6 ppm upfield and ~0.1 ppm downfield, again due to 
the presence or absence of π-stacking with the macrocycle. 
 
Figure  5.8  – 1H NMR spectra  of the  aromatic region for 
[(Py(tBuPh)BzIm)2Ph⊂DB24C8][HBF4]4 [2]rotaxane (top), and the 
[(Py(tBuPh)BzIm)2Ph][HBF4]4 naked axle (botom) in CD3CN. 
 
 Protons e and f behave similarly, with e shifting ~0.3 ppm upfield and slightly 
downfield and f shifting ~0.1 ppm upfield and slightly downfield. The protons that shift 
the most upfield due to π-stacking with the macrocycle are the central four from the 
aromatic strut of the axle, b, c, d, and e.  Protons a and f do not shift very much.  The 
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protons from the central aromatic rings labelled i, also splits into two peaks shifting ~0.3 
and ~0.1 ppm downfield, due to the presence or lack of hydrogen bonding with the 
oxygen atoms of the macrocyclic wheel.  
5.3 SYNTHESIS OF MOP AND MORP 
 
Scheme 5.4 – Synthesis of M2L4 cage from H-shaped ligands, with macrocycles 
omitted on the product for the [2]rotaxane. 
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The combination of either the H-shaped naked axle, Py(tBuPh)BzIm)2Ph, or the 
H-shaped [2]rotaxane, (Py(tBuPh)BzIm)2Ph⊂DB24C8, with Pd(II) metal centers should 
result in the synthesis of a M2L4 cage as outlined in Scheme 5.4.   
 
Figure 5.9 – MM3 modelled structure of the expected product of the combination of 
Pd(II) ions and H-shaped ligand, Py(tBuPh)BzIm)2Ph, side view, with hydrogen 
atoms omitted for clarity. 
  
Preliminary efforts have been made to combine the two H-shaped ligands with 
Pd(II) ions, however thus far all attempts have resulted in mixtures with mostly broad 
NMR spectra.  Attempts to produce produce crystals suitable for single crystal X-ray 
analysis from mixtures of Pd(II) ions and either the [2]rotaxane or naked axle ligands 
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have also been unsuccessful thus far.  Two different sources of Pd(II) ions have been 
utilized, Pd(NO3)2 and [Pd(MeCN)4][BF4]2, as well as a few different solvents and 
solvent mixtures.  Only the neutral version of the H-shaped ligands have been employed 
thus far, and the relatively poor solubility of these species could be a contributing factor 
to the lack of success in the self-assembly of these ligands to date. 
 
Figure 5.10 – MM3 modelled structure of the expected product of the combination 
of Pd(II) ions and H-shaped ligand, Py(tBuPh)BzIm)2Ph, top down view, with 
hydrogen atoms omitted for clarity. 
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Figure 5.8 and 5.9 shows the MM3 calculated model of what the structure of the 
product of the combination of the H-shaped axle, Py(tBuPh)BzIm)2Ph, with Pd(II) metal 
centers would be expected to look like.  Together the two perspectives reveal a paddle 
wheel-like cubic structure.  The structure of the product of the H-shaped [2]rotaxane 
would not be substantially different, the only difference being the DB23C8 macrocyclic 
wheel occupying some of the space in the cavity. 
5.4 SUMMARY AND CONCLUSIONS 
 A new unsymmetrical H-shaped [2]rotaxane, incorporating the  
bisbenzimidazole/DB24C8 templating motif, has been synthesized and characterized.  
The matching naked axle ligand was also produced.  Pyridine donor groups were 
incorporated into the structures of the molecules for the purpose of incorporating the 
ligands into M2L4 type self-assembled molecular cages.  The combination of both the H-
shaped [2]rotaxane and naked axle ligands with Pd(II) ions has been attempted, with no 
success thus far.  The use of two different sources of Pd(II) ions as well as a variety of 
different solvents and solvent mixtures have been explored.  Further experimentation 
with solvent mixtures as well as the use of the more soluble protonated versions of the H-
shaped ligands is needed. 
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5.5 EXPERIMENTAL 
5.5.1 General Comments 
4,7-Dibromo-2,1,3-benzthiadiazole was synthesized using a slightly modified 
literature method.163  4-tert-Butylphenylboronic acid, sodium carbonate, MgSO4, cobalt 
(II) chloride hexahydrate, tetrakis(triphenylphosphine)palladium(0), sodium borohydride, 
NaCl, terepthaldehyde, zirconium (IV) chloride, HBF4·Et2O, DB24C8, Et3N, potassium 
carbonate, 4-pyridineboronic acid, PEPPSI-iPr, and Na2SO4, were purchased from 
Aldrich or TCI America and used as received.  Deuterated solvents were obtained from 
Cambridge Isotope Laboratories and used as received.  Solvents were dried using an 
Innovative Technologies Solvent Purification System.  Thin layer chromatography (TLC) 
was performed using Teledyne Silica gel 60 F254 plates and viewed under UV light.  
Column chromatography was performed using Silicycle Ultra Pure Silica Gel (230 – 400 
mesh).  Column chromatography was performed using Silicycle Ultra Pure Silica Gel 
(230 – 400 mesh).  1H NMR, 13C NMR and 2-D experiments were performed on a Bruker 
Avance 500 instrument, with a working frequency of 500.13 MHz for 1H nuclei, and 
125.7 MHz for 13C nuclei.  1H and 13C chemical shifts are quoted in ppm relative to 
tetramethylsilane, using the residual solvent peak as a reference standard.  Conventional 
2-D NMR experiments 1H-1H COSY and 1H-13C HMQC were conducted and used to 
help assign all peaks.  High resolution mass spectrometry (HR-MS) experiments were 
performed on a Micromass LCT electrospray (ESI) time-of-flight (TOF) mass 
spectrometer.  Solutions of 50-100 ng/µL were prepared and injected for analysis at a rate 
of 5 µL/min, using a syringe pump.  Infrared (IR) experiments were performed on a 
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Bruker Alpha FT-IR spectrometer.  Melting points were recorded using a Fischer-Johns 
melting point apparatus.      
 
· 
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5.5.2 Synthesis of 4-bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole 
4,7-Dibromo-2,1,3-benzthiadiazole (3.00 g, 0.0102 mol), 4-tert-butylphenylboronic acid 
(1.28 g, 0.0072 mol), tetrakis(triphenylphosphine)palladium(0) (0.12 g, 0.108 mmol), and 
sodium carbonate (0.91 g, 0.0086 mol) were dissolved in toluene (12 mL), THF (12 mL), 
and H2O (2.5 mL) under N2.  The resulting mixture was heated to reflux for 24 h, and 
cooled to RT.  H2O (10 mL) was added, and the resulting mixture extracted with Et2O (3 
x 25 mL).  The combined organic layers were combined, dried over MgSO4, filtered, and 
concentrated.  The crude product was purified by flash column chromatography (SiO2, 
9:1 Hexanes/CH2Cl2 v/v, gradient to 100 % CH2Cl2, then to 100 % EtOAc) to give a 
bright yellow green powder.  Yield: 2.00 g, 80%.  MP: 138-140 °C.  IR (ATR) ν/cm-1 = 
2959, 2899, 2863, 1533, 1505, 1477, 1460, 1407, 1369, 1361, 1328, 1262, 1198, 1149, 
1121, 1100, 1024, 1017, 942, 933, 880, 844, 822, 788, 756, 742, 653, 622, 583, 555, 549, 
528, 507, 497.  HR-MS (ESI): calcd for [M+H]+, [C16H16BrN2S]+, m/z = 347.0218, found 
m/z = 347.0226, error 2.2 ppm. 
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Table 5.1 - 1H NMR data of 4-bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole in 
CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c,f 7.58 overlapped m  3 - 
d 7.92 d  1 3Jdc = 7.6 
e 7.84 d  2 3Jef = 8.5 
g 1.40 s 9 - 
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Table 5.2 – 13C NMR data of 4-bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole in 
CDCl3. 
Carbon δ (ppm) # Carbons 
4 112.92 1 
5 128.17 1 
6 132.52 1 
7 134.12 1 
8 133.92 1 
9 129.04 2 
10 125.95 2 
11 152.10 1 
12 34.96 1 
13 31.50 3 
14 154.07 1 
15 153.47 1 
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5.5.3 Synthesis of 1,2-diamino-3-bromo-6-(4-t-butylphenyl)benzene 
4-Bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole (1.96 g, 5.65 mmol) was dissolved 
in EtOH (60 mL) and THF (8 mL).  Cobalt (II) chloride hexahydrate (0.134 g, 0.57 
mmol) and sodium borohydride (1.07 g, 28.25 mmol) were added, the resulting mixture 
refluxed for 3 hr, cooled to RT, filtered, and concentrated.  The residue was dissolved in 
CH2Cl2 (80 mL) and H2O (80 mL) and the layers separated.  The H2O layer was further 
extracted with CH2Cl2 (2 x 80 mL).  The combined organic layers were washed with sat. 
aq. NaCl (40 mL), dried over Na2SO4, filtered, and concentrated to give an orange yellow 
solid (stored under N2 in dark).  Yield: 1.52 g, 84%.  MP: 142-144 °C.  IR (ATR) ν/cm-1 
= 3436, 3398, 3353, 3303, 3218, 3080, 3026, 2960, 2901, 2863, 1625, 1586, 1511, 1466, 
1445, 1396, 1356, 1261, 1219, 1110, 1091, 1013, 866, 846, 836, 788, 750, 736, 730, 634, 
609, 595, 569, 543, 518.  HR-MS (ESI): calcd for [M+H]+, [C16H20BrN2]+, m/z = 
319.0810, found m/z = 319.0813, error 0.9 ppm. 
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Table 5.3 - 1H NMR data of 1,2-diamino-3-bromo-6-(4-t-butylphenyl)benzene in 
CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 7.04 d  1 3Jcd = 8.3 
d 6.61 d  1 3Jdc = 8.3 
e 7.35 d 2 3Jef = 8.4 
f 7.49 d  2 3Jfe = 8.4 
g 1.38 s 9 - 
h 3.69 broad s 4 - 
 
 
 
 
 
 
 
 
An Unsymmetrical Benzimidazole [2]Rotaxane Ligand 
 
243 
 
Table 5.4 – 13C NMR data of 1,2-diamino-3-bromo-6-(4-t-butylphenyl)benzene in 
CDCl3. 
Carbon δ (ppm) # Carbons 
4 110.27 1 
5 122.02 1 
6 122.76 1 
7 128.51 1 
8 136.10 1 
9 128.88 2 
10 126.05 2 
11 150.60 1 
12 34.83 1 
13 31.57 3 
14 133.31 1 
15 133.11 1 
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5.5.4 Synthesis of 
4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-benzimidazole 
1,2-Diamino-3-bromo-6-(4-t-butylphenyl)benzene (0.70 g, 2.19 mmol), 
terephthaldehyde (1.18 g, 8.77 mmol), and zirconium (IV) chloride (0.03 mg 0.11 mmol) 
was dissolved in MeCN (80 mL), and stirred in air at RT overnight.  The solvent was 
removed from the resulting solution and the residue recrystallized from MeCN to produce 
a light yellow powder.  Yield: 0.78 g, 82 %.  MP: 142-144 °C.  IR (ATR) ν/cm-1 = 3249, 
3063, 3030, 2962, 2903, 2865, 2737, 1697, 1608, 1491, 1474, 1458, 1437, 1400, 1364, 
1304, 1258, 1208, 1169, 1151, 1087, 1014, 939, 919, 864, 793, 733, 698, 549, 501.  
HR-MS (ESI): calcd for [M+H]+, [C24H22BrN2O]+, m/z = 433.0916, found m/z = 
433.0927, error 2.5 ppm. 
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Table 5.5 - 1H NMR data of 4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-
benzimidazole in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 7.26 d  1 3Jcd = 7.8 
d 7.52 d  1 3Jdc = 7.8 
e 7.75 d 2 3Jef = 7.7 
f 7.55 d  2 3Jfe = 7.7 
g 1.39 s 9 - 
h - - - - 
i 8.29 d 2 3Jij = 8.1 
j 7.98 d 2 3Jji = 8.1 
k 10.06 s 1 - 
 
Table 5.6 - 1H NMR data of 4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-
benzimidazole in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 7.32 d  1 3Jcd = 8.0 
d 7.55 d  1 3Jdc = 8.0 
e 7.86 d 2 3Jef = 8.3 
f 7.60 d  2 3Jfe = 8.4 
g 1.41 s 9 - 
h - - - - 
i 8.37 d 2 3Jij = 8.4 
j 8.05 d 2 3Jji = 8.4 
k 10.09 s 1 - 
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Table 5.7 – 13C NMR data of 4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-
benzimidazole in CDCl3. 
Carbon δ (ppm) # Carbons 
4 112.61 1 
5 124.20 1 
6 126.94 1 
7 129.78 1 
8 134.53 1 
9 128.35 2 
10 126.30 2 
11 151.45 1 
12 34.92 1 
13 31.55 3 
14 134.43 1 
15 143.19 1 
16 150.41 1 
17 130.95 1 
18 127.73 2 
19 130.41 2 
20 137.54 1 
21 191.65 1 
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5.5.5 Synthesis of [Br(tBuPh)BzImPhC=O][BF4]  
(4-bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-benzimidazolium 
tetrafluoroborate) 
4-Bromo-7-(4-t-butylphenyl)-2-(4-benzaldehyde)-1H-benzimidazole (0.70 g, 1.60 
mmol) was dissolved in Et2O (min).  HBF4·Et2O (0.29 g, 1.76 mmol) was added 
dropwise, the resulting suspension stirred at RT for 10 min, filtered, washed with Et2O, 
and dried to produce an orange yellow powder.  Yield: 0.68 g, 81 %.  MP: 160-165 °C 
(decomp).  IR (ATR) ν/cm-1 = 3516, 3075, 2962, 2905, 2868, 2751, 1697, 1624, 1609, 
1572, 1497, 1474, 1438, 1388, 1364, 1306, 1290, 1261, 1210, 1173, 1153, 1014, 921, 
797, 763, 735, 694, 622, 561, 549, 517, 500.  HR-MS (ESI): calcd for [M+H]+, 
[C24H22BrN2O]+, m/z = 433.0916, found m/z = 433.0927, error 2.5 ppm. 
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Table 5.8 - 1H NMR data of [Br(tBuPh)BzImPhC=O][BF4] in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 7.41 d  1 3Jcd = 8.1 
d 7.70 d  1 3Jdc = 8.1 
e 7.67 d 2 3Jef = 8.6 
f 7.59 d  2 3Jfe = 8.6 
g 1.37 s 9 - 
h - - - - 
i 8.24 d 2 3Jij = 8.5 
j 8.08 d 2 3Jji = 8.5 
k 10.09 s 1 - 
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Table 5.9 – 13C NMR data of [Br(tBuPh)BzImPhC=O][BF4] in CD3CN. 
Carbon δ (ppm) # Carbons 
4 106.14 1 
5 127.18 1 
6 129.56 1 
7 134.64 1 
8 135.72 1 
9 129.78 2 
10 127.24 2 
11 152.98 1 
12 35.48 1 
13 31.65 3 
14 129.90 1 
15 133.96 1 
16 152.00 1 
17 130.90 1 
18 130.48 2 
19 130.99 2 
20 139.86 1 
21 193.12 1 
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5.5.6 Synthesis of (Br(tBuPh)BzIm)2Ph⊂DB24C8 
[Br(tBuPh)BzImPhC=O][BF4] (0.65 g, 1.24 mmol), and DB24C8 (1.70 g, 3.79 mmol) 
were suspended in CHCl3 (40 mL), and stirred until the solution became clear.  
1,2-diamino-3-bromo-6-(4-t-butylphenyl)-benzene (0.44 g, 1.37 mmol), and zirconium 
(IV) chloride (0.03 g, 0.12 mmo) were added, the solution stirred in air at RT overnight, 
filtered, and the solvent removed.  The residue was washed with Et2O (2 x 20 mL), 
dissolved in MeCN (min), Et3N (0.2 mL) added, and the resulting mixture heated to 
boiling and allowed to cool.  A tan powder was obtained after filtering, washing with 
MeCN and drying.  Yield: 0.60 g, 41 %.  MP: >300 °C.  IR (ATR) ν/cm-1 = 3355, 3064, 
3037, 2962, 2923, 2901, 2869, 2831, 1593, 1504, 1478, 1447, 1439, 1367, 1353, 1324, 
1305, 1276, 1250, 1215, 1123, 1045, 935, 918, 873, 853, 840, 803, 776, 755, 737, 710, 
604, 573, 548, 521.  HR-MS (ESI): calcd for [M+H]+, [C64H69Br2N4O8]+, m/z = 
1181.3462, found m/z = 1181.3529, error 5.7 ppm, calcd for [M+2H]2+, 
[C64H70Br2N4O8]2+, m/z = 591.1770, found m/z = 591.1733, error 6.3 ppm.  
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Table 5.10 - 1H NMR data of [(Br(tBuPh)BzIm)2Ph⊂DB24C8][BF4]2 in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
c 7.21 d  1 3Jcd = 8.1 
c 7.96 d 1 3Jcd = 8.2 
d 6.94 d 1 3Jdc = 8.1 
d 7.62 d  1 3Jdc = 8.2 
e 7.28 d 2 3Jef = 8.4 
e,f 7.70 overlapped m 4 - 
f 7.64 d 2 3Jfe = 8.4 
g 1.41 s 9 - 
g 1.42 s 9 - 
h,h 
12.61 
12.84 
13.10 
13.14  
4 s 4 - 
i 8.69 d 2 3Jii = 8.5 
i 8.40 d 2 3Jii = 8.5 
j 6.62 m 4 - 
k 6.45 m 4 - 
l 3.75 m 8 - 
m 3.82, 3.52 2 m 8 - 
n 3.62, 3.05 2 m 8 - 
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Table 5.11 – 13C NMR data of [(Br(tBuPh)BzIm)2Ph⊂DB24C8][BF4]2 in CD3CN. 
Carbon δ (ppm) # Carbons 
4 104.26 1 
4 105.44 1 
5 129.46 1 
5 131.47 1 
6 126.69 1 
6 129.62 1 
7 131.35 1 
7 132.78 1 
8 132.44 1 
8 129.77 1 
9 130.08 2 
9 127.53 2 
10 127.10 2 
10 129.63 2 
11 153.63 1 
11 153.72 1 
12 35.57 1 
12 35.58 1 
13 31.61 3 
13 31.63 3 
14 132.96 1 
14 129.79 1 
15 128.30 1 
15 132.86 1 
16 150.96 1 
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16 151.92 1 
17 125.89 1 
17 131.28 1 
18 132.83 2 
18 130.56 2 
19 121.97 4 
20 113.34 4 
21 148.28 4 
22 66.39 4 
23 69.00, 71.16 4 
24 70.91, 71.16 4 
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5.5.7 Synthesis of (Py(tBuPh)BzIm)2Ph⊂DB24C8 
(Br(tBuPh)BzIm)2Ph⊂DB24C8 (0.55 g, 0.47 mmol) was dissolved in dioxane (20 mL) 
and H2O (3 mL) under N2.  Potassium carbonate (0.64 g, 4.66 mmol), 4-pyridineboronic 
acid (0.17 g, 1.40 mmol), and PEPPSI-iPr catalyst (13 mg, 0.019 mmol) were added and 
the mixture heated to reflux overnight, cooled to RT, and HBF4·Et2O added until all 
solids dissolved.  The organic phase was separated and the water phase extracted with 
EtOAc (2 x 20 mL).  The combined organic phase was dried over MgSO4, filtered, and 
the solvent removed.  The residue was dissolved in MeCN (minimum) and Et3N (~ 1mL) 
added to precipitate the product.  The suspension was heated to boiling, cooled to RT, 
and filtered.  The solids were suspended in fresh MeCN, Et3N (1 mL) added, the 
suspension heated to boiling, cooled to RT and filtered, twice. After the 3rd filtration the 
resulting tan powder was air-dried.  Yield: 0.47 g, 85 %.  MP: >300 °C.  IR (ATR) ν/cm-
1 = 3340, 3064, 3036, 2960, 2923, 2901, 2869, 1594, 1502, 1475, 1445, 1420, 1366, 
1324, 1285, 1248, 1210, 1123, 1040, 1019, 930, 910, 873, 859, 846, 834, 807, 738, 717, 
694, 623, 603, 582, 555, 521, 510.  HR-MS (ESI): calcd for [M+H]+, [C74H77N6O8]+, m/z 
= 1177.5803, found m/z = 1177.5797, error 0.5 ppm, calcd for [M+2H]2+, 
[C74H78N6O8]2+, m/z = 589.2941, found m/z = 589.2986, error 7.6 ppm.  
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Table 5.12 - 1H NMR data of [(Py(tBuPh)BzIm)2Ph⊂DB24C8][BF4]4 in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.94 m 2 3Jab = 6.7 
a 8.87 m 2 3Jab = 6.5 
b 8.45 d 2 3Jbc = 6.7 
b 7.35 d 2 3Jbc = 6.5 
c 7.98 d  1 3Jcd = 7.9 
c 7.35 d 1 3Jcd = 8.0 
d 7.90 d  1 3Jdc = 7.9 
d 7.28 d 1 3Jdc = 8.0 
e 7.74 d  2 3Jef = 8.3 
e 7.67 d 2 3Jef = 8.5 
f 7.79 d 2 3Jfe = 8.3 
f 7.43 d 2 3Jfe = 8.5 
g 1.44 s 9 - 
g 1.43 s 9 - 
h 13.37, 13.22 br s 2 - 
h 13.29, 12.81 v. br s 2 - 
i 8.69 d 2 3Jii = 8.6 
i 8.49 d 2 3Jii = 8.6 
j 6.64 m 8 - 
k 6.29 m 8 - 
l 3.69 m 8 - 
m 3.43 m 8 - 
n 3.57, 2.89 2 m 8 3Jnn = 4.2 
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Table 5.13 – 13C NMR data of [(Py(tBuPh)BzIm)2Ph⊂DB24C8][BF4]4 in CD3CN. 
Carbon δ (ppm) # Carbons 
1 143.35 2 
1 143.08 2 
2 128.41 2 
2 128.37 2 
3 154.88 1 
3 154.35 1 
4 120.69 1 
4 122.78 1 
5 128.76 1 
5 129.74 1 
6 126.70 1 
6 128.87 1 
7 132.49 1 
7 132.79 1 
8 131.72 1 
8 132.20 1 
9 130.36 2 
9 127.59 2 
10 127.19 2 
10 129.88 2 
11 154.31 1 
11 154.19 1 
12,12 35.65 2 
An Unsymmetrical Benzimidazole [2]Rotaxane Ligand 
 
257 
13 31.58 3 
13 31.62 3 
14 132.63 1 
14 129.98 1 
15 129.06 1 
15 130.69 1 
16 152.36 1 
16 151.66 1 
17 130.84 1 
17 126.38 1 
18 133.04 2 
18 130.69 2 
19 122.28 4 
20 113.59 4 
21 148.21 4 
22 69.14 4 
23 66.41 4 
24 70.72, 70.89 4 
 
  
An Unsymmetrical Benzimidazole [2]Rotaxane Ligand 
 
258 
5.5.8 Synthesis of 4-(4-pyridine)-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole 
4-Bromo-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole (1.72 g, 5.28 mmol) was dissolved 
in dioxane (30 mL) and H2O (30 mL) under N2.  Potassium carbonate (3.65 g, 26.41 
mmol), 4-pyridineboronic acid (0.61 g, 4.96 mmol), and PEPPSI-IPr catalyst (72 mg, 
0.11 mmol) were added, mixture refluxed overnight, cooled to RT, and the solvent 
removed.  The residue was dissolved in CH2Cl2 (50 mL), and the resulting solution 
washed with H2O (2 x 20 mL) and sat. NaCl(aq) (10 mL) dried over MgSO4, filtered and 
the solvent removed.  The crude product was purified by flash column chromatography 
(SiO2, 1:1 CH2Cl2/EtOac v/v) to give a fluorescent yellow powder.  Yield: 1.67 g, 98%.  
MP: 132-133 °C.  IR (ATR) ν/cm-1 = 3029, 2960, 2924, 2865, 1595, 1551, 1542, 1497, 
1466, 1415, 1363, 1318, 1220, 1202, 1123, 1109, 1070, 1037, 1018, 993, 936, 890, 852, 
834, 817, 737, 622, 590, 581, 551, 526, 518.  HR-MS (ESI): calcd for [M+H]+, 
[C21H20N3S]+, m/z = 346.1378, found m/z = 346.1375, error 0.9 ppm. 
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Table 5.14 - 1H NMR data of 4-(4-pyridine)-7-(4-t-butylphenyl)-2,1,3-
benzthiadiazole in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.72 d 2 3Jab = 5.4 
b 7.88 overlapped d 2 - 
c 7.83 overlapped d  1 3Jcd = 7.4 
d 7.74 d  1 3Jdc = 7.4 
e 7.86 overlapped d  2 3Jfe = 8.3 
f 7.53 d 2 3Jef = 8.3 
g 1.35 s 9 - 
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Table 5.15 – 13C NMR data of 4-(4-pyridine)-7-(4-t-butylphenyl)-2,1,3-
benzthiadiazole in CDCl3. 
Carbon δ (ppm) # Carbons 
1 150.14 2 
2 123.53 2 
3 144.74 1 
4 129.77 1 
5 127.51 1 
6 128.87 1 
7 135.17 1 
8 134.09 1 
9 128.98 2 
10 125.73 2 
11 151.96 1 
12 34.76 1 
13 31.31 3 
14 154.20 1 
15 153.52 1 
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5.5.9 Synthesis of 1,2-diamino-3-(4-pyridine)-6-(4-t-butylphenyl)-benzene 
4-(4-Pyridine)-7-(4-t-butylphenyl)-2,1,3-benzthiadiazole (1.76 g, 4.82 mmol) was 
dissolved in EtOH (50 mL) and THF (7 mL).  Cobalt (II) chloride hexahydrate (0.0.12 g, 
0.48 mmol) and sodium borohydride (0.91 g, 24.11 mmol) were added, and the resulting 
mixture refluxed for 3 h, cooled to RT, and concentrated.  The residue was dissolved in 
CH2Cl2 (70 mL) and H2O (70 mL) and the layers separated.  The H2O layer was further 
extracted with CH2Cl2 (2 x 70 mL).  The combined organic layers were washed with sat. 
aq. NaCl (30 mL), dried over Na2SO4, filtered, and concentrated to give a brown solid 
(stored under N2 in dark).  Yield: 1.52 g, 99 %.  MP: 145-152 °C.  IR (ATR) ν/cm-1 = 
3418, 3363, 3286, 3213, 3069, 3029, 2961, 2903, 2866, 1626, 1593, 1553, 1534, 1479, 
1440, 1402, 1362, 1312, 1262, 1217, 1168, 1109, 1090, 1066, 1015, 992, 827, 795, 765, 
748, 735, 693, 633, 620, 601, 591, 567, 556, 497.  HR-MS (ESI): calcd for [M+H]+, 
[C21H24N3]+, m/z = 318.1970, found m/z = 318.1982, error 3.8 ppm. 
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Table 5.16 - 1H NMR data of 1,2-diamino-3-(4-pyridine)-6-(4-t-butylphenyl)-
benzene in CDCl3. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.70 d 2 3Jab = 6.0 
b 7.46 d 2 3Jba = 6.0 
c 6.83 d  1 3Jcd = 7.9 
d 6.78 d  1 3Jdc = 7.9 
e 7.42 d 2 3Jef = 8.4 
f 7.51 d  2 3Jfe = 8.4 
g 1.39 s 9 - 
h 3.66 broad s 4 - 
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Table 5.17 – 13C NMR data of 1,2-diamino-3-(4-pyridine)-6-(4-t-butylphenyl)-
benzene in CDCl3. 
Carbon δ (ppm) # Carbons 
1 150.30 2 
2 123.99 2 
3 147.85 1 
4 124.95 1 
5 120.37 1 
6 121.26 1 
7 129.59 1 
8 136.20 1 
9 128.69 2 
10 125.83 2 
11 150.36 1 
12 34.61 1 
13 31.35 3 
14 132.42 1 
15 132.18 1 
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5.5.10 Synthesis of (Py(tBuPh)BzIm)2Ph 
1,2-Diamino-3-(4-pyridine)-6-(4-t-butylphenyl)-benzene (0.70 g, 2.21 mmol), 
terepthaldehyde (0.13 g, 1.00 mmol), and zirconium (IV) chloride (23 mg 0.22 mmol) 
was dissolved in CHCl3 (250 mL), and stirred in air at RT for 24 h.  The solvent was 
removed from the resulting solution and the residue was dissolved in Et2O, the solution 
heated to boiling, cooled to RT, filtered, and air-dried, to produce a dark red crystalline 
solid.  Yield: 0.48 g, 66 %  MP: >300 °C.  IR (ATR) ν/cm-1 = 3065, 2957, 2901, 2862, 
1626, 1598, 1530, 1475, 1441, 1417, 1392, 1365, 1325, 1286, 1269, 1249, 1220, 1203, 
1156, 1084, 1065, 1017, 1002, 959, 840, 806, 785, 739, 704, 694, 623, 554, 515, 510.  
HR-MS (ESI): calcd for [M+H]+, [C50H45N6]+, m/z = 729.3706, found m/z = 729.3712, 
error 1.8 ppm, calcd for [M+2H]2+, [C50H46N6]2+, m/z = 365.1892, found m/z = 365.1848, 
error 12.0 ppm 
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Table 5.18 - 1H NMR data of [(Py(tBuPh)BzIm)2Ph][BF4]4 in CD3CN. 
Proton δ (ppm) Multiplicity # Protons J (Hz) 
a 8.89 d 4 3Jab = 6.6 
b 8.56 d 4 3Jba = 6.6 
c 7.96 d  2 3Jcd = 7.9 
d 7.83 d  2 3Jdc = 7.9 
e 7.76 d 4 3Jef = 8.5 
f 7.72 d  4 3Jfe = 8.5 
g 1.42 s 18 - 
h - - - - 
i 8.44 s 4 - 
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Table 5.19 – 13C NMR data of [(Py(tBuPh)BzIm)2Ph][BF4]4 in CD3CN. 
Carbon δ (ppm) # Carbons 
1 143.04 4 
2 128.05 4 
3 155.40 2 
4 122.74 2 
5 128.97 2 
6 128.05 2 
7 133.13 2 
8 133.00 2 
9 129.69 4 
10 127.62 4 
11 153.96 2 
12 35.60 2 
13 31.60 6 
14 128.99 2 
15 132.53 2 
16 152.11 2 
17 127.99 2 
18 131.18 4 
 
 
 
CHAPTER 6 
 
Future Directions 
 
This thesis details the design and synthesis of a series of Metal Organic Polygons 
(MOPs) and Metal Organic Rotaxane Polygons (MORPs) using cis-protected metal 
fragments in combination with [2]pseudorotaxane and [2]rotaxane ligands.  The 
combination of a flexible naked axle with a cis-protected metal fragment resulted in the 
self-assembly of dimeric square-shaped MOPs in all cases.  In Chapter 2 it was shown 
that the combination of the dimeric MOPs with the DB24C8 macrocyclic wheel resulted 
in the rearrangement of the MOPs into larger tetrameric square [5]MN and catenated 
[5]MN, with [2]pseudorotaxanes as ligands.   
Chapters 3 and 4 demonstrated that the use of interlocked [2]rotaxanes as ligands 
leads to the self-assembly of trimeric triangular [4]MN, tetrameric square [5]MN and 
catenated [5]MN.  In all three cases the presence or absence of the macrocyclic wheel 
controls the size and shape of the final assembly.  In Chapter 2 the absence or presence of 
pseudorotaxane formation controls the self-assembly process.  In Chapter 3 and 4 the 
presence or absence of the macrocyclic wheel controls the shape of the ligand, which in 
turn controls the size and shape of the product. 
Chapter 5 describes a rigid bent ligand in which the absence or presence of the 
macrocyclic wheel does not control the shape of the ligand or the expected product.  
Instead the macrocyclic wheel would change the nature/properties of the cavity of the 
self-assembled M2L4 cage. 
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 The work described in this thesis used either DB24C8 or 24C6 as the macrocyclic 
wheel component.  The systems described in Chapter 2 and 5 that utilize DB24C8 can be 
modified fairly easily by modifying the DB24C8 macrocyclic wheel.  The aromatic rings 
of the DB24C8 crown ether can be substituted with a variety of functional groups.  This 
would allow the modification of the cavities of the assemblies without changing the basic 
skeleton. 
 The two [2]rotaxane ligands utilized in Chapters 3 and 4 can be modified by 
substituting B24C6 for the 24C6 macrocyclic wheel.  The aromatic ring could then be 
modified similar to DB24C8 with various functional groups.  The use of a bulkier crown 
ether would be expected to favor the formation of square [5]MN over triangular [4]MN, 
or catenated [5]MN, by decreasing the size of the cavity.  Modification of the appropriate 
crown ether macrocyclic wheel would provide for a facile method to modify the 
properties and/or size of the cavity of the MORPs. 
 The MORPs described in this work employ either pyridine or pyrazole moieties 
to coordinate to the cis-protected metal fragments.  The other main coordinating group 
commonly incorporated into MOPs is the carboxylate group, which could be 
incorporated into the design from Chapters 3 and 4 as illustrated in Figure 6.1.  This 
[2]rotaxane design is even more compact than the pyrazole-containing design. 
 
Figure 6.1 – Design of [2]rotaxane incorporating carboxylate groups. 
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 The eventual goal of this work would be the design of a system in which ligand 
consists of a [2]rotaxane shuttle, which when combined with cis-protected metal 
fragments would allow for control of the size and shape of the self-assembled product, as 
well as the  rearrangement of the assembly by an external stimulus. 
 
References 
 
270 
REFERENCES 
 
1. Lehn, J.-M. Supramolecular Chemistry: Concepts and Perspectives; Wiley-VCH: 
Wienheim, 1995. 
2. Lehn, J.-M. Supramolecular Chemistry. Science 1993, 260 (1551), 1762-1763. 
3. The Nobel Prize in Chemistry 1987. 
http://www.nobelprize.org/nobel_prizes/chemistry/laureates/1987/ (accessed Nov 25, 
2013). 
4. Pedersen, C. J. The Discovery of Crown Ethers (Noble Lecture). Angewandte 
Chemie International Edition 1988, 27, 1021-1027. 
5. Pedersen, C. J. Cyclic polyethers and their complexes with metal salts. Journal of 
the American Chemical Society 1967, 59, 2495-2496, 7017-7036. 
6. Lehn, J.-M. Supramolecular Chemistry - Scope and Perspectives, Molecules, 
Supermolecules and Molecular Devices (Nobel Lecture). Angewandte Chemie 
International Edition 1988, 27, 89-112. 
7. Dietrich, B.; Lehn, J.-M.; Sauvage, J.-P. Diaza-polyoxa-macrocycles et 
macrobicycles. Tetrahedron Letters 1969, 10, 2885-2888. 
8. Dietrich, B.; Lehn, J.-M.; Sauvage, J.-P. Les Cryptates. Tetrahedron Letters 1969, 
10, 2889-2892. 
9. Cram, D. J. The Design of Molecular Hosts, Guests, and Their Complexes (Nobel 
Lecture). Angewandte Chemie International Edition 1988, 27, 1009-1112. 
10. Cram, D. J.; Kaneda, T.; Hlegeson, R. C.; Lein, G. M. Spherands - ligands whose 
binding of cations relieves enforced electron-electron repulsions. Journal of the American 
Chemical Society 1979, 101, 6752-6754. 
11. Trueblood, K. N.; Knobler, C. B.; Maverick, E.; Helgeson, R. C.; Brown, S. B.; 
Cram, D. J. Spherands, the first ligand systems fully organized during synthesis rather 
than during complexation. Journal of the American Chemical Society 1981, 103, 5594-
5596. 
12. Solomons, T. W. G.; Fryhle, C. B. Organic Chemistry, 8th ed.; Wiley, 2004. 
13. Varshey, D. B.; Sander, J. R. G.; T., F.; MacGillivray, L. R. Supramolecular 
Interactions. In Supramolecular Chemistry: From Molecules to Nanomaterials; Gale, P. 
A., Steed, J. W., Eds.; John Wiley & Sons: Chichester, 2012; Vol. 1: Concepts, pp 9-24. 
14. Steed, J. W.; Atwood, J. L. Supramolecular Chemistry, 2nd ed.; Wiley: Chichester, 
2009. 
References 
 
271 
15. Whitesides, G. M.; Mathias, J. P.; Seto, C. T. Molecular self-assembly and 
nanochemistry: a chemical strategy for the synthesis of nanostructures. Science 1991, 
254, 1312-1319. 
16. Sato, S.; Murase, T.; Fujita, M. Self-Assembly of Coordination Cages and Spheres. 
In Supramolecular Chemistry: From Molecules to Nanomaterials; Gale, P. A., Steed, J. 
W., Eds.; John Wiley & Sons: Chichester, 2012; Vol. 5: Self-Assembly and 
Supramolecular Devices, pp 2071-2084. 
17. Cook, T. R.; Zheng, Y.-R.; Stang, P. J. Metal−Organic Frameworks and Self-
Assembled Supramolecular, Coordination Complexes: Comparing and Contrasting the 
Design, Synthesis, and Functionality of Metal−Organic Materials. Chemical Reviews 
2013, 113, 734-777. 
18. Stein, G. C.; Van Koten, G.; Vrieze, K.; Brevard, C.; Spek, A. L. Structural 
Investigations of Silver(I) and Copper(I) Complexes with Neutral N4 Donor Ligands: X-
Ray Crystal and Molecular Structure of the Dimer [Ag{µ-(R,S)-1,2-(py-2-
CH=N)2Cy}2](O3SCF3)2 and 1H, 13C, and INEPT 109Ag and 15N NMR Solution Studies. 
Journal of the American Chemical Society 1984, 106, 4486-4492. 
19.(a) Maverick, A. W.; Klavetter, F. E. Cofacial Binuclear Copper Complexes of a 
Bis(ß-ketone) Ligand. Inorganic Chemistry 1984, 23, 4129-4130.   
19.(b) Maverick, A. W.; Buckongham, S. C.; Yao, Q.; Bradbury, J. R.; G., S. 
Intramolecular Coordination of Bidentate Lewis Bases to a Cofacial Binuclear Copper(II) 
Complex. Journal of the American Chemical Society 1986, 108, 7430-7431 
20. Fujita, M.; Yazaki, J.; Ogura, K. Preparation of a macrocyclic polynuclear complex, 
[(en)Pd(4,4'-bpy)]4(NO3)8 (en = ethylenediamine, bpy = bipyridine), which recognizes an 
organic molecule in aqueous media. Journal of the American Chemical Society 1990, 
112, 5645-5647. 
21. Stang, P. J.; Cao, D. H. Transition Metal Based Cationic Molecular Boxes. Self-
Assembly of Macrocyclic Platinum(II) and Palladium(II) Tetranuclear Complexes. 
Journal of the American Chemical Society 1994, 116, 4981-4982. 
22. Stang, P. J.; Cao, D. H.; Saito, S.; Arif, A. M. Self-Assembly of Cationic, 
Tetranuclear, Pt(II) and Pd(II) Macrocyclic Squares. X-ray Crystal Structure of 
[Pt2+(dppp)(4,4'-bipyridyl)2-OSO2CF3]4. Journal of the American Chemical Society 1995, 
117, 6273-6283. 
23. Olenyuk, B.; Whiteford, J. A.; Stang, P. J. Design and Study of Synthetic Chiral 
Nanoscopic Assemblies. Preparation and Characterization of Optically Active Hybrid, 
Iodonium−Transition-Metal and All-Transition-Metal Macrocyclic Molecular Squares. 
Journal of the American Chemical Society 1996, 118, 8221-8230. 
24. Stang, P. J.; Cao, D. H.; Chen, K.; Gray, G. M.; Muddiman, D. C.; Smith, R. D. 
Molecular Architecture via Coordination:  Marriage of Crown Ethers and Calixarenes 
References 
 
272 
with Molecular Squares, Unique Tetranuclear Metallamacrocycles from Metallacrown 
Ether and Metallacalixarene Complexes via Self-Assembly. Journal of the American 
Chemical Society 1997, 119, 5163-5168. 
25. Stang, P. J.; Olenyuk, B.; Fan, J.; Arif, A. M. Combining Ferrocenes and Molecular 
Squares:  Self-Assembly of Heterobimetallic Macrocyclic Squares Incorporating Mixed 
Transition Metal Systems and a Main Group Element. Single-Crystal X-ray Structure of 
[Pt(dppf)(H2O)2][OTf]2. Organometallics 1996, 15, 904-908. 
26. Stang, P. J.; Fan, J.; Olenyuk, B. Molecular architecture via coordination: self-
assembly of cyclic cationic porphyrin aggregates via transition-metal bisphosphane 
auxiliaries. Chemical Communications 1997, 1453-1454. 
27. Fan, J.; Whiteford, J. A.; Olenyuk, B.; Levin, M. D. S. P. J.; Fleischer, E. B. Self-
Assembly of Porphyrin Arrays via Coordination to Transition Metal Bisphosphine 
Complexes and the Unique Spectral Properties of the Product Metallacyclic Ensembles. 
Journal of the American Chemical Society 1999, 121, 2741-2752. 
28. Würthner, F.; Sautter, A. Highly fluorescent and electroactive molecular squares 
containing perylene bisimide ligands. Chemical Communications 2000, 445-446. 
29. You, C.-C.; Hippius, C.; Grüne, M.; Würthner, F. Light-Harvesting 
Metallosupramolecular Squares Composed of Perylene Bisimide Walls and Fluorescent 
Antenna Dyes. Chemistry: A European Journal 2006, 12, 7510-7519. 
30. Ferrer, M.; Rodríguez, L.; Rossell, O. Study of the self-assembly reactions between 
the organic linker 1,4-bis(4-pyridyl)butadiyne and the metal-containing corners 
(diphosphine)M(II) (M=Pd, Pt; diphosphine=dppp, dppf, depe, dppbz). Journal of 
Organometallic Chemistry 2003, 681, 158-166. 
31. Ferrer, M.; Gutiérrez, A.; Mounir, M.; Rossoll, O.; Ruiz, E.; Rang, A.; Engeser, M. 
Self-Assembly Reactions between the Cis-Protected Metal Corners (N−N)MII (N−N = 
Ethylenediamine, 4,4‘-Substituted 2,2‘-Bipyridine; M = Pd, Pt) and the Fluorinated Edge 
1,4-Bis(4-pyridyl)tetrafluorobenzene. Inorganic Chemistry 2007, 46, 3395-3406. 
32. Rang, A.; Nieger, M.; Engeser, M.; Lützen, A.; Schalley. Self-assembling squares 
with amino acid-decorated bipyridines: heterochiral self-sorting of dynamically 
interconverting diastereomers. Chemical Communications 2008, 4789-4791. 
33. Rang, A.; Engeser, M.; Maier, N. M.; Nieger, M.; Lindner, W.; Schalley, C. S. 
Synthesis of Axially Chiral 4,4′-Bipyridines and Their Remarkably Selective Self-
Assembly into Chiral Metallo-Supramolecular Squares. Chemistry: A European Journal 
2008, 14, 3855-3859. 
34. Fyles, T. M.; Tong, C. C. Long-lived and highly conducting ion channels formed by 
lipophilic ethylenediamine palladium(II) complexes. New Journal of Chemistry 2007, 31, 
655-661. 
References 
 
273 
35. Fujita, M.; Sasaki, O.; Mitsuhashi; Fujita, T.; Yazaki, J.; Yamaguchi, K.; Ogura, K. 
On the structure of transition-metal-linked molecular squares. Chemical Communications 
1996, 1535-1536. 
36. Qin, Z.; Jennings, M. C.; Puddephatt, R. J. Stacked molecular triangles: self-
assembly using coordination chemistry and hydrogen bonding. Chemical 
Communications 2001, 2676-2677. 
37. Weilandt, T.; Troff, R. W.; Saxell, H.; Rissanen, K.; Schalley, C. A. Metallo-
Supramolecular Self-Assembly: the Case of Triangle-Square Equilibria. Inorganic 
Chemistry 2008, 47, 7588-7598. 
38. Fujita, M.; Nagao, S.; Iida, M.; Ogata, K.; Ogura, K. Palladium(II)-Directed 
Assembly of Macrocyclic Dinuclear Complexes Composed of (en)Pd2+ and Bis(4-
pyridyl)-Substituted Bidentate Ligands. Remarkable Ability for Molecular Recognition 
of Electron-Rich Aromatic Guests. Journal of the American Chemical Society 1993, 115, 
1574-1576. 
39. Fujita, M.; Ibukuro, F.; Hagihara, H.; Ogura, K. Quantitative self-assembly of a 
[2]catenane from two preformed molecular rings. Nature 1994, 367, 720-723. 
40. Debata, N. B.; Tripathy, D.; Chand, D. K. Self-assembled coordination complexes 
from various palladium(II) components and bidentate or polydentate ligands. 
Coordination Chemistry Reviews 2012, 256, 1831-1945. 
41. Stang, P. J.; Chen, K.; Arif, A. M. Modular Assembly of Hybrid Iodonium-
Transition Metal Cationic Tetranuclear Macrocyclic Squares. Single Crystal Molecular 
Structure of {[(Et3P)2Pd(OTf)2][(NC5H4C6H4)2I(OTf)]}2. Journal of the American 
Chemical Society 1995, 117, 8793-8797. 
42. Stang, P. J.; Chen, K. Hybrid, Iodonium-Transition Metal, Cationic Tetranuclear 
Macrocyclic Squares. Journal of the American Chemical Society 1995, 117, 1667-1668. 
43. Kim, H.-J.; Lim, C. W.; Hong, J.-I. Aromatic anion recognition by a self-assembled 
receptor in water. Materials Science & Engineering C 2001, 18, 265-269. 
44. Jeong, K. S.; Kim, S. Y.; Shin, U.-S.; Kogej, M.; Hai, N. T. M.; P., B.; Jeong, N.; 
Kirchner, B.; Reiher, M.; Schalley, C. A. Synthesis of Chiral Self-Assembling Rhombs 
and Their Characterization in Solution, in the Gas Phase, and at the Liquid−Solid 
Interface. Journal of the American Chemical Society 2005, 127, 17672-17685. 
45. Ghosh, S.; Chakrabarty, R.; Mukherjee, P. S. Coordination driven self-assembly of 
four new molecular boats using a ﬂexible imidazole-containing donor linker. Dalton 
Transactions 2008, 1850-1856. 
46. Tsuge, A.; Matsubara, A.; Moriguchi, T.; Sei, Y.; Yamaguchi, K. Self-assembled 
coordination cage derived from small-sized pyridinophane. Tetrahedron Letters 2006, 47, 
6607-6609. 
References 
 
274 
47. Yao, L.-Y.; Qin, L.; Xie, T.-Z.; Li, Y.-Z.; Yu, S.-Y. Synthesis and Anion Sensing of 
Water-Soluble Metallomacrocycles. Inorganic Chemistry 2011, 50, 6055-6062. 
48. Xiao, X.-Q.; Jia, A.-Q.; Lin, Y.-J.; Jin, G.-X. Self-Assembly of Palladium-Based 
Macrocycles with N-Heterocyclic Carbene as the “Corner” Ligand. Organometallics 
2010, 29, 4842-4848. 
49. Chatterjee, B.; Noveron, J. C.; Resendiz, M. J. E.; Liu, J.; Yamamoto, T.; Parker, 
D.; Cinke, M.; Nguyen, C. V.; Arif, A. M.; Stang, P. J. Self-Assembly of Flexible 
Supramolecular Metallacyclic Ensembles: Structures and Adsorption Properties of Their 
Nanoporous Crystalline Frameworks. Journal of the Chemical Society 2004, 126, 10645-
10656. 
50. Hori, A.; Akasaka, A.; Biradha, K.; Sakamoto, S.; Yamaguchi, K.; Fujita, M. 
Chirality Induction through the Reversible Catenation of Coordination Rings. 
Angewandte Chemie International Edition 2002, 41, 3269-3272. 
51. Chang, S.-Y.; Jang, H.-Y.; Jeaong, K.-S. Quantitative Comparison of Kinetic 
Stabilities of Metallomacrocycle-Based Rotaxanes. Chemistry: A European Journal 
2003, 9, 1535-1541. 
52. Fujita, M.; Nagao, S.; Ogura, K. Guest-Induced Organization of a Three-
Dimensional Palladium(I1) Cagelike Complex. A Prototype for "Induced-Fit" Molecular 
Recognition. Journal of the American Chemical Society 1995, 117, 1649-1650. 
53. Fujita, M.; Oguro, D.; Miyazawa, M.; Oka, H.; Yamaguchi, K.; Ogura, K. Self-
assembly of ten molecules into nanometer-sized organic host frameworks. Nature 1995, 
378, 469-471. 
54. Ikeda, A.; Ayabe, M.; Shinkai, S.; Sakamoto, S.; Yamaguchi, K. A Self-Assembled 
Porphyrin-Based Dimeric Capsule Constructed by a Pd(II)-Pyridine Interaction Which 
Shows Efficient Guest Inclusion. Organic Letters 2000, 2, 3707-3710. 
55. Fujita, N.; Biradha, K.; Fujita, M.; Sakamoto, S.; Yamaguchi, K. A Porphyrin 
Prism: Structural Switching Triggered by Guest Inclusion. Angewandte Chemie 
International Edition 2001, 40, 1718-1721. 
56. Yamanoi, Y.; Sakamoto, Y.; Kosukawa, T.; Fujita, M.; Sakamoto, S.; Yamaguchi, 
K. Dynamic Assembly of Coordination Boxes from (en)Pd(II) Unit and a Rectangular 
Panel-Like Ligand: NMR, CSI-MS, and X-ray Studies. Journal of the American 
Chemical Society 2001, 123, 980-981. 
57. Takeda, N.; Umemoto, K.; Yamaguchi, K.; Fujita, M. A nanometre-sized 
hexahedral coordination capsule assembled from 24 components. Nature 1999, 398, 794-
796. 
References 
 
275 
58. Kumazawa, K.; Yamanoi, Y.; Yoshizawa, M.; Kusukawa, T.; Fujita, M. A 
Palladium(II)-Clipped Aromatic Sandwich. Angewandte Chemie International Edition 
2004, 43, 5936-5940. 
59. Suzuki, K.; Tominaga, M.; Kawano, M.; Fujita, M. Self-assembly of an M6L12 
coordination cube. Chemical Communications 2009, 1638-1640. 
60. Tominaga, M.; Suzuki, K.; Kawano, M.; Kusukawa, T.; Ozeki, T.; Sakamoto, S.; 
Yamaguchi, K.; Fujita, M. Finite, Spherical Coordination Networks that Self-Organize 
from 36 Small Components. Angewandte Chemie International Edition 2004, 43, 5621-
5625. 
61. Dun, Q.-F.; Iwasa, J.; Ogawa, D.; Ishido, Y.; Dato, S.; Ozeki, T.; Sei, Y.; 
Yamaguchi, K.; Fujita, M. Self-Assembled M24L48 Polyhedra and Their Sharp Structural 
Switch upon Subtle Ligand Variation. Science 2010, 328, 1144-1147. 
62. Bunzen, J.; Iwasa, J.; Bonakdarzadeh, P.; Numata, E.; Rissanen, K.; Sato, S. F. M. 
Self-Assembly of M24L48 Polyhedra Based on Empirical Prediction. Angewandte Chemie 
International Edition 2012, 51, 3161-3163. 
63. Tominaga, M.; Suzuki, K.; Murase, T.; Fujita, M. 24-Fold Endohedral 
Functionalization of a Self-Assembled M12L24 Coordination Nanoball. Journal of the 
American Chemical Society 2005, 127, 11950-11951. 
64. Sato, S.; Iida, J.; Suzuki, K.; Kawano, M.; Ozeki, T.; Fujita, M. Fluorous 
Nanodroplets Structurally Confined in an Organopalladium Sphere. Science 2006, 313, 
1273-1276. 
65. Murase, T.; Sato, A.; Fujita, N. Nanometer-Sized Shell Molecules That Confine 
Endohedral Polymerizing Units. Angewandte Chemie International Edition 2007, 46, 
1083-1085. 
66. Kamiya, N.; Tominaga, M.; Sato, S.; Fujita, M. Saccharide-Coated M12L24 
Molecular Spheres That Form Aggregates by Multi-interaction with Proteins. Journal of 
the American Chemical Society 2007, 129, 3816-3817. 
67. Suzuki, K.; Sato, S.; Fujita, M. Template synthesis of precisely monodisperse silica 
nanoparticles within self-assembled organometallic spheres. Nature Chemistry 2010, 2, 
25-29. 
68. Sun, Q.-F.; Sato, S.; Fujita, M. Self-assembled Inverse Dendrimer. Chemistry 
Letters 2011, 40, 726-727. 
69. Sun, Q.-F.; Murase, T.; Sato, S.; Fujita, M. A Sphere-in-Sphere Complex by 
Orthogonal Self-Assembly. Angewandte Chemie International Edition 2011, 50, 10318-
10321. 
References 
 
276 
70. Sun, Q.-F.; Sato, S.; Fujita, M. An M18L24 stellated cuboctahedron through post-
stellation of an M12L24 core. Nature Chemistry 2012, 4, 330-333. 
71. Fujita, D.; Suzuki, K.; Sato, S.; Yagi-Utsumi, M.; Yamaguchi, Y.; Mizuno, N.; 
Kumasaka, T. T. M.; Noda, M.; Uchiyama, S.; Kato, K.; Fujita, M. Protein encapsulation 
within synthetic molecular hosts. Nature Communications 2012, 3, 1093. 
72. Ichijo, T.; Sato, S.; Fujita, M. Size-, Mass-, and Density-Controlled Preparation of 
TiO2 Nanoparticles in a Spherical Coordination Template. Journal of the American 
Chemical Society 2013, 135, 6786-6789. 
73. Harris, K.; Fujita, D.; Fujita, M. Giant hollow MnL2n spherical complexes: structure, 
functionalisation and applications. Chemical Communications 2013, 49, 6703-6712. 
74. Harris, K.; Sun, Q.-F.; Sato, S.; Fujita, M. M12L24 Spheres with Endo and Exo 
Coordination Sites: Scaffolds for Non-Covalent Functionalization. Journal of the 
Chemical Society 2013, 135, 12497-12499. 
75. Ma, X.; Tian, H. Rotaxanes - Self-Assembled Links. In Supramolecular Chemistry: 
From Molecules to Nanomaterials; Gale, P. A., Steed, J. W., Eds.; John Wiley & Sons: 
Chichester, 2012; Vol. 5: Self-Assembly and Supramolecular Devices, pp 2311-2329. 
76. Gatti, F. G.; Leigh, D. A.; Nepogodiev, S. A.; Slawin, A. M. Z.; Teat, S. J.; Wong, J. 
K. Y. Stiff, and Sticky in the Right Places:  The Dramatic Influence of Preorganizing 
Guest Binding Sites on the Hydrogen Bond-Directed Assembly of Rotaxanes. Journal of 
the American Chemical Society 2001, 123, 5983-5989. 
77. Park, J. S.; Wilson, J. N.; Hardcastle, K. I.; Bunz, U. H. F.; Srinivasarao, M. 
Reduced Fluorescence Quenching of Cyclodextrin−Acetylene Dye Rotaxanes. Journal of 
the American Chemical Society 2006, 128, 7714-7715. 
78. Anelli, P. L.; Spencer, N.; Stoddart, J. F. A molecular shuttle. Journal of the 
American Chemical Society 1991, 113, 5131-5133. 
79. Coskun, A.; Friedman, D. C.; Li, H.; Patel, K.; Khatib, H. A.; Stoddart, J. F. A 
Light-Gated STOP−GO Molecular Shuttle. Journal of the American Chemical Society 
2009, 131, 2493-2495. 
80. Champin, B.; Mobian, P.; Sauvage, J.-P. Transition metal complexes as molecular 
machine prototypes. Chemical Society Reviews 2007, 36, 358-366. 
81. Poleschak, I.; Kern, J.-M.; Sauvage, J.-P. A copper-complexed rotaxane in motion: 
pirouetting of the ring on the millisecond timescale. Chemical Communications 2004, 
474-476. 
82. Evans, N. H.; Beer, P. D. Self-Assembled Links: Catenanes. In Supramolecular 
Chemistry: From Molecules to Nanomaterials; Gale, P. A., Steed, J. W., Eds.; John 
References 
 
277 
Wiley & Sons: Chichester, 2012; Vol. 5: Self-Assembly and Supramolecular Devices, pp 
2225-2243. 
83. Bitsch, F.; Dietrich-Buchecker, C. O.; Khémiss, A-K.; Sauvage J-P.; Van 
Dorsselaer, A. Multiring interlocked systems: structure elucidation by electrospray mass 
spectrometry. Journal of the American Chemical Society 1991, 113, 4023-4025. 
84. Amabilino, D. B.; Ashton, P. R.; Balzani, V.; Boyd, S. E.; Credi, A.; Lee, J. Y.; 
Menzer, S.; Stoddart, J. F.; Venturi, M.; Williams, D. J. Oligocatenanes made to order. 
Journal of the American Chemical Society 1998, 120, 4295-4307. 
85. Beer, P.; Gale, P.; Smith, D. Supramolecular Chemistry; Oxford Chemistry Primers: 
England, 1998. 
86. Whang, D.; Park, K. -M.; Heo, J.; Ashton, P.; Kim, K. Molecular Necklace: 
Quantitative self-assembly of a cyclic oligorotaxane from nine molecules. Journal of the 
American Chemical Society 1998, 120, 4899-4900. 
87. Park, K. -M.; Heo, J.; Roh, S. -G.; Jeon, Y. -M.; Whang, D.; Kim, K. Self-assembly 
of interlocked structures: rotaxanes, polyrotaxanes and molecular necklaces. Molecular 
Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and 
Liquid Crystals 1999, 327, 65-70. 
88. Heo, J.; Kim, S. -Y.; Roh, S. -Y.; Park, K. -M.; Park, G. -J.; Whang, D.; Kim, K. 
Self-assembly of interlocked structures and open framework materials using coordination 
bonds. Molecular Crystals and Liquid Crystals Science and Technology, Section A: 
Molecular Crystals and Liquid Crystals 2000, 342, 29-38. 
89. Park, K. -M.; Kim, S. -Y.; Heo, J.; Whang, D.; Sakamoto, S.; Yamaguchi, K.; Kim, 
K. Designed self-assembly of molecular necklaces. Journal of the American Chemical 
Society 2002, 124, 2140-2146. 
90. Kim, K. Mechanically interlocked molecules incorporating cucubituril and their 
supramolecular assemblies. Chemical Society Reviews 2002, 31, 96-107. 
91. Roh, S. -G.; Park, K.; Park, G. -J.; Sakamoto, S.; Yamaguchi, K.; Kim, K. Synthesis 
of a five-membered molecular necklace: a 2+2 approach. Agewandte Chemie 
International Edition 1999, 38 (5), 637-641. 
92. Ko, Y. H.; Kim, K.; Kang, J. -K.; Chun, H.; Lee, J. W.; Sakamoto, S.; Yamaguchi, 
K.; Fettinger, J. C.; Kim, K. Designed self-assembly of molecular necklaces using host-
stabilized charge-transfer interactions. Journal of the American Chemical Society 2004, 
126, 1932-1933. 
93. Ko, Y. H.; Kim, E.; Hwang, I.; Kim, K. Supramolecular assemblies built with host-
stabalized charge-transfer interactions. Chemical Communications 2007, 1305-1315. 
References 
 
278 
94. Chas, M.; Platas-Iglesias, C.; Peinador, C.; Quintela, J. M. New self-assembled 
dinuiclear Pd(II) and Pt(II) metallomacrocycles of a 4,4'bipyridin-1-ium ligand with an 
inner cavity. Tetrahedron Letters 2006, 47, 3119-3122. 
95. Chas, M.; Pía, E.; Toba, R.; Peinador, C.; Quintela, J. M. New hybrid [2]catenanes 
based on a 4,4'bipyridinium ligand. Inorganic Chemistry 2006, 45 (16), 6117-6119. 
96. Blanco, V.; Chas, M.; Abella, D.; Peinador, C.; Quintela, J. M. Molecular 
Catenation via Metal-Directed Self-Assembly and π-Donor/π-Acceptor Interactions:  
Efficient One-Pot Synthesis, Characterization, and Crystal Structures of [3]Catenanes 
Based on Pd or Pt Dinuclear Metallocycles. Journal of the American Chemical Society 
2007, 129, 13978-13986. 
97. Chas, M.; Abella, D.; Blanco, V.; E., P.; Blanco, G.; Fernández, A.; Platas-Iglesias, 
C.; Peinador, C.; Quintela, J. M. Synthesis of New Self-assembled PdII and PtII 
Rectangular Metallomacrocycles: A Comparative Study of their Inclusion Complexes. 
Chemistry - A European Journal 2007, 13, 8572-8582. 
98. Blanco, V.; Chas, M.; Abella, D.; Pía, E.; Platas-Iglesias, C.; Peinador, C.; Quintela, 
J. M. Self-assembly of 1:2 inclusion complexes between a metallocyclic host and a 
dihydroxyaromatic guests: a redox controlled complexation complexation process. 
Organic Letters 2008, 10, 409-412. 
99. Abella, D.; Blanco, V.; E., P.; Chas, M.; Platas-Iglesias, C.; Peinador, C.; Quintela, 
J. M. Stereoselective self-assembly of atropoisometric Pd(II) metallocycles induced by 
aromatic guest. Chemical Communications 2008, 2879-2881. 
100. Blanco, V.; Abella, D.; Pía, E.; Platas-Iglesias, C.; Peinador, C.; Quintela, J. M. 
Regioselective catenation of dinuclear palladium and platinum metallocycles promoted 
by π-π interactions. Inorganic Chemistry 2009, 48, 4098-4107. 
101. Blanco, V.; Gutiérres, A.; Platas-Iglesias, C.; Peinador, C.; Quintela, J. M. 
Expanding the cavity size: preparation of 2:1 inclusion complexes based on dinuclear 
square metallocycles. Journal of Organic Chemistry 2009, 74, 6577-6583. 
102. Peinador, C.; Pía, E.; Blanco, V.; García, M. D.; Quintela, J. M. Complexation of 
pyrene in aqueous solution with a self-assembled palladium metallocycle. Organic 
Letters 2010, 12, 1380-1383. 
103. Chas, M.; Blanco, V.; Peinador, C.; Quintela, J. M. Synthesis of [3]catenanes based 
on metal-directed self-assembly and π-donor/π-acceptor interactions. Organic Letters 
2007, 9, 675-678. 
104. Peinador, C.; Blanco, V.; Quintela, J. M. A new doubly interlocked [2]catenane. 
Journal of the American Chemical Society 2009, 131, 920-921. 
105. Celentano, G.; Benincori, T.; Radaelli, S.; Sada, M.; Sannicolo, F. Effects of the 
Electronic Properties of Chiral Chelating Diphosphines in Stereoselective Diels-Alder 
References 
 
279 
Cycloaddition Reactions promoted by their transition metal complexes. Journal of 
Organometallic Chemistry 2002, 643-644, 424-430. 
106. Ašanin, D. P.; Rajković, S.; Molnar-Gabor, D.; Djuran, M. I. Hydrolysis of the 
Peptide Bond in N-Acetylated L-Methionylglycine Catalyzed by Various Palladium(II) 
Complexes: Dependence of the Hydrolytic Reactions on the Nature of the Chelate Ligand 
in cis-[Pd](L)(H2O)2]2+ Complexes. Monatshefte für Chemie 2004, 135, 1445-1453. 
107. Loeb, S. J.; Tiburcio, J.; Vella, S. J.; Wisner, J. A. A versatile template for the 
formation of [2]pseudorotaxanes. 1,2-Bis(pyridinium)ethane axles and 24-crown-8 ether 
wheels. Organic & Biomolecular Chemistry 2006, 4, 667-680. 
108. Lehn, J. -M. Supramolecular Chemistry: Concepts and Perspectives; VCH: 
Wienheim, 1995. 
109. Price, W. S. Pulsed field gradient nuclear magnetic resonance as a tool for studying 
translational diffusion: part 1. basic theory. Concepts in Magnetic Resonance 1997, 9, 
299-336. 
110. Cohen, Y.; L., A.; Frish, L. Diffusion NMR spectroscopy in supramolecular and 
combinatorial chemistry: an old parameter - new insights. Angewandte Chemie 
International Edition 2005, 44, 520-554. 
111. Otto, W. H.; Keefe, M. H.; Splan, K. E.; Hupp, J. T.; Larive, C. K. Analysis of 
molecular square size and purity via pulsed-field gradient NMR spectroscopy. Inorganic 
Chemistry 2002, 41, 6172-6174. 
112. Nilsson, M. The DOSY Toolbox: A new tool for processing PFG NMR diffusion 
data. Journal of Magnetic Resonance 2009, 200, 296-302. 
113. Raymo, F. M.; Stoddart, J. F. Molecular Catenanes, Rotaxanes and Knots; Wiley-
VCH: Weinheim, 1999. 
114. Ashton, P. R.; Campbell, P. J.; Chrystal, E. J. T.; Glinke, P. T.; Menzer, S.; Philp, 
D.; Spencer, N.; Stoddart, J. F.; Tasker, P. A.; Williams, D. J. Dialkylammonium 
ion/crown ether complexescomplexes: the forerunners of a new family of interlocked 
molecules. Angewandte Chemie, International Edition in English 1995, 34, 1865-1869. 
115. Ashton, P. R.; Chrystal, E. J. T.; Glink, P. T.; Menzer, S.; Schiavo, C.; Spencer, N.; 
Stoddart, J. F.; Tasker, P. A.; White, A. J. P.; Williams, D. J. Molecular meccano. 6 
Pseudorotaxanes formed between secondary dialkylammonium salts and crown ethers. 
Chemistry - A European Journal 1996, 2, 709-728. 
116. Glink, P. T.; Schiavo, C.; Stoddart, J. F.; Williams, D. J. The genisis of a new range 
of molecules. Chemical Communications 1996, 1483-1490. 
117. Cantrill, S. J.; Pease, A. R.; Stoddart, J. F. A molecular meccano kit. Dalton 2000, 
3715-3734. 
References 
 
280 
118. Elizarov, A. M.; Chiu, S.-H.; Stoddart, J. F. An Acid-Base Switchable [2]Rotaxane. 
Journal of Organic Chemistry 2002, 67, 9175-9181. 
119. Loeb, S. J.; Tiburcio, J.; Vella, S. J. [2]Pseudorotaxane Formation from N-
Benzylanilinium Axles and 24-Crown-8 Ether Wheels. Organic Letters 2005, 7, 4923-
4926. 
120. Vella, S. J.; Tiburcio, J.; Loeb, S. J. Optically sensed, molecular shuttles driven by 
acid-base chemistry. Chemical Communications 2007, 4752-4754. 
121. Vukotic, V. N.; Harris, K. J.; Zhu, K.; Schurko, R. W.; Loeb, S. J. Metal-Organic 
Frameworks with Dynamic Interlocked Components. Nature Chemistry 2012, 4, 456-
460. 
122. Zysman-Colman, E.; Arias, K.; Siegel, J. S. Synthesis of arylbromides from arenes 
and N-bromosuccinimide (NBS) in acetonitrile — A convenient method for aromatic 
bromination. Canadian Journal of Chemistry 2009, 87, 440-447. 
123. Yu, S.-Y.; Huang, H.-P.; Li, S.-H.; Jiao, Q.; Lu, Y.-Z.; Wu, B.; Sei, Y.; Yamaguchi, 
K.; Pan, Y.-J.; and Ma, H. W. Solution Self-Assembly, Spontaneous Deprotonation, and 
Crystal Structures of Bipyrazolate-Bridged Metallomacrocycles with Dimetal Centers. 
Inorganic Chemistry 2005, 44, 9471-9488. 
124. Yu, S.-H.; Jiao, Q.; Li, S.-H.; Huang, H. P.; Li, Y.-Z.; Pan, Y.-J.; Sei, Y.; 
Yamguchi, K. Self-Assembly of Tripyrazolate-Linked Macrotricyclic M12L4 Cages with 
Dimetallic Clips. Organic Letters 2007, 9 (7), 1379-1382. 
125. Sun, Q.-F.; Wong, K. M.-C.; Liu, L.-X.; Huang, H.-P.; Yu, S.-Y.; Yam, V. W.-W.; 
Li, Y.-Z.; Pan, Y.-J.; Yu, K.-C. Self-Assembly, Structures, and Photophysical Properties 
of 4,4'Bipyrazolate-Linked Metallo-Macrocycles with Dimetal Clips. Inorganic 
Chemistry 2008, 47, 2142-2154. 
126. Ning, G.-H.; Yao, L.-Y.; Liu, L.-X.; Xie, T.-Z.; Li, Y.-Z.; Qin, Y.; Pan, Y.-J.; Yu, 
S.-Y. Self-Assembly and Host-Guest Interaction of Metallomacrocycles Using 
Fluorescenct Dipyrazole Linker with Dimetallic Clips. Inorganic Chemistry 2010, 49, 
7783-7792. 
127. Jiang, X.-F.; Hu, J.-H.; Tong, J.; Yu, S.-H. Coexistence of molecular Pd6 triangle 
and Pd8 square self-assembled from napthyl-dipyrazole with dipalladium motifs. 
Inorganic Chemistry Communications 2013, 36, 232-235. 
128. Qin, L.; Yao, L.-Y.; Yu, S.-Y. Self-Assembly of [M8L4] and [M4L2] Fluorescent 
Metallomacrocycles with Carbazole-Based Dipyrazole Ligands. Inorganic Chemistry 
2012, 51, 2443-2453. 
129. Yao, L.-Y.; Yu, Z.-S.; Qin, L.; Li, Y.-Z.; Qin, Y.; Yu, S.-Y. Self-assembly of 
metallomacrocycles with dipyrazole ligands and anion sensing of [Pd4Fe2] macrocycle 
with ferrocene-based dipyrazole ligand. Dalton Transactions 2013, 42, 3447-3454. 
References 
 
281 
130. Tong, J.; Yu, S.-Y.; Li, H. Programmable self-assembly of homo- or hetero-
metallomacrocycles using 4-(1H-pyrazolyl-4-yl)pyridine. Chemical Communications 
2012, 48, 5343-5345. 
131. Yu, S.-Y.; Fujita, M.; Yamaguchi, K. A dimer-to-dimer metal-metal linear 
aggregate from a (μ-1,3-NO3)2 double-bridged cis-(2,2′-bipyridine)palladium(II) cofacial 
dimer. Journal of the Chemical Society, Dalton Transactions 2001, 3412-3416. 
132. Zhu, K.; Vukotic, V. N.; Loeb, S. J. Molecular Shuttling of a Copact and Rigid, H-
Shaped [2]Rotaxane. Angewandte Chemie International Edition 2012, 51, 2168-2172. 
133. Noujeim, N.; Zhu, K.; Vukotic, N. V.; Loeb, S. J. [2]Pseudorotaxanes from T-
Shaped Benzimidazolium Axles and [24]Crown-8 Wheels. Organic Letters 2012, 14, 
2484-2487. 
134. Zhu, K.; Vukotic, V. N.; Noujeim, N.; Loeb, S. J. Bis(benzimidazolium) axles and 
crown ether wheels: a versatile templating pair for the formation of [2]rotaxane molecular 
shuttles. Chemical Science 2012, 3, 3265-3271. 
135. McMorran, D. A.; Steel, P. J. The First Coordinatively Saturated, Quadruply 
Stranded Helicate and Its Encapsulation of a Hexafluorophosphate Anion. Angewandte 
Chemie International Edition 1998, 37, 3295-3297. 
136. Chand, D. K.; Biradha, K.; Fujita, M. Self-assembly of a novel macrotricyclic Pd(II) 
metallocage encapsulating a nitrate ion. Chemical Communications 2001, 1652-1653. 
137. Yue, N.; Qin, Z.; Jennings, M. C.; Eisler, D. J.; Puddephatt, R. J. Host complexes 
that adapt to their guests: amphitopic receptors. Inorganic Chemistry Communications 
2003, 6, 1269-1271. 
138. Yue, N. L. S.; Eisler, N. J.; Jennings, M. J.; Puddephatt, R. J. Macrocyclic and 
Lantern Complexes of Palladium(II) with Bis(amidopyridine) Ligands: Synthesis, 
Structure, and Host-Guest Chemistry. Inorganic Chemistry 2004, 43, 7671-7681. 
139. Yue, N. L. S.; Eisler, D. J.; Jennings, M. J.; Puddephatt, R. J. A lantern complex of 
palladium(II) as a host for anion inclusion. Inorganic Chemistry Communications 2005, 
8, 31-33. 
140. Fukuda, M. F.; Sekiya, R.; Kuroda, R. A Quadruply Stranded Metallohelicate and 
Its Spontaneous Dimerization into an Interlocked Metallohelicate. Angewandte Chemie 
International Edition 2008, 47, 706-710. 
141. Sekiya, R.; Kuroda, R. Pd2+···O3SR- interaction encourages anion encapsulation of a 
quadruply-stranded Pd complex to achieve chirality or high solubility. Chemical 
Communications 2011, 47, 12346-12348. 
References 
 
282 
142. Clever, G. H.; Tashiro, S.; Shionoya, M. Inclusion of Anionic Guests inside a 
Molecular Cage with Palladium(II) Centers as Electrostatic Anchors. Angewandte 
Chemie International Edition 2009, 48, 7010-7012. 
143. Clever, G. H.; Tashiro, S.; Shionoya, M. Light-Triggered Crystallization of a 
Molecular Host-Guest Complex. Journal of the American Chemical Society 2010, 132, 
9973-9975. 
144. Han, M.; Hey, J.; Kawamura, W.; Stalke, D.; Shionoya, M.; Clever, G. H. An 
Inclusion Complex of Hexamolybdate inside a Supramolecular Cage and Its Structural 
Conversion. Inorganic Chemistry 2012, 51, 9574-9576. 
145. Clever, G. H.; Shionoya, M. A pH Switchable Pseudorotaxane Based on a Metal 
Cage and a Bis-anionic Thread. Chemistry a European Journal 2010, 16, 11792-11796. 
146. Clever, G. H.; Kawamura, W.; Shionoya, M. Encapsulation versus Aggregation of 
Metal-Organic Cages Controlled by Guest Size Variation. Inorganic Chemistry 2011, 50, 
4689-4691. 
147. Clever, G. H.; Kawamura, W.; Tashiro, S.; Shiro, M.; Shionoya, M. Stacked 
Platinum Complexes of the Magnus Salt Type Inside a Coordination Cage. Angewandte 
Chemie International Edition 2012, 51, 2606-2609. 
148. Johnstone, M. D.; Frank, M.; Clever, G. H.; Pfeffer, F. M. Rapid Solvent-Free 
Synthesis of Pyridyl-Functionalised [5]Polynorbornane-Based Ligands for Metal–
Organic Rings and Cages. European Journal of Organic Chemistry 2013, 5848-5853. 
149. Liao, P.; Langloss, B. W.; Johnson, A. M.; Knudsen, E. R.; Tham, F. S.; Julian, R. 
R.; Hooley, R. J. Two-component control of guest binding in a self-assembled cage 
molecule. Chemical Communications 2010, 46, 4932-4932. 
150. Johnson, A. M.; Hooley, R. J. Steric Effects Control Self-Sorting in Self-Assembled 
Clusters. Inorganic Chemistry 2011, 50, 4671-4673. 
151. Johnson, A. M.; Moshe, O.; Gamboa, A. S.; Langloss, B. W. L. K. F. K.; Larive, C. 
K.; Hooley, R. J. Synthesis and Properties of Meta-Ligand Complexes with Endohedral 
Amine Functionality. Inorganic Chemistry 2011, 50, 9430-9442. 
152. Lewis, J. E. M.; Gavey, E. L.; Cameron, S. A.; Crowley, J. D. Stimuli-responsive 
Pd2L4 metallosupramolecular cages: towards targeted cisplatin drug delivery. Chemical 
Science 2012, 3, 778-784. 
153. Crowley, J. D.; Gavey, E. L. Use of di-1,4-substituted-1,2,3-triazole “click” ligands 
to self-assemble dipalladium(II) coordinatively saturated, quadruply stranded helicate 
cages. Dalton Transactions 2010, 39, 4035-4037. 
References 
 
283 
154. Scott, S. Ø.; Gavey, E. L.; Lind, S. J.; Gordon, K. C.; Crowley, J. D. Self-assembled 
palladium(II) “click” cages: synthesis, structural modification and stability. Dalton 
Transactions 2011, 40, 12117-12124. 
155. Sahoo, H. S.; Chand, D. K. Conformation of N,N'-bis(3-pyridylformyl)piperazine 
and spontaneous formation of a saturated quadruple stranded metallohelicate. Dalton 
Transactions 2010, 39, 7223-7225. 
156. Kishi, N.; Li, Z.; Yoza, K.; Akita, M.; Yoshizawa, M. An M2L4 Molecular Capsule 
with an Anthracene Shell: Encapsulation of Large Guests up to 1 nm. Journal of the 
American Chemical Society 2011, 133, 11438-11441. 
157. Freye, S.; Hey, J.; Torras-Galán, A.; Stalke, D.; Herbst-Irmer, R.; John, M.; Clever, 
G. H. Allosteric Binding of Halide Anions by a New Dimeric Interpenetrated 
Coordination Cage. Angewandte Chemie International Edition 2012, 51, 2191-2194. 
158. Freye, S.; Engelhard, D. M.; John, M.; Clever, G. H. Counterion Dynamics in an 
Interpenetrated Coordination Cage Capable of Dissolving AgCl. Chemistry a European 
Journal 2013, 19, 2114-2121. 
159. Freye, S.; Michel, R.; Stalke, D.; Pawliczek, M.; Frauendorf, H.; Clever, G. H. 
Template Control over Dimerization and Guest Selectivity of Interpenetrated 
Coordination Cages. Journal of the American Chemical Society 2013, 135, 8476-8479. 
160. Frank, M.; Hey, J.; Balcioglu, I.; Chen, Y.-S.; Stralke, D.; Suenobu, T.; Fikizumi, 
S.; Frauendorf, H.; Clever, G. H. Assembly and Stepwise Oxidation of Interpenetrated 
Coordination Cages Based on Phenothiazine. Angewandte Chemie International Edition 
2013, 52, 10102-10106. 
161. Han, M.; Michel, R.; He, B.; Chen, Y.-S.; Stalke, D.; John, M.; Clever, G. H. Light-
Triggered Guest Uptake and Release by a Photochromic Coordination Cage. Angewandte 
Chemie International Edition 2013, 52, 1319-1323. 
162. Gütz, C.; Hovorka, R.; Schnakenburg, G.; A., L. Homochiral Supramolecular M2L4 
Cages by High-Fidelity Self-Sorting of Chiral Ligands. Chemistry a European Journal 
2013, 19, 10890-10894. 
163. DaSilveira Neto, B. A.; Lopes, A. S. A.; Ebeling, G.; Gonçalves, R. S.; Costa, V. E. 
U.; Quina, F. H.; Dupont, J. Photophysical and electrochemical properties of π-extended 
molecular 2,1,3-benzothiadiazoles. Tetrahedron 2005, 61, 10975-10982. 
164. Sheldrick, G. M. SHELXTL 5.03 Program Library, Brüker Analytical Instrument 
Division, Madison, Wisconsin, USA. (section 2.5.15). 
165. Putz, H.; Brandenburg, K. DIAMOND 3.2i – Crystal and Molecular Structure 
Visualization Crystal Impact, GbR, Kreuzherrenstra. 102, 53227 Bonn, Germany, 
http://www.crystalimpact.com/diamond, 2012. 
References 
 
284 
166. Persistence of Vision Raytracer (POV-Ray) 3.6.2, Persistence of Vision Pty, Ltd., 
Williamstown, Victoria, Australia, http://www.povray.org/, 2004. 
Appendix 
 
285 
APPENDIX 
General Experimental Details for Single Crystal X-Ray Diffraction Studies 
 Crystals were frozen in paratone oil inside a cryoloop. Reflection data was 
integrated from frame data obtained from hemisphere scans on a Brüker APEX 
diffractometer with a CCD detector. Decay was monitored by 50 standard data frames 
measured at the beginning and end of data collection. Diffraction data and unit-cell 
parameters were consistent with assigned space groups. Lorentzian polarization 
corrections and empirical absorption corrections, based on redundant data at varying 
effective azimuthal angles, were applied to the data series. The structures were solved by 
direct methods, completed by subsequent Fourier syntheses and refined using full-matrix 
least-squares methods against |F2| data. All non-hydrogen atoms were refined 
anisotropically. Hydrogen atoms were treated as idealized contributions. Scattering 
factors and anomalous dispersion coefficients are contained in the SHELXTL program 
library.164 Ball-and-stick and space-filling models were generated using the program 
DIAMOND165 and POV-Ray.166  
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Table A.1 – Crystal Data Collection, Solution and Structure Refinement Parameters 
for Single-Crystal Structure Determinations of Chapter 2 MOPs. 
Compound 
[Pt2(BPE)2(dppp)2][OTf]8 
·(NaOTf)2(CH3NO2)8(H2O)1/2 
[Pd2(BPE)2(en)2][OTf]8 
·(CH3NO2)5(H2O)2 
Formula C116H117F30N16Na2O46.5P4Pt2S10 C61H75F24N17O36Pd2S8 
Formula Weight 3929.90 2547.66 
Crystal System monoclinic triclinic 
Space Group P2(1)/n (10) P-1 (2) 
T (K) 446(2) 173(2) 
a (Å) 13.4007(14) 12.6399(12) 
b (Å) 29.068(3) 14.8237(14) 
c (Å) 41.813(4) 15.5566(15) 
α () - 72.9040(10) 
β () 92.2080(10) 70.4560(10) 
γ () - 68.9510(10) 
V (Å3) 16276(3) 2513.0(4) 
Z 4 1 
ρ, g cm-3 1.604 1.683 
μ, mm-1 2.005 0.655 
Reflections 28603 8819 
Variables/Restraints 2144/667 684/530 
R1 [I > σ2(I)]a 0.0731 0.0737 
R1 (all data) 0.1067 0.0771 
R2w [I > 2σ(I)]b 0.1837 0.1989 
R2w (all data) 0.2025 0.2033 
GoF on F2 1.083 1.017 
a R1 = ∑ ||Fo| - |Fc|| / ∑ |Fo|; b R2w = [∑[w(Fo2 - Fc2)2] / ∑[w(Fo2)2]]1/2 , where w = q[σ2(Fo2) + (aP)2 + bP]-1  
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Table A.2 – Crystal Data Collection, Solution and Structure Refinement Parameters 
for Single-Crystal Structure Determinations of Chapter 3 Ligand and MOP. 
Compound 
Py(Me)2PhN- 
CPh(Me)2Py⊂24C6 
[Pt2(Py(Me)2PhN-CPh(Me)2Py)2 
(dppp)2]1/2[OTf]1·(CH2Cl2)3/2 
Formula C45H63N3O6 C57H53Cl3F3N3O3P2PtS 
Formula Weight 741.98 1280.46 
Crystal System triclinic monoclinic 
Space Group P-1 (2) C2 (5) 
T (K) 173(2) 173(2) 
a (Å) 10.4495(17) 35.658(7) 
b (Å) 12.662(2) 10.912(2) 
c (Å) 17.918(3) 19.351(4) 
α () 84.349(2) - 
β () 79.418(2) 122.87 
γ () 65.712(2) - 
V (Å3) 2123.5(6) 6324(2) 
Z 2 4 
ρ, g cm-3 1.160 1.345 
μ, mm-1 0.076 2.478 
Reflections 7432 6612 
Variables/Restraints 482/0 252/76 
R1 [I > σ2(I)]a 0.1035 0.1234 
R1 (all data) 0.1687 0.1599 
R2w [I > 2σ(I)]b 0.2795 0.2929 
R2w (all data) 0.3262 0.3139 
GoF on F2 1.069 1.103 
a R1 = ∑ ||Fo| - |Fc|| / ∑ |Fo|; b R2w = [∑[w(Fo2 - Fc2)2] / ∑[w(Fo2)2]]1/2 , where w = q[σ2(Fo2) + (aP)2 + bP]-1  
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Table A.3 – Crystal Data Collection, Solution and Structure Refinement Parameters 
for Single-Crystal Structure Determinations of Chapter 3 MORP and Chapter 4 
Ligand. 
Compound 
[Pt3(Py(Me)2PhN-CPh(Me)2Py 
⊂24C6)3(dppp)3]1/3[OTf]2·(CH2Cl2)8 
Pyr(Me)2PhN-
CPh(Me)2Pyr⊂24C6 
·(CH3OH)(H2O) 
Formula C81H103Cl14F6N3O12PtS2 C41H65N5O8 
Formula Weight 2242.11 755.98 
Crystal System triclinic monoclinic 
Space Group P-1 (2) P21/c (14) 
T (K) 150(2) 173(2) 
a (Å) 30.265(4) 18.884(3) 
b (Å) 34.308(4) 16.232(2) 
c (Å) 37.320(5) 15.080(2) 
α () 106.903(2) - 
β () 101.913(2) 111.5462(18) 
γ () 109.644(2) - 
V (Å3) 32870(7) 4299.4(11) 
Z 12 4 
ρ, g cm-3 1.359 1.1068 
μ, mm-1 1.750 0.081 
Reflections 94305 7565 
Variables/Restraints 5041/8246 487/0 
R1 [I > σ2(I)]a 0.1097 0.1284 
R1 (all data) 0.2292 0.1661 
R2w [I > 2σ(I)]b 0.2615 0.3391 
R2w (all data) 0.3058 0.3770 
GoF on F2 0.856 0.997 
a R1 = ∑ ||Fo| - |Fc|| / ∑ |Fo|; b R2w = [∑[w(Fo2 - Fc2)2] / ∑[w(Fo2)2]]1/2 , where w = q[σ2(Fo2) + (aP)2 + bP]-1  
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